Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296281-62299075	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix: 52.7;endometrium 1: 15.7;epididymis: 44.1;fallopian tube: 54.2"	"Cell type enriched"	"Detected in some"	6	"Endometrial ciliated cells: 3089.4"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"	NA	NA									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	52.7	0.0	0.0	0.0	15.7	44.1	0.0	54.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	3089.4	111.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	457.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0
SCGB1D1	"LIPA, LPHA, MGC71958"	ENSG00000168515	"Secretoglobin family 1D member 1"	O95968	11	62190216-62193539	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"endometrial cancer: 23.3;ovarian cancer: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 6.0"														"Secreted in other tissues"	NA	NA									"unprognostic (6.95e-3)"						"unprognostic (9.01e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
DKK4		ENSG00000104371	"Dickkopf WNT signaling pathway inhibitor 4"	Q9UBT3	8	42374063-42377229	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;esophagus: 5.0"	"Group enriched"	"Detected in some"	5	"Basal prostatic cells: 5.2;Early spermatids: 2.1;Pancreatic endocrine cells: 4.4;Prostatic glandular cells: 3.7;Spermatocytes: 2.2;Urothelial cells: 5.3"	"Cancer enriched"	"Detected in many"	20	"endometrial cancer: 174.4"	"Region enhanced"	"Detected in some"		"cerebellum: 3.4;midbrain: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052916	Uncertain				"Secreted in other tissues"	NA	NA					"HPA052916: AB_2681987"	"unprognostic (1.64e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.73e-2)"		"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"		"unprognostic (8.11e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.8	3.4	0.1	0.5	0.0	0.0	2.4	0.0	0.7	5.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	3.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.8	1.4	0.5	0.3	0.0	0.0	0.4	1.1	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.1	0.7	3.2	0.0	0.9	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.3	5.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.1	0.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	5.3
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735396-100829944	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 29.8;kidney: 85.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.3;pons and medulla: 3.4"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.0	0.0	1.7	0.0	1.2	0.0	0.0	2.1	0.6	2.9	0.2	0.0	0.0	1.8	29.8	0.0	8.5	0.0	0.0	0.4	2.9	85.9	0.1	0.0	0.0	6.1	0.6	0.1	0.2	0.4	5.9	0.8	0.0	3.2	0.2	0.0	1.2	0.0	11.6	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.4	1.4	0.1	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	2.1	0.6	0.4	2.9	6.1	0.6	0.1	3.2	4.7	1.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	5.9	0.0	0.0	145.3	0.0	0.0	0.0	0.0	49.0	0.0	9.4	129.5	14.8	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	246.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.5	0.0	0.0	0.6	1.1	1.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0
PKHD1L1		ENSG00000205038	"PKHD1 like 1"	Q86WI1	8	109362461-109537207	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"thyroid gland: 69.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.4;Endometrial ciliated cells: 47.0;Endothelial cells: 14.0;Glandular and luminal cells: 49.9;Plasma cells: 28.2"	"Group enriched"	"Detected in some"	18	"endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HHSteC: 1.4;TIME: 1.6;U-266/70: 3.9"	"Not detected"	"Not detected"							HPA044458	Uncertain					NA	NA		13000000			"HPA044458: AB_2678949"	"unprognostic (9.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.76e-6)"	"unprognostic (4.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.73e-2)"	12.8	2.7	0.2	0.5	0.1	0.4	2.6	0.1	0.3	13.9	1.4	2.4	1.1	6.0	0.3	1.7	14.2	0.4	5.3	0.1	0.4	1.9	0.6	7.0	1.2	0.2	0.1	0.1	2.6	0.5	0.0	0.8	0.0	0.1	0.7	1.6	0.0	0.7	0.2	0.2	1.7	4.3	0.4	0.2	0.5	1.6	0.5	0.1	0.1	69.4	0.6	1.1	1.2	1.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.4	0.2	0.1	0.1	0.1	0.2	0.1	0.4	1.3	0.0	2.8	0.7	24.4	0.3	0.0	0.0	0.6	0.0	0.1	0.0	1.9	1.5	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	47.0	3.4	14.0	1.8	0.4	0.2	0.0	0.1	6.6	1.1	49.9	1.3	0.0	10.4	0.6	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.5	0.6	0.3	1.8	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	28.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.1	0.0
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859665-4863936	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 47.8;choroid plexus: 78.9"	"Group enriched"	"Detected in many"	6	"Adipocytes: 118.4;Endometrial ciliated cells: 364.0;Glandular and luminal cells: 462.0"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 47.9;EFO-21: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	18.2	6.0	10.5	0.7	9.5	0.2	12.9	10.2	17.0	47.8	78.9	1.5	0.5	17.7	0.3	0.9	9.6	1.3	7.2	16.3	15.6	2.0	0.5	4.3	0.6	15.1	10.6	8.8	3.5	2.3	0.4	21.3	4.1	11.3	5.6	0.1	0.6	8.9	3.6	20.3	5.1	1.1	3.2	13.4	4.5	2.0	0.7	11.8	0.2	9.2	2.0	0.4	11.3	14.6	10.8	2.5	1.5	0.5	2.8	8.0	5.1	8.9	6.1	2.8	3.5	1.7	47.9	15.3	0.3	21.4	4.4	17.0	0.1	10.6	0.0	1.2	2.0	12.2	0.1	8.0	17.4	0.6	0.1	1.4	1.0	0.8	2.6	0.9	1.1	0.8	4.1	7.9	0.3	1.9	1.2	1.3	2.4	0.2	0.7	11.1	6.4	6.4	0.6	0.2	1.5	0.4	0.3	5.4	0.3	4.0	0.8	0.9	2.1	2.0	4.1	9.1	13.0	9.9	1.0	0.9	5.7	2.6	3.1	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	10.5	9.5	10.2	17.0	16.3	15.6	15.1	10.6	8.8	11.3	13.4	11.8	10.8	118.4	0.0	0.0	17.3	0.5	7.1	2.4	0.3	4.6	0.8	8.6	24.3	5.5	0.0	0.0	0.0	4.2	0.3	1.6	3.9	0.0	0.2	0.4	364.0	35.7	48.1	0.0	0.0	1.1	0.9	0.1	34.8	1.1	462.0	0.0	1.1	5.7	0.2	0.5	0.0	1.2	2.5	0.0	0.6	8.8	0.0	1.2	4.4	16.0	3.7	0.0	0.7	0.0	1.0	0.3	0.3	0.1	0.4	1.6	3.3	0.6	0.5	0.0	0.7	0.0	13.6	18.2	0.8	1.5	2.6	4.7	0.3	4.8	14.6	2.6	2.0
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542445-117549546	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 79.6;epididymis: 105.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1"	"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favorable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	6.3	0.1	22.0	0.2	20.8	0.2	2.8	15.8	31.6	50.0	15.8	0.4	0.1	79.6	105.2	0.4	53.4	1.5	0.5	26.0	18.1	39.5	0.1	0.1	0.6	15.7	16.4	19.9	12.0	0.0	0.1	1.8	0.4	17.6	1.1	0.1	0.3	2.4	53.1	10.9	8.8	0.1	45.3	13.2	0.2	0.1	1.2	17.3	0.1	0.3	5.3	0.4	4.8	4.5	21.8	0.0	0.0	0.0	2.6	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	25.4	31.6	0.0	0.1	0.6	0.0	0.0	0.1	2.8	0.8	0.1	0.2	0.0	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.2	31.1	9.4	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	2.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	22.0	20.8	15.8	31.6	26.0	18.1	15.7	16.4	19.9	17.6	13.2	17.3	21.8	4.6	0.0	0.0	43.4	1.0	10.7	2.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	239.1	0.0	0.2	0.0	0.1	90.1	0.0	1.4	75.6	126.5	3.1	0.0	0.0	0.1	0.0	0.3	18.0	0.0	68.6	0.0	88.3	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	8.0	2.6	60.3	2.5	21.4	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	41.0	0.0	2.5	0.1	185.0	0.0	0.1	52.6	8.6	32.1	0.3	0.3	0.0	7.5	0.1	2.2	2.2	0.3	1.7
IGLJ3		ENSG00000211678	"Immunoglobulin lambda joining 3"		22	22904850-22905025	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"intestine: 557.2;lymphoid tissue: 229.5;salivary gland: 150.5;stomach 1: 466.5;urinary bladder: 149.1"	"Group enriched"	"Detected in some"	44	"B-cells: 4.5;Plasma cells: 4.3"	"Group enriched"	"Detected in some"	13	"colorectal cancer: 5.1;endometrial cancer: 10.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Group enriched"	"Detected in many"	24	"memory B-cell: 1223.9;naive B-cell: 1139.6"	"Lineage enriched"	"Detected in many"	25	"B-cells: 1223.9"	"Group enriched"	"Detected in some"	7	"Daudi: 53.6;REH: 69.6;U-266/70: 42.8;U-266/84: 22.5"															NA	NA								"unprognostic (1.19e-1)"	"unprognostic (2.06e-3)"				"unprognostic (2.05e-1)"						"unprognostic (1.37e-1)"	"unprognostic (5.00e-1)"			5.7	29.7	0.4	214.4	0.2	37.8	32.8	0.1	1.5	9.8	0.3	131.4	557.2	3.2	0.0	40.3	4.0	33.0	3.1	0.1	0.1	3.0	9.9	42.1	133.2	0.4	0.2	0.0	31.4	1.9	0.0	0.0	0.1	0.1	9.7	72.1	0.0	150.5	1.6	0.0	1.5	207.6	6.2	0.0	209.4	466.5	6.1	0.2	23.5	0.8	0.0	229.5	149.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	69.6	2.5	6.7	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	1.0	42.8	22.5	4.3	0.0	0.0	0.0	0.8	1.6	0.7	0.9	0.3	4.3	1223.9	0.8	0.5	1.3	1139.6	0.4	0.5	8.5	0.6	1.2	49.2	0.8	193.9	0.4	0.2	0.1	1.5	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1N1	"OR1-26, OR1N3"	ENSG00000171505	"Olfactory receptor family 1 subfamily N member 1"	Q8NGS0	9	122526358-122527296	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"endometrial cancer: 0.8;ovarian cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA															"unprognostic (3.63e-2)"								0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414319-111427735	"Plasma proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	134	"fallopian tube: 2089.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0"	"Region enhanced"	"Detected in many"		"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Supported	Vesicles,Microtubules	"Secreted in female reproductive system"	NA	NA			Vesicles	Microtubules	"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	3.4	1.6	7.7	1.1	8.2	1.9	3.6	8.5	10.9	3.8	6.4	3.3	1.1	15.5	5.2	3.0	2089.3	1.1	2.2	8.2	7.8	4.9	8.1	3.9	2.2	8.0	7.5	8.2	6.8	1.5	6.9	2.4	2.0	8.1	5.6	2.2	4.3	4.3	1.5	2.6	7.0	5.3	1.5	6.9	4.6	2.8	9.3	7.2	1.2	2.4	1.0	2.1	4.7	3.8	8.7	0.4	0.4	0.9	0.5	1.8	2.0	1.7	0.2	1.4	0.3	0.7	0.6	0.0	0.8	1.7	0.6	0.0	0.5	0.3	0.3	0.5	2.0	4.9	0.3	0.8	2.4	0.6	0.9	2.2	1.8	2.9	0.0	1.0	1.4	0.4	3.2	0.3	1.5	0.1	0.5	0.6	1.2	0.2	6.4	1.7	0.6	0.2	0.7	1.4	3.7	0.6	0.6	0.1	5.0	0.7	2.4	0.3	0.8	0.8	0.1	0.2	2.5	0.7	1.8	0.5	0.4	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.2	8.5	10.9	8.2	7.8	8.0	7.5	8.2	8.1	6.9	7.2	8.7	1.2	0.0	1.1	3.3	0.6	3.1	1.1	0.3	0.0	2.1	1.7	1.9	0.6	0.0	0.5	0.0	0.0	5.6	0.2	1.1	1.9	0.2	4.0	9.7	0.7	1.6	0.0	0.0	10.4	0.0	2.6	0.6	0.0	12.0	0.0	1.0	1.4	2.9	0.6	0.0	8.5	1.5	2.0	0.6	1.4	6.1	1.5	0.5	0.0	3.7	0.0	0.4	0.0	1.5	2.4	0.2	0.5	1.9	0.1	1.6	0.6	2.8	1.3	0.6	0.0	0.7	1.1	3.8	0.7	1.0	3.1	17.4	0.8	0.2	1.6	1.6
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101129813	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 64.4;endometrium 1: 104.4;fallopian tube: 34.6;smooth muscle: 79.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.0;Endometrial ciliated cells: 90.1;Endometrial stromal cells: 177.1;Glandular and luminal cells: 76.3;Late spermatids: 40.9"	"Group enriched"	"Detected in some"	13	"breast cancer: 10.1;endometrial cancer: 11.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	338	"T-47d: 170.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced					NA	NA					"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"	"unprognostic (2.59e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.23e-3)"	"prognostic favorable (5.76e-8)"	"unprognostic (2.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.44e-3)"	1.1	1.7	2.0	0.3	1.1	0.0	7.0	1.0	1.0	64.4	1.0	1.8	0.5	104.4	0.8	0.7	34.6	0.9	3.7	0.8	6.4	1.1	0.3	1.4	0.2	1.6	1.5	0.5	16.4	0.6	0.3	1.1	1.8	1.6	3.7	0.7	0.1	3.9	9.1	0.6	0.4	0.7	79.0	1.7	1.8	0.6	3.5	6.2	0.2	1.3	1.8	0.2	1.7	10.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	170.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	1.0	1.0	0.8	6.4	1.6	1.5	0.5	1.6	1.7	6.2	1.3	1.3	3.2	0.0	0.3	0.7	0.1	1.1	0.0	0.0	1.3	35.9	19.8	18.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	64.0	90.1	177.1	3.5	0.0	0.0	0.1	0.0	0.1	12.5	0.0	76.3	0.0	34.7	2.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	40.9	14.6	1.9	0.0	22.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	10.5	0.0	0.3	0.0	0.0	0.0	0.2	6.6	1.4	14.9	3.9	2.3	0.0	0.6	0.0	2.3	15.1	0.0	1.0
TGM7	TGMZ	ENSG00000159495	"Transglutaminase 7"	Q96PF1	15	43276271-43302255	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 62.0;Late spermatids: 16.7"	"Cancer enriched"	"Detected in single"	13	"endometrial cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	35	"EFO-21: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (2.45e-2)"		"unprognostic (2.04e-1)"		"unprognostic (2.82e-2)"				"unprognostic (1.71e-2)"		"unprognostic (1.07e-1)"			"unprognostic (2.01e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170744-116174974	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.9;lung: 8.9;smooth muscle: 13.3"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 2: 20.4"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"cerebellum: 2.0"							NA	NA									"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.1	0.0	0.1	0.0	8.9	0.8	0.0	2.7	0.1	1.7	0.0	0.0	0.6	0.0	8.9	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 197.3;thyroid gland: 570.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.1	1.9	0.6	1.4	0.5	1.7	0.1	1.2	14.7	1.6	1.8	0.6	8.9	33.2	2.2	37.8	3.6	2.1	1.1	1.9	197.3	1.2	1.6	1.7	4.5	1.4	0.4	1.7	1.0	1.4	1.4	1.9	2.9	1.1	0.9	1.5	1.9	26.4	0.5	1.8	2.4	0.8	3.2	0.8	1.4	2.5	2.0	0.5	570.1	0.3	1.1	2.1	1.0	2.2	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.9	1.4	0.1	1.2	1.1	1.9	4.5	1.4	0.4	2.9	3.2	2.0	2.2	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020396-97024950	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 14.2;placenta: 11.8;skin 1: 20.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.9;Endometrial ciliated cells: 217.8;Extravillous trophoblasts: 245.2;Glandular and luminal cells: 191.2;Syncytiotrophoblasts: 314.8"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 53.7;HAP1: 27.2;SuSa: 13.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory bulb: 29.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 7.5;olfactory bulb: 18.0"	HPA005670	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.1	0.3	2.3	0.2	3.6	0.0	1.0	0.2	3.1	7.6	0.7	0.4	0.3	14.2	1.0	1.9	1.3	0.4	0.5	1.5	3.6	0.2	0.0	0.2	1.7	1.3	0.4	1.9	1.6	0.0	0.2	0.8	11.8	1.3	1.8	0.0	0.0	3.3	2.9	0.3	20.6	0.1	0.9	0.3	0.1	0.1	0.9	1.7	1.9	1.5	0.0	2.2	0.7	3.0	1.3	0.0	0.0	0.0	8.2	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.2	27.2	0.0	0.0	0.0	4.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.0	3.6	1.5	2.1	0.2	0.0	0.0	13.4	0.0	0.0	0.0	1.7	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.6	0.2	3.1	1.5	3.6	1.3	0.4	1.9	1.3	0.3	1.7	1.3	1.4	0.0	0.0	0.0	0.0	9.8	1.1	1.7	0.6	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.2	217.8	13.3	2.9	0.0	0.0	0.1	0.0	245.2	1.5	0.0	191.2	0.0	1.6	0.0	0.0	16.9	0.0	12.8	0.0	0.0	0.0	1.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	59.2	0.2	8.0	4.2	11.6	7.9	20.6	314.8	1.6	0.1	0.0	1.6
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304752	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 20.0;salivary gland: 12.9"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046607, HPA062660"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA046607: , HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.3	0.9	6.9	0.3	13.9	0.0	0.1	0.1	9.1	1.6	0.0	2.7	0.7	0.6	0.3	0.3	1.2	0.2	0.9	15.4	5.2	0.3	0.4	0.1	0.0	5.3	9.9	9.5	0.3	0.1	0.0	1.9	0.0	4.3	1.0	0.3	0.4	12.9	1.2	0.0	0.1	1.3	0.3	0.0	0.0	0.8	0.2	20.0	0.0	1.6	0.1	0.0	0.6	0.8	5.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	13.9	0.1	9.1	15.4	5.2	5.3	9.9	9.5	4.3	0.0	20.0	5.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	1.0	4.8	0.3	0.0	0.0	7.2	0.7	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	6.6	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.4;retina: 29.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA					"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	7.0	36.7	0.2	68.4	0.0	1.1	16.5	84.4	9.3	0.0	0.2	0.1	17.1	11.6	0.1	11.0	0.0	0.1	83.0	25.9	0.4	0.0	0.2	0.0	5.2	16.0	49.0	0.6	1.4	0.0	21.9	0.1	16.1	0.8	0.1	29.3	4.2	2.3	0.2	1.6	0.1	6.3	1.0	0.2	1.2	1.4	30.4	0.1	0.0	0.6	0.0	0.1	0.4	49.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	68.4	16.5	84.4	83.0	25.9	5.2	16.0	49.0	16.1	1.0	30.4	49.4	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
IGLJ6		ENSG00000211682	"Immunoglobulin lambda joining 6"		22	22918132-22918201	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"intestine: 6.7;lymphoid tissue: 8.0;urinary bladder: 5.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"colorectal cancer: 1.2;endometrial cancer: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	48	"memory B-cell: 31.6;naive B-cell: 38.3"	"Lineage enriched"	"Detected in single"	52	"B-cells: 38.3"	"Group enriched"	"Detected in some"	8	"Daudi: 14.5;U-698: 4.3"															NA	NA																							0.0	0.0	0.0	7.3	0.2	0.0	0.4	0.0	0.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.0	8.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	5.4	1.0	0.0	0.1	0.0	0.0	0.0	2.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.2	0.0	0.3	0.1	0.3	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672673-32773023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 12.8;thyroid gland: 13.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	90	"memory B-cell: 10.5;naive B-cell: 7.3"	"Lineage enriched"	"Detected in single"	106	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"hippocampal formation: 14.9;olfactory bulb: 8.1"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.4	0.2	0.2	1.9	0.3	2.5	0.5	0.0	0.6	2.9	0.0	0.2	0.2	1.7	1.0	0.2	6.6	0.3	0.1	0.3	0.3	4.0	0.0	0.3	7.2	1.4	1.0	0.2	0.3	0.0	7.0	0.3	0.9	0.6	1.4	0.2	4.7	0.4	12.8	0.0	0.1	2.0	0.8	0.8	8.7	0.2	1.0	0.7	0.3	13.9	0.0	5.4	0.6	0.5	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	15.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.2	1.3	0.0	8.4	0.0	3.2	0.4	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.6	0.3	0.3	1.4	1.0	0.2	0.6	0.8	0.7	0.2	1.3	0.0	0.0	0.3	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.1	0.0	3.9	0.0	4.5	7.1	0.3	2.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.7	0.0	0.1	1.7	9.8	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	19.4	0.0	1.5	0.2	0.0	0.0	0.0	45.7	0.0	0.5	1.1	0.0	0.8	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.2	4.7	0.1	0.0
KRTAP11-1	KAP11.1	ENSG00000182591	"Keratin associated protein 11-1"	Q8IUC1	21	30880644-30881580	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	70	"skin 1: 116.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"endometrial cancer: 1.3;urothelial cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054008	Enhanced					NA	NA		2700000			"HPA054008: AB_2682341"																		1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	116.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC3B	LRP15	ENSG00000179796	"Leucine rich repeat containing 3B"	Q96PB8	3	26622806-26717537	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 26.6;choroid plexus: 7.8;skeletal muscle: 9.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 256.9;Early spermatids: 115.3;Inhibitory neurons: 50.0;Oligodendrocyte precursor cells: 38.2"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.5;SuSa: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015568	Approved					NA	NA					"HPA015568: AB_1853282"	"unprognostic (1.22e-2)"			"unprognostic (2.94e-1)"	"unprognostic (1.87e-1)"		"unprognostic (7.42e-2)"	"unprognostic (8.82e-4)"		"unprognostic (2.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.91e-4)"	"unprognostic (3.31e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-1)"	0.2	0.1	17.7	0.0	20.1	0.0	0.4	26.6	24.7	0.2	7.8	0.4	0.0	0.8	0.0	0.4	0.4	0.0	0.3	22.2	16.0	0.0	0.1	0.0	0.0	16.3	18.0	19.8	1.6	0.0	0.0	1.5	0.0	19.7	0.1	0.5	1.1	0.5	0.1	9.6	0.1	0.3	0.4	15.6	0.1	0.5	7.2	15.6	0.7	0.1	0.2	0.0	4.8	0.2	16.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	20.1	26.6	24.7	22.2	16.0	16.3	18.0	19.8	19.7	15.6	15.6	16.8	0.8	0.0	0.0	256.9	0.0	0.1	0.0	0.0	0.0	1.6	1.2	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.2	3.2	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.0	11.6	0.6	0.1	0.0	9.4	0.0	0.8	0.0	38.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	1.6	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.1
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 6.8;endometrium 1: 6.3"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 61.4;Excitatory neurons: 167.9;Glandular and luminal cells: 174.6"	"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 29.0;HEL: 9.7;RPTEC TERT1: 14.4;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 11.8;hippocampal formation: 7.8"	HPA027067	Approved					NA	NA					"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.1	5.3	3.6	0.2	6.6	0.0	0.1	0.3	6.8	2.7	0.7	0.2	0.1	6.3	1.0	0.1	0.8	0.7	0.0	5.6	2.1	2.1	1.4	3.8	0.4	1.7	0.9	4.6	0.3	0.1	0.2	0.1	2.7	2.3	0.4	0.1	0.0	0.1	2.8	0.0	0.0	0.2	0.8	0.4	0.3	0.4	0.2	1.0	0.0	1.3	0.0	0.3	0.1	0.8	6.4	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	6.6	0.3	6.8	5.6	2.1	1.7	0.9	4.6	2.3	0.4	1.0	6.4	0.0	0.0	0.5	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.4	23.5	4.2	0.0	1.7	167.9	0.0	0.0	0.2	0.0	174.6	0.0	0.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	7.5	0.0	0.0	0.0	10.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.6	0.8	0.0	0.1	0.1	0.6	0.0	0.0	0.0
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005553-97011040	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.1;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 32.9;Early spermatids: 22.6;Endometrial ciliated cells: 37.3;Extravillous trophoblasts: 70.4;Glandular and luminal cells: 27.5;Syncytiotrophoblasts: 17.4"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 33.4;HAP1: 15.3;SH-SY5Y: 11.0;SuSa: 19.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory bulb: 27.0"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.3	0.0	2.5	0.0	6.1	0.3	0.1	0.0	3.6	2.0	0.0	0.2	0.0	2.6	0.8	0.0	0.4	0.0	0.1	0.8	3.9	0.0	0.0	0.0	0.3	2.0	0.0	1.6	0.2	0.0	0.0	0.1	3.0	2.2	0.3	0.0	0.0	1.1	0.9	0.1	1.3	0.0	0.2	0.0	0.1	0.0	5.5	1.9	0.3	0.4	0.1	0.2	0.4	0.2	0.3	0.0	0.0	0.0	10.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	1.9	15.3	0.0	0.0	0.0	3.9	0.0	5.9	7.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	2.6	1.6	0.0	0.0	0.0	0.0	2.2	7.3	11.0	1.0	0.0	0.3	19.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.9	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	6.1	0.0	3.6	0.8	3.9	2.0	0.0	1.6	2.2	0.0	1.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	32.9	0.1	0.0	0.0	0.0	22.6	37.3	2.2	0.2	0.0	0.0	0.0	0.0	70.4	0.2	0.0	27.5	0.0	0.0	0.0	0.0	3.3	0.0	8.0	0.0	0.0	0.0	0.0	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.8	6.8	10.2	0.0	0.0	17.4	0.3	0.0	0.0	0.1
IGLJ2		ENSG00000211676	"Immunoglobulin lambda joining 2"		22	22899481-22899655	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 263.2;lymphoid tissue: 191.4;stomach 1: 214.6"	"Cell type enriched"	"Detected in single"	5	"Plasma cells: 1.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.9;endometrial cancer: 21.6"	"Region enhanced"	"Detected in single"		"pons: 1.3"	"Group enriched"	"Detected in many"	12	"memory B-cell: 876.1;naive B-cell: 864.5"	"Lineage enriched"	"Detected in many"	12	"B-cells: 876.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.8;HMC-1: 34.1;RH-30: 89.7;U-698: 19.8"															NA	NA						"unprognostic (6.99e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.13e-2)"		"unprognostic (5.94e-7)"		"unprognostic (1.51e-2)"			"unprognostic (3.63e-2)"			"unprognostic (3.66e-2)"	"unprognostic (5.17e-2)"		"unprognostic (2.92e-1)"	8.5	55.5	0.2	174.6	0.0	25.6	11.3	0.1	0.8	6.1	0.2	135.8	263.2	3.0	4.2	13.6	1.0	12.6	2.9	0.1	0.0	2.1	6.9	21.7	95.3	0.3	0.1	0.0	4.8	6.0	0.1	0.0	0.0	1.3	4.0	31.4	0.0	76.3	4.3	0.0	0.2	207.7	1.9	0.0	129.5	214.6	2.4	0.1	15.7	0.3	0.0	191.4	61.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.7	89.7	1.3	0.0	0.0	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	0.0	0.6	19.8	0.0	0.5	0.0	1.4	1.9	0.6	0.4	0.2	0.7	876.1	0.3	0.3	0.9	864.5	0.2	0.4	9.3	0.7	0.8	71.8	0.5	136.5	0.2	0.0	0.1	0.8	0.1	0.0	0.3	0.1	0.0	1.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.7;testis: 10.1"	"Group enriched"	"Detected in some"	9	"Breast glandular cells: 17.7;Breast myoepithelial cells: 29.1"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	17.7	29.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.5	1.2	0.1	1.8	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.1
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"intestine: 53.0"	"Cell type enriched"	"Detected in some"	96	"Enteroendocrine cells: 19377.2"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.9"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Low region specificity"	"Detected in single"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100				"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	1.7	0.3	1.5	0.3	0.1	0.4	0.2	0.7	0.3	0.1	53.0	2.5	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.3	1.3	0.2	0.2	0.3	0.4	0.3	0.3	0.0	0.7	0.2	0.0	0.0	0.5	0.3	37.0	0.8	0.1	0.8	0.1	0.1	42.0	0.1	0.2	0.1	0.5	1.1	0.4	0.3	0.5	0.1	0.1	0.0	0.0	0.5	0.1	0.2	0.2	0.4	0.3	0.6	0.0	0.4	0.1	0.5	0.3	0.5	0.3	0.2	0.6	0.5	0.4	0.2	0.4	0.1	0.3	1.2	0.2	0.7	0.2	0.0	0.4	0.2	2.9	0.8	0.1	0.5	0.2	0.6	0.1	0.3	0.2	0.5	0.4	0.6	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.8	0.0	0.4	0.1	0.3	0.0	0.7	0.3	0.5	0.0	0.5	0.6	0.5	0.1	0.4	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.7	0.3	0.3	0.4	0.3	0.3	0.5	0.2	0.4	0.5	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	65.0	1.9	0.0	1.0	7.9	1.3	0.1	19377.2	0.0	3.5	0.0	0.1	0.0	0.0	18.9	8.9	0.1	0.0	0.0	0.0	0.0	3.3	199.9	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	35.5	0.0	0.0	0.0	20.7	0.1	0.0	0.0	0.0	0.0	0.1	2.3	4.3	0.0	0.1	0.0	1.0	0.0	36.8	0.0
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HEK 293: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Uncertain	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTNNA2	"CAP-R, CT114"	ENSG00000066032	"Catenin alpha 2"	P26232	2	79185231-80648861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Differentiation"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.3;epididymis: 67.6;retina: 81.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3673.8;Early spermatids: 560.8;Excitatory neurons: 1358.5;Inhibitory neurons: 1056.9;Oligodendrocyte precursor cells: 1304.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.9;glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	96	"basophil: 55.3"	"Lineage enriched"	"Detected in single"	553	"granulocytes: 55.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.1;Karpas-707: 8.2;NTERA-2: 6.7;SCLC-21H: 3.8;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"							CAB037175	Enhanced					NA	NA					"CAB037175: AB_476883"	"unprognostic (9.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.96e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (8.44e-4)"	"unprognostic (1.73e-4)"	"unprognostic (2.83e-1)"	0.1	4.8	74.7	0.6	81.2	0.1	0.0	56.2	101.3	0.2	28.9	1.6	0.3	3.3	67.6	0.2	1.9	0.2	0.1	78.8	57.9	0.1	0.1	0.0	0.0	50.0	70.1	70.0	0.1	0.8	0.0	7.2	0.0	49.7	1.0	0.9	81.2	0.2	0.8	0.2	0.1	0.7	0.5	34.0	0.0	1.1	17.6	75.2	0.0	0.0	0.0	0.0	0.1	0.4	68.6	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	3.8	10.7	0.0	0.0	0.5	1.0	0.0	0.6	0.0	0.4	0.7	0.2	0.0	2.3	0.0	0.0	2.7	0.0	2.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	74.7	81.2	56.2	101.3	78.8	57.9	50.0	70.1	70.0	49.7	34.0	75.2	68.6	0.0	0.0	0.0	3673.8	0.0	0.0	0.0	0.0	0.0	17.2	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	560.8	12.9	7.0	0.5	0.0	0.0	1358.5	0.0	0.0	0.1	0.0	34.3	0.0	4.7	0.0	0.0	0.0	5.0	1056.9	0.0	0.0	0.0	0.0	144.4	2.5	0.5	0.0	187.4	0.0	112.1	0.0	1304.4	230.7	0.3	0.0	3.0	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.0	0.2	10.3	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1
GDF5	"BMP14, CDMP1"	ENSG00000125965	"Growth differentiation factor 5"	P43026	20	35433347-35454746	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Chondrogenesis	"Cytokine, Growth factor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 10.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.2;Basal prostatic cells: 1.0;granulocytes: 1.3"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.6;BJ hTERT+: 5.4;GAMG: 9.4;HHSteC: 5.8;HSkMC: 14.4;U-87 MG: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA015648	Uncertain				"Secreted to blood"	NA	NA					"HPA015648: AB_1849589"	"unprognostic (4.59e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.96e-3)"	0.9	0.1	0.1	0.0	0.3	0.0	0.6	0.1	0.4	0.3	0.3	1.2	0.0	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.6	0.2	0.0	2.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.9	0.1	0.0	10.0	1.2	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.6	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	17.6	0.1	2.8	5.4	0.4	1.0	0.0	0.0	0.0	0.0	4.5	9.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	14.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.6	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LRRC71	"C1orf92, FLJ32884"	ENSG00000160838	"Leucine rich repeat containing 71"	Q8N4P6	1	156920632-156933094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 7.2;fallopian tube: 12.5;testis: 25.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 236.9;Late spermatids: 605.3"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.5;PC-3: 1.6;TIME: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.18e-1)"	"unprognostic (1.68e-7)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	0.1	0.5	3.0	0.0	1.0	0.0	0.1	1.3	0.7	0.6	7.2	0.0	0.0	0.2	0.0	0.0	12.5	0.0	0.1	0.7	1.5	0.1	0.0	2.4	0.0	3.0	3.9	0.0	0.1	0.0	0.0	0.2	0.1	2.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	25.6	1.3	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.0	1.3	0.7	0.7	1.5	3.0	3.9	0.0	2.4	4.4	1.3	1.0	0.2	0.0	1.8	0.7	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.0	0.7	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	236.9	37.8	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.0	605.3	4.4	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	3.4	0.0	0.1	0.0	0.0	89.6	0.6	0.0	0.0	1.1	54.2	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OMG	OMGP	ENSG00000126861	"Oligodendrocyte myelin glycoprotein"	P23515	17	31272013-31297539	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 117.5;choroid plexus: 51.4"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 458.9;Respiratory ciliated cells: 708.8"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.5;glioma: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008206, HPA012693"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008206: AB_1854240, HPA012693: AB_1854239"	"unprognostic (8.05e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.96e-13)"	"unprognostic (7.80e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.42e-2)"	0.0	0.1	76.9	0.0	84.6	0.7	0.0	74.9	117.5	0.0	51.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	77.7	76.2	0.0	0.0	0.1	0.0	78.0	75.6	73.2	0.0	0.0	0.0	0.3	0.0	78.3	0.0	0.1	19.6	0.0	0.0	0.0	0.0	0.1	0.0	71.8	0.3	0.1	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	95.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	84.6	74.9	117.5	77.7	76.2	78.0	75.6	73.2	78.3	71.8	76.1	95.9	0.5	0.0	3.7	18.3	0.3	0.4	0.0	72.8	0.0	4.2	0.1	0.1	0.7	0.0	44.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	458.9	3.8	1.6	0.0	0.0	28.0	0.0	0.6	1.5	0.0	7.0	0.0	0.0	0.7	0.1	0.5	0.0	18.7	0.0	61.1	20.1	0.7	0.0	0.0	1.1	0.0	3.7	0.2	78.2	1.0	78.4	101.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	708.8	2.4	0.0	0.7	19.1	0.0	0.0	0.2	0.1	11.8	1.4	0.0	0.0	0.0
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590105-180591499	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 272.2;lung: 512.5;salivary gland: 752.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2883.9;Breast myoepithelial cells: 4199.8;Club cells: 13674.8;Respiratory ciliated cells: 3325.6;Urothelial cells: 3139.7"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 51.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.3;T-47d: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		10000000				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	1.4	1.6	0.9	0.2	1.0	0.5	123.6	0.5	1.0	272.2	9.4	0.5	0.6	1.5	1.3	75.4	30.2	3.0	0.7	0.9	4.3	1.4	7.1	512.5	0.4	1.2	0.9	0.9	2.0	18.3	0.0	12.7	0.1	0.7	38.2	0.0	0.0	752.6	2.4	0.3	4.6	1.0	0.0	0.9	9.5	51.2	3.0	2.1	0.8	3.1	0.0	0.8	14.6	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.3	2.4	17.2	13.3	1.8	3.3	4.5	10.1	0.0	5.9	5.0	0.0	0.0	51.8	0.2	4.3	2.6	0.9	1.0	0.5	1.0	0.9	4.3	1.2	0.9	0.9	0.7	0.9	2.1	1.3	36.4	173.1	1441.5	0.0	5.9	0.5	51.2	2883.9	0.6	0.0	1831.7	4199.8	0.4	1554.2	13674.8	0.0	0.0	0.0	30.4	0.1	0.0	20.5	0.1	1.6	0.1	40.5	0.0	10.7	0.2	1.6	0.3	15.2	3.6	1.7	35.3	1.0	68.9	1.1	0.4	0.0	0.0	0.1	1566.5	1.2	0.6	0.2	0.6	14.8	5.4	0.0	0.6	0.0	0.0	0.0	0.1	146.1	0.5	0.0	0.0	214.9	0.0	0.0	3325.6	0.0	0.0	1.6	305.2	0.3	4.4	140.8	0.4	0.0	20.2	0.1	0.2	3139.7
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746200-12763699	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 14.9;fallopian tube: 26.9;testis: 49.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 223.3;Endometrial ciliated cells: 50.3;Late spermatids: 92.8;Respiratory ciliated cells: 88.1;Spermatocytes: 70.7"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028396			Uncertain	Cytosol		NA	NA			Cytosol		"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	5.9	0.0	1.2	0.3	0.0	2.1	0.6	0.6	14.9	0.0	0.0	0.4	0.1	0.1	26.9	0.0	0.0	1.0	5.0	0.0	0.0	1.9	0.1	3.6	5.2	0.3	0.1	0.1	0.0	0.6	0.1	3.3	0.0	0.0	0.1	0.1	0.0	1.2	0.2	0.0	0.0	4.2	0.1	0.1	49.3	1.8	0.0	0.6	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.9	1.2	2.1	0.6	1.0	5.0	3.6	5.2	0.3	3.3	4.2	1.8	3.8	0.0	3.2	0.5	0.3	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.3	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	223.3	50.3	0.4	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	92.8	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	88.1	0.0	6.6	0.1	1.3	70.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"fallopian tube: 107.4;testis: 149.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2151.8;Endometrial ciliated cells: 931.5;Late spermatids: 3412.7;Respiratory ciliated cells: 808.8;Spermatocytes: 514.1"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;SCLC-21H: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.0	0.1	2.7	0.0	2.0	0.0	0.2	2.1	2.8	1.1	11.8	0.3	0.3	1.1	1.2	0.1	107.4	0.0	0.0	2.4	3.1	0.2	0.0	4.4	0.0	3.3	2.5	1.6	0.1	0.9	0.2	2.5	0.0	2.7	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	2.2	0.0	0.3	149.0	2.1	0.3	0.4	0.0	0.0	0.3	0.0	2.4	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.7	2.0	2.1	2.8	2.4	3.1	3.3	2.5	1.6	2.7	2.2	2.1	2.4	0.0	0.0	4.1	0.7	0.2	0.0	0.2	53.9	0.0	0.6	0.8	0.9	3.5	0.0	61.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2151.8	931.5	6.1	1.8	0.0	0.0	1.1	0.2	0.0	0.7	0.0	11.2	3.8	0.0	0.0	0.0	0.1	0.0	1.0	0.4	57.0	0.0	0.3	3412.7	21.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	18.8	0.0	2.4	0.0	0.8	808.8	0.0	6.6	0.2	9.0	514.1	20.2	0.0	0.1	0.0	1.1	0.0	0.2	0.4
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"fallopian tube: 59.9"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 74.2;Respiratory ciliated cells: 160.4"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;HeLa: 1.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.2"	HPA076277	Enhanced				"Intracellular and membrane"	NA	NA					"HPA076277: AB_2732306"	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.4	0.1	3.6	0.1	1.0	0.2	0.2	1.2	0.4	3.3	0.8	0.4	0.1	1.8	0.4	0.1	59.9	0.1	0.1	0.5	1.7	0.2	0.1	7.4	0.0	2.2	4.5	0.2	0.2	0.0	0.0	0.1	0.1	3.5	0.3	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.2	1.4	0.0	0.1	7.6	1.2	0.0	0.2	0.0	0.0	0.2	0.4	1.0	0.1	0.5	0.1	0.0	0.1	1.3	0.1	0.1	0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.7	0.0	0.6	0.4	0.0	1.9	2.0	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.7	0.4	0.1	0.1	1.0	0.5	0.1	0.2	0.1	3.9	3.6	1.0	1.2	0.4	0.5	1.7	2.2	4.5	0.2	3.5	1.4	1.2	1.0	0.2	0.0	3.4	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.1	0.1	0.4	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	74.2	0.9	0.5	0.0	0.0	0.1	0.2	0.1	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	20.3	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	160.4	0.0	0.0	0.2	1.7	4.8	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.1
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781019-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	90	"epididymis: 612.9;pancreas: 179.9"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 39.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 8.4"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.3	0.8	0.0	2.2	0.0	4.3	0.3	2.3	0.0	0.2	0.0	0.0	0.0	612.9	0.0	0.0	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.8	0.5	1.2	0.1	179.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.3	2.3	2.9	0.4	0.8	0.5	1.2	0.6	0.3	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	39.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel subunit alpha 4"	Q8IV77	11	6234765-6244479	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Ion channel, Ligand-gated ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 17.4;testis: 6.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.1;Early spermatids: 5.0;Endometrial ciliated cells: 2.7;Excitatory neurons: 3.0;Inhibitory neurons: 2.5;Late spermatids: 3.6;Oligodendrocytes: 3.1;Respiratory ciliated cells: 3.5"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA074128			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA074128: "	"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.1	0.2	2.3	0.2	1.5	0.4	0.2	1.7	1.2	0.5	0.6	0.2	0.3	0.6	0.2	0.2	17.4	0.2	0.1	1.1	1.3	0.2	0.2	1.4	0.2	2.2	2.1	0.9	0.4	0.4	0.0	0.7	0.0	2.3	0.2	0.1	1.1	0.1	0.5	0.0	0.3	0.2	0.1	1.9	0.3	0.2	6.2	1.6	0.3	0.2	0.0	0.2	0.2	0.2	2.2	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.5	1.7	1.2	1.1	1.3	2.2	2.1	0.9	2.3	1.9	1.6	2.2	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362875-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.3;liver: 5.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 68.4;Inhibitory neurons: 18.5"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	45	"plasmacytoid DC: 9.2"	"Lineage enriched"	"Detected in single"	45	"dendritic cells: 9.2"	"Cell line enhanced"	"Detected in some"		"AF22: 30.0;BEWO: 23.9;HAP1: 10.7;NTERA-2: 25.4;SuSa: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.0	4.5	5.4	0.1	8.1	0.2	0.1	0.5	13.3	0.2	0.6	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	9.9	3.8	2.1	5.6	0.4	0.5	1.5	1.3	7.3	0.5	2.2	3.9	0.9	0.3	4.5	2.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.3	0.2	0.3	1.0	1.9	1.2	0.1	0.0	0.1	0.2	0.1	5.8	0.0	0.8	30.0	1.9	0.0	0.0	23.9	0.0	0.0	0.0	0.0	1.3	0.0	0.1	4.7	0.0	0.1	0.0	10.7	0.0	0.0	1.0	1.3	0.0	0.0	7.9	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	25.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.2	19.2	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	5.4	8.1	0.5	13.3	9.9	3.8	1.5	1.3	7.3	4.5	0.3	1.9	5.8	0.0	0.0	0.0	3.3	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.2	1.5	0.1	1.7	0.1	0.0	0.0	68.4	0.6	0.4	0.5	0.0	0.2	0.0	1.0	0.0	3.6	0.1	0.0	18.5	0.0	0.0	0.0	0.0	3.5	0.0	0.5	0.0	5.6	0.0	0.0	0.0	3.5	2.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.4	0.0	0.9	0.0	0.4
FAM181A	C14orf152	ENSG00000140067	"Family with sequence similarity 181 member A"	Q8N9Y4	14	93918894-93929608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 9.1;testis: 32.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 48.9;Spermatocytes: 35.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"AF22: 4.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 31.9"	HPA001603	Enhanced					NA	NA					"HPA001603: AB_1078326"		"unprognostic (8.19e-2)"		"unprognostic (6.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.31e-1)"		"unprognostic (2.05e-2)"		"unprognostic (1.84e-2)"					"unprognostic (6.27e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.37e-2)"	0.0	0.0	5.5	0.0	5.1	0.0	0.0	5.6	7.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.9	9.1	0.0	0.0	0.9	0.0	6.8	5.3	4.5	0.0	0.0	0.0	2.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	6.0	0.0	0.0	32.8	5.5	0.0	1.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.1	5.6	7.6	4.9	9.1	6.8	5.3	4.5	5.8	6.0	5.5	5.5	0.0	3.2	3.1	8.8	0.0	0.0	0.0	1.6	0.0	0.1	0.1	0.4	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	6.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.7	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.1	35.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF18	"FGF-18, ZFGF5"	ENSG00000156427	"Fibroblast growth factor 18"	O76093	5	171419647-171457626	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 19.8;Cardiomyocytes: 24.4;Endometrial ciliated cells: 13.0;Glandular and luminal cells: 24.9"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.0;ovarian cancer: 21.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"EFO-21: 188.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	HPA018795	Uncertain				"Secreted in other tissues"	NA	NA					"HPA018795: AB_1848523"	"unprognostic (3.01e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-8)"	"unprognostic (7.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.76e-2)"	2.9	0.3	1.0	0.3	0.9	0.0	2.1	0.9	2.3	0.7	2.4	0.7	0.6	0.9	0.1	0.3	1.5	0.7	10.3	1.0	1.0	0.5	0.1	2.6	0.3	1.2	1.1	0.8	0.4	0.5	0.1	1.6	0.5	1.4	1.2	0.1	0.1	1.1	0.3	3.9	1.2	0.7	0.4	0.8	0.5	0.6	0.8	1.4	0.3	1.9	0.4	0.3	0.9	0.5	1.0	0.0	0.3	0.3	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.1	3.4	0.4	0.2	188.2	0.0	0.2	0.2	0.0	0.1	0.0	3.1	0.3	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.9	0.1	3.4	0.0	0.1	0.0	0.3	2.1	0.1	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.5	0.1	0.5	0.0	0.2	0.6	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.9	2.3	1.0	1.0	1.2	1.1	0.8	1.4	0.8	1.4	1.0	6.9	6.4	0.0	0.0	2.0	2.4	2.6	0.5	6.2	0.1	6.6	19.8	24.4	1.5	1.3	1.8	0.0	0.1	3.4	0.5	0.0	0.0	6.2	13.0	3.1	4.2	1.8	0.0	0.8	0.0	0.3	9.4	0.5	24.9	0.0	0.0	2.9	0.0	0.1	0.0	2.1	1.0	0.0	0.0	2.1	0.7	0.3	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.4	3.2	1.1	0.0	0.0	0.0	0.0	5.4	4.6	0.7	1.6	5.6	3.1	0.0	2.4	0.5	1.8	0.9
IGLJ7		ENSG00000211684	"Immunoglobulin lambda joining 7"		22	22921390-22921435	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 12.5;lymphoid tissue: 19.2;stomach 1: 17.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.0;endometrial cancer: 1.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.5"	"Group enriched"	"Detected in some"	222	"memory B-cell: 314.0;naive B-cell: 370.8"	"Lineage enriched"	"Detected in many"	240	"B-cells: 370.8"	"Cell line enriched"	"Detected in single"	21	"U-266/70: 2.0"															NA	NA																							0.7	4.2	0.1	14.6	0.2	1.1	0.0	0.3	2.5	0.0	0.0	6.2	12.5	0.0	0.0	2.1	0.0	3.3	0.0	0.2	0.9	0.0	0.0	2.0	3.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.9	0.0	6.0	0.0	0.0	0.0	5.4	0.0	0.0	3.9	17.7	1.9	0.1	0.3	0.0	0.0	19.2	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.6	314.0	0.0	0.0	0.0	370.8	0.0	0.0	0.0	0.0	1.5	0.2	0.0	27.6	0.1	0.2	0.3	2.5	0.2	0.9	0.7	0.4	0.0	0.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685738	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Distal enterocytes: 18.1;Excitatory neurons: 57.8;Horizontal cells: 52.2;Inhibitory neurons: 40.0;Oligodendrocyte precursor cells: 39.2"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.3;NTERA-2: 18.0;RPMI-8226: 29.0;SuSa: 9.8;T-47d: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	3.3	4.5	17.9	2.8	17.9	1.7	2.5	7.0	17.9	3.0	16.3	7.2	1.2	5.5	0.3	1.8	7.6	4.3	5.4	20.6	13.5	10.9	1.0	2.8	2.1	11.1	14.6	18.6	2.5	1.9	14.8	13.0	0.8	10.4	1.5	5.4	3.9	3.0	2.3	1.6	0.4	4.9	7.2	4.8	7.6	2.1	4.2	18.1	3.1	3.2	3.2	0.7	1.4	2.2	12.5	0.0	4.3	3.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	9.3	0.6	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	1.5	0.0	18.0	0.0	0.1	0.2	0.0	29.0	0.0	0.2	2.4	0.4	5.6	0.1	0.0	9.8	10.1	0.0	0.0	0.0	3.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	17.9	7.0	17.9	20.6	13.5	11.1	14.6	18.6	10.4	4.8	18.1	12.5	3.9	0.0	0.0	22.2	0.3	0.4	0.7	0.1	0.0	7.0	0.6	1.9	1.5	0.0	0.1	1.8	2.1	0.1	0.0	18.1	0.0	3.8	0.0	0.5	0.2	2.3	11.4	2.7	57.8	0.9	0.1	2.9	0.0	0.8	0.0	0.1	3.3	0.0	7.0	52.2	40.0	2.3	2.0	0.3	1.1	0.5	0.0	0.2	0.0	9.4	0.2	4.6	0.0	39.2	1.6	4.9	5.6	0.0	0.1	0.3	0.0	5.5	0.0	1.1	0.0	0.9	0.5	0.1	0.3	0.5	0.1	0.4	0.2	1.4	1.0	0.4
MT4	MTIV	ENSG00000102891	"Metallothionein 4"	P47944	16	56565073-56568957	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 116.0"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 19.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 6.7;endometrial cancer: 11.6"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA																				"unprognostic (8.81e-2)"			0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.1	1.9	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	116.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	6.3	0.0	0.0	0.0	0.0	18.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.8	19.7	0.0	0.0	0.0	0.0	0.0
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.9;brain: 100.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.9	0.7	55.2	0.1	44.1	0.0	1.7	46.1	100.2	0.0	0.4	0.2	0.1	0.3	1.3	0.1	1.0	0.1	0.8	45.9	29.0	5.3	0.0	0.0	0.2	55.6	45.5	32.7	0.2	2.4	0.9	1.8	0.1	62.2	1.0	0.1	3.8	2.3	1.6	5.8	1.0	0.2	0.2	27.4	0.3	0.4	9.0	86.7	0.2	0.3	2.6	0.0	0.0	0.0	39.5	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	55.2	44.1	46.1	100.2	45.9	29.0	55.6	45.5	32.7	62.2	27.4	86.7	39.5	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 37.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 4.1;Late spermatids: 10.2;Syncytiotrophoblasts: 8.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	0.7	0.0	0.1	0.0	0.1	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.1	0.0	0.0	2.9	0.1	0.7	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242239-62244812	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"breast: 1240.5;cervix: 4036.1"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3242.1;Glandular and luminal cells: 3417.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 10.4"									HPA035318	Approved				"Secreted in other tissues"	NA	NA					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favorable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favorable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		7.4	5.0	3.5	0.0	3.4	0.0	1240.5	3.0	5.4	4036.1	11.4	0.3	0.1	89.7	358.9	10.2	111.2	0.1	2.6	3.0	6.5	9.0	0.2	0.1	0.1	4.1	4.5	2.5	1.1	4.5	0.5	5.2	0.2	3.5	8.6	0.2	1.8	69.7	2.9	7.3	305.1	0.5	0.0	2.9	0.0	0.3	0.2	3.9	0.4	0.6	6.0	0.0	0.2	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.4	0.1	0.0	1.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.4	3.0	5.4	3.0	6.5	4.1	4.5	2.5	3.5	2.9	3.9	4.1	2.1	0.0	0.0	0.0	1.6	27.4	4.8	0.0	0.0	0.5	647.8	251.6	10.9	0.0	0.0	7.3	0.0	0.0	5.3	0.0	23.5	0.3	0.0	3242.1	409.9	12.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	3417.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	15.0	823.6	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	46.1	0.0	0.9	0.0	0.2	8.6	0.0	0.0	0.0	7.0	0.1	20.0	0.0	0.0	1.1
SCX	"bHLHa41, bHLHa48, SCXA, SCXB"	ENSG00000260428	"Scleraxis bHLH transcription factor"	Q7RTU7	8	144266453-144268481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.7;thyroid gland: 38.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 14.2;Horizontal cells: 16.8"	"Group enriched"	"Detected in all"	6	"endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;HaCaT: 5.3"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Low region specificity"	"Detected in some"			HPA043183	Uncertain					NA	NA					"HPA043183: AB_2678357"	"unprognostic (5.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.89e-3)"	1.2	3.4	2.9	0.9	2.1	0.6	1.4	7.7	6.9	6.7	2.5	7.0	0.9	2.9	0.5	3.4	3.9	0.1	8.2	2.5	2.5	6.0	2.1	3.5	0.4	5.3	2.4	2.3	2.6	3.8	0.8	19.7	0.2	5.3	4.5	0.2	0.1	2.7	0.1	14.0	3.1	5.0	0.2	0.7	4.6	5.9	5.2	2.4	0.7	38.4	1.2	0.1	2.7	3.3	3.8	2.0	0.4	0.1	0.5	0.0	0.0	4.8	0.1	0.0	0.1	0.0	0.1	1.4	1.3	1.4	0.2	0.2	5.3	0.0	0.0	0.0	0.9	0.8	0.3	1.9	0.2	0.2	0.1	2.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.2	0.6	0.1	3.0	0.5	1.1	1.1	0.4	2.3	1.6	0.2	0.8	0.1	2.0	0.2	0.9	0.5	1.8	2.2	0.1	2.3	0.9	0.3	0.4	3.5	1.6	0.3	1.8	0.6	0.3	0.8	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.1	7.7	6.9	2.5	2.5	5.3	2.4	2.3	5.3	0.7	2.4	3.8	3.4	0.0	2.7	8.5	2.5	0.0	1.2	0.0	0.6	14.2	6.7	8.3	6.2	1.5	1.3	3.7	0.0	1.5	7.5	2.2	1.9	0.6	0.2	5.7	1.4	1.2	2.4	0.0	5.9	1.4	0.6	1.2	8.2	7.1	0.0	3.2	0.4	0.4	0.4	16.8	8.5	2.3	0.0	0.6	0.0	0.9	0.3	0.9	0.0	1.0	0.0	8.2	1.0	2.5	0.3	1.5	2.1	0.7	0.7	2.7	1.5	0.2	0.0	1.5	0.0	4.2	6.4	2.5	9.0	0.6	0.0	1.1	3.1	0.3	1.8	1.0
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652675-63679020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"fallopian tube: 174.9"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 410.9;Respiratory ciliated cells: 726.5"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA043322, HPA058399"	Enhanced					NA	NA					"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.1	0.2	0.4	0.6	0.6	0.8	0.2	3.7	2.1	3.2	0.0	0.3	0.4	3.0	0.4	0.2	174.9	0.5	0.0	0.7	0.4	0.1	0.1	13.6	0.8	0.9	0.2	0.6	0.3	0.9	0.1	0.0	0.2	1.7	0.4	0.5	1.0	0.3	0.2	0.3	1.2	0.5	0.3	0.0	0.3	0.8	0.3	0.4	0.1	17.9	0.1	0.2	0.1	0.0	1.1	0.2	0.1	0.2	0.4	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.2	1.0	0.2	0.1	0.7	0.1	0.2	0.6	0.1	0.0	0.2	0.5	0.9	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.3	1.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.4	0.6	3.7	2.1	0.7	0.4	0.9	0.2	0.6	1.7	0.0	0.4	1.1	0.0	3.2	4.2	0.3	0.0	0.0	0.1	34.0	0.0	0.0	0.3	0.1	0.3	0.0	60.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	3.6	410.9	2.3	0.3	0.0	0.0	0.1	0.4	0.0	1.4	0.0	4.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	38.7	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	726.5	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.5	0.2
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31580938	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"epididymis: 23.8;fallopian tube: 20.6;liver: 61.3;prostate: 16.9;seminal vesicle: 18.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	23.8	0.0	20.6	0.0	0.0	0.0	0.0	0.3	61.3	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.1	0.0	18.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.7	29.6	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.4	20.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	59.9	0.6	0.1	0.0	3.7	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.2	0.0	0.7	0.0	0.3	7.3	0.0	0.0	0.0	0.2	1.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.6
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102050-17131378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 18.0;gallbladder: 5.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 93.8;Respiratory ciliated cells: 72.8;Spermatocytes: 18.7;Spermatogonia: 23.8"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 2.4;SCLC-21H: 6.0;T-47d: 7.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.0	0.0	0.6	0.1	0.3	0.0	3.1	0.3	0.4	0.4	1.8	0.9	0.1	0.5	0.3	0.0	18.0	5.3	0.0	0.4	0.5	0.0	0.1	2.4	0.0	0.5	0.6	0.3	0.0	3.5	0.0	0.5	0.1	0.3	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.3	0.4	0.4	0.5	0.5	0.6	0.3	0.3	0.5	0.3	0.6	0.0	0.0	1.3	0.0	0.0	0.0	1.7	2.9	0.0	0.1	5.0	1.4	0.7	2.8	8.3	0.0	0.0	0.0	0.0	1.2	0.0	0.6	1.3	93.8	0.9	0.5	1.8	0.0	0.5	0.2	0.0	0.4	0.0	2.3	0.0	0.7	0.0	0.3	0.0	0.0	0.2	0.7	2.0	0.0	0.4	2.8	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.6	0.3	0.4	0.0	0.7	0.0	0.0	72.8	0.0	6.6	1.3	2.7	18.7	23.8	0.0	0.9	0.0	0.3	0.0	1.8	0.6
TUBA4B	"FLJ13940, TUBA4"	ENSG00000243910	"Tubulin alpha 4b"	Q9H853	2	219253243-219272197	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	10	"fallopian tube: 40.4"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 148.9;Respiratory ciliated cells: 83.1"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.20e-5)"	"unprognostic (1.47e-4)"	"unprognostic (1.85e-1)"	"unprognostic (3.70e-3)"	"unprognostic (9.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.78e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.08e-1)"	0.0	0.0	2.5	0.0	0.6	0.0	0.0	0.8	0.2	0.8	3.9	0.0	0.1	0.5	0.7	0.0	40.4	0.0	0.0	0.4	0.8	1.4	0.2	3.5	0.1	1.6	2.6	0.0	0.1	0.0	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	3.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.2	0.3	0.3	0.6	0.1	0.1	0.0	0.3	1.4	2.5	0.6	0.8	0.2	0.4	0.8	1.6	2.6	0.0	1.7	3.0	0.7	1.5	0.0	0.0	3.2	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	1.8	0.0	0.0	0.0	0.0	1.9	0.0	1.8	148.9	0.9	0.1	1.8	0.0	0.3	0.2	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	27.9	83.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.9;fallopian tube: 32.9;pancreas: 30.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA			"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	15.4	0.0	0.0	0.4	4.6	5.1	0.4	32.9	5.1	0.2	0.0	0.1	17.5	1.1	0.7	0.0	0.0	0.0	0.0	0.1	30.3	0.0	0.1	0.9	0.0	3.0	0.0	0.0	22.2	7.9	0.2	2.6	0.0	0.1	0.0	0.0	3.7	1.1	0.1	0.1	0.0	0.0	0.0	3.2	0.1	0.0	1.0	0.1	1.7	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	7.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	4.2	0.1	1.2	0.0	0.0	244.8	0.1	29.9	14.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.5	6.9	0.0	0.0	62.3	18.4	1.1	0.0	22.6	55.2	0.0	3.4	1.1	0.0	0.0	83.6	2.5	42.7	4.4	0.6	0.0	0.0	0.8	34.2	1.4	0.4	0.0	79.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	6.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	11.3	0.0	0.0	0.0	1.6	0.0	0.3	8.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	3.0	0.5	0.0	0.0	4.8
AL589987.1		ENSG00000230707	"Novel protein (LOC389895)"		X	140091415-140092911	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.4;brain: 3.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"endometrial cancer: 2.0;glioma: 1.0;ovarian cancer: 0.9;testis cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HAP1: 2.1;NTERA-2: 1.7;U-251 MG: 2.2"									HPA041568	Uncertain					NA	NA					"HPA041568: AB_10796677"				"unprognostic (1.27e-1)"	"unprognostic (3.32e-2)"					"unprognostic (2.17e-1)"		"unprognostic (4.08e-2)"			"unprognostic (5.26e-1)"	"unprognostic (1.28e-2)"		0.1	6.4	2.5	0.1	3.0	0.0	0.0	2.4	3.8	0.9	1.2	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	2.8	2.6	0.0	0.0	0.0	0.0	2.4	2.2	2.7	0.3	0.0	0.1		0.0	2.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	0.0	1.4	2.3	0.0	0.1	0.0	0.0	0.0		2.4	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	2.4	3.8	2.8	2.6	2.4	2.2	2.7	2.4	2.3	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD66		ENSG00000230062	"Ankyrin repeat domain 66"	B4E2M5	6	46746917-46759506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"fallopian tube: 40.5"	"Group enriched"	"Detected in some"	8	"Endometrial ciliated cells: 104.2;Respiratory ciliated cells: 184.4"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (1.67e-3)"	"unprognostic (2.52e-1)"			"unprognostic (2.44e-2)"		"unprognostic (2.03e-2)"		"unprognostic (9.36e-2)"		"unprognostic (4.30e-3)"	"unprognostic (2.19e-1)"			0.0	0.0	2.4	0.0	1.0	0.0	0.0	1.5	0.5	0.8	0.7	0.0	0.0	0.8	0.0	0.0	40.5	0.0	0.0	0.5	2.1	0.0	0.0	3.2	0.0	4.2	3.1	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	1.5	0.5	0.5	2.1	4.2	3.1	0.2	3.2	3.9	1.7	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.1	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	184.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
AOC1	"ABP, ABP1, DAO"	ENSG00000002726	"Amine oxidase copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 229.1;kidney: 137.8;placenta: 500.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 272.2;Distal enterocytes: 517.5;Paneth cells: 532.1;Proximal enterocytes: 957.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"eosinophil: 31.2"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.5;HaCaT: 6.2;NB-4: 6.4;RPMI-8226: 7.7;THP-1: 27.1"					"Low region specificity"	"Detected in many"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		2500000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.7	0.1	0.4	13.1	0.2	1.9	0.2	0.3	0.3	7.2	0.5	143.5	185.7	2.1	1.9	3.3	0.1	1.8	0.7	0.3	0.7	137.8	5.8	0.6	1.3	0.3	0.4	0.0	0.3	1.4	0.0	0.0	500.8	0.3	6.1	95.0	0.1	0.7	1.0	0.1	1.3	229.1	3.5	0.5	0.5	18.2	2.1	0.4	2.1	0.2	0.0	3.9	0.8	0.4	0.5	0.0	0.1	0.1	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	3.2	20.5	0.0	2.7	0.0	1.7	6.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.3	0.1	6.4	0.2	1.9	0.0	0.0	0.0	7.7	0.3	0.2	2.2	2.5	0.1	0.9	0.0	0.3	0.8	27.1	0.6	0.2	0.1	0.6	0.0	0.2	0.1	0.1	0.2	1.0	0.1	0.2	0.1	31.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.3	0.3	0.7	0.3	0.4	0.0	0.3	0.5	0.4	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.8	272.2	0.0	2.1	0.0	517.5	15.6	0.0	7.1	1.9	0.5	0.4	43.3	0.0	0.1	3.3	63.4	0.5	13.7	4.8	5.7	0.0	0.0	0.0	2.8	0.0	0.1	129.7	2.0	0.0	1.7	18.4	0.0	1.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	3.7	532.1	0.0	0.0	0.7	957.9	145.2	0.2	0.0	0.0	0.0	0.3	3.7	1.3	0.0	0.1	3.4	0.9	0.0	117.9	0.3
ARMC3	"CT81, FLJ32827"	ENSG00000165309	"Armadillo repeat containing 3"	Q5W041	10	22928024-23038523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 13.7;choroid plexus: 29.3;fallopian tube: 44.9;testis: 33.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 364.4;Endometrial ciliated cells: 169.1;Late spermatids: 90.1;Respiratory ciliated cells: 204.6;Spermatocytes: 70.0"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 4.0;ovarian cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"CAPAN-2: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037823, HPA037824"	Enhanced					NA	NA					"HPA037823: AB_2675689, HPA037824: AB_10671634"	"unprognostic (8.11e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"		"unprognostic (5.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.37e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.21e-3)"	"unprognostic (9.53e-4)"	"unprognostic (1.40e-2)"	0.0	0.0	8.4	0.0	4.0	0.0	0.0	4.9	2.8	1.2	29.3	0.0	0.0	1.5	0.1	0.1	44.9	0.0	0.1	2.2	13.7	0.4	0.0	3.6	0.0	10.3	9.1	0.9	0.0	0.3	0.0	1.3	0.0	8.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	9.9	0.0	0.0	33.9	4.9	0.1	0.3	0.1	0.0	0.0	0.0	8.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.4	4.0	4.9	2.8	2.2	13.7	10.3	9.1	0.9	8.0	9.9	4.9	8.8	0.0	0.0	1.1	8.1	0.0	0.0	0.0	6.0	0.0	0.0	0.1	0.1	0.3	0.0	22.4	0.0	6.2	0.0	0.1	0.0	0.0	0.4	364.4	169.1	1.4	0.8	0.0	0.0	9.1	0.0	0.0	0.4	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	12.2	0.0	0.0	90.1	3.4	1.5	0.0	2.8	0.0	0.0	0.0	1.5	9.0	0.0	0.0	3.8	0.0	0.3	0.0	1.5	204.6	1.1	0.0	0.0	3.0	70.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 18.7;thyroid gland: 20.9"	"Group enriched"	"Detected in some"	4	"Melanocytes: 5.4;Spermatogonia: 5.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9"	"Region enhanced"	"Detected in many"		"pons: 18.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in many"	5	"amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7"	HPA059886		Supported			"Secreted to blood"	NA	NA					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.2	0.0	0.9	0.3	0.8	0.1	0.2	0.5	2.5	0.1	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.3	9.8	0.3	0.8	0.1	0.1	7.3	7.6	0.0	0.1	1.5	0.3	2.2	0.1	18.7	0.1	0.2	0.1	0.3	0.0	0.8	0.1	0.4	0.1	2.1	0.1	0.1	0.3	1.4	0.0	20.9	0.1	0.1	0.0	0.1	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.9	0.0	0.4	0.1	0.0	10.4	0.0	0.0	0.0	0.6	2.9	0.1	0.1	0.4	0.0	0.2	0.0	0.0	1.1	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.0	0.6	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.8	0.5	2.5	0.3	9.8	7.3	7.6	0.0	18.7	2.1	1.4	4.7	0.0	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.4	0.2	0.9	0.5	0.2	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	5.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine	Q13938	19	5912339-5916211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 114.3;fallopian tube: 337.7"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8"					"Low region specificity"	"Detected in all"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	10.8	26.1	47.5	11.0	31.9	10.1	11.7	72.1	30.3	35.8	46.2	16.0	7.0	21.9	4.7	13.0	337.7	11.3	11.6	31.7	114.3	32.0	21.7	49.9	12.3	60.8	69.8	16.8	13.9	24.2	3.3	28.2	9.4	82.5	40.7	2.8	2.2	25.1	31.1	4.4	15.4	18.8	2.3	70.2	25.4	37.8	6.5	51.5	5.7	31.0	1.1	4.2	44.6	13.8	65.7	2.2	2.3	0.9	6.3	2.1	3.2	4.0	0.7	0.7	0.3	0.6	1.5	13.8	0.9	4.0	1.5	0.7	2.3	0.1	0.6	0.0	4.7	1.9	0.8	4.8	4.7	2.5	0.8	3.5	4.1	4.2	0.4	0.8	4.0	1.0	4.7	0.7	5.4	0.7	4.4	2.4	4.0	0.7	19.4	12.6	3.1	0.3	4.7	1.8	6.2	1.0	4.9	1.0	65.1	6.6	2.0	4.3	4.7	1.5	0.6	0.4	4.6	17.1	19.8	6.5	1.1	7.7	1.8	2.8	0.4	0.7	0.3	1.7	0.6	0.9	0.9	1.0	1.3	0.8	1.8	0.8	0.7	0.7	1.8	0.4	1.5	1.0	0.8	47.5	31.9	72.1	30.3	31.7	114.3	60.8	69.8	16.8	82.5	70.2	51.5	65.7	5.3	12.8	16.5	11.1	3.3	4.8	32.1	122.8	1.8	2.5	8.9	8.8	2.2	0.0	161.5	121.4	4.2	24.3	7.4	5.3	35.2	34.7	6.5	2622.9	48.3	5.5	19.2	0.4	2.6	5.9	22.8	12.9	33.6	330.8	6.3	8.1	0.0	0.0	5.2	6.7	3.2	25.1	197.4	0.0	5.9	5.7	4.7	6.6	10.6	6.5	3.0	7.7	9.2	3.5	12.9	36.9	3.3	4.9	3.8	20.4	4.2	4.5	1557.4	4.2	6.6	3.5	42.7	0.4	0.6	0.9	4.1	20.5	9.2	3.3	9.3	128.6
CCDC33	"CT61, FLJ32855"	ENSG00000140481	"Coiled-coil domain containing 33"	Q8N5R6	15	74202705-74336472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 23.8;testis: 20.3"	"Group enriched"	"Detected in some"	9	"Early spermatids: 54.2;Endometrial ciliated cells: 70.1;Late spermatids: 54.6;Respiratory ciliated cells: 56.7"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.4;ovarian cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 4.4;SCLC-21H: 2.4;SH-SY5Y: 2.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 7.4"							NA	NA						"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (2.16e-1)"		"unprognostic (3.16e-3)"		"unprognostic (3.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.05e-2)"		"unprognostic (4.46e-1)"	"unprognostic (4.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.37e-2)"	0.0	0.2	1.8	0.0	0.7	0.0	0.0	0.7	0.4	1.2	0.4	0.0	0.0	0.3	0.1	0.0	23.8	0.0	0.0	0.3	0.8	0.0	0.0	2.7	0.0	1.7	1.9	0.0	0.1	0.0	0.0	0.4	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.1	20.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.4	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.7	0.7	0.4	0.3	0.8	1.7	1.9	0.0	1.5	2.8	0.6	0.7	0.2	0.0	1.5	0.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	54.2	70.1	1.5	0.2	0.0	0.0	0.6	0.0	0.0	0.5	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.1	0.0	0.0	54.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.4	56.7	0.0	0.0	0.0	1.1	0.6	0.2	0.0	0.0	1.8	0.1	0.2	0.0	0.1
CIBAR2	"FAM92B, FLJ44299"	ENSG00000153789	"CBY1 interacting BAR domain containing 2"	Q6ZTR7	16	85098358-85112472	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 86.3"	"Cell type enriched"	"Detected in single"	8	"Plasma cells: 2.4"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 5.4;lung cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA041022	Enhanced					NA	NA					"HPA041022: AB_10795500"	"unprognostic (1.77e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.10e-13)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	0.1	1.3	7.9	1.3	1.9	0.4	0.3	2.2	1.2	1.9	9.3	0.7	1.3	1.4	0.2	0.1	86.3	0.2	0.0	1.4	4.7	0.2	0.0	10.3	0.6	6.9	7.7	0.2	0.1	0.1	0.0	16.3	0.0	5.2	0.1	0.4	0.4	0.5	0.1	0.0	0.4	0.7	0.0	6.9	2.6	0.4	0.4	3.4	0.2	0.0	0.0	1.9	1.2	0.0	2.7	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	7.9	1.9	2.2	1.2	1.4	4.7	6.9	7.7	0.2	5.2	6.9	3.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974361	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 107.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 49.9;Breast myoepithelial cells: 40.1;Intestinal goblet cells: 56.9;Prostatic glandular cells: 49.3"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 81.8;OE19: 82.7;SK-BR-3: 174.6;T-47d: 139.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	6.3	8.6	4.2	4.5	3.6	7.6	48.7	4.2	4.7	30.8	4.1	11.6	11.5	13.1	13.1	8.3	19.4	6.8	4.8	3.4	3.6	7.5	14.1	5.8	6.0	3.7	3.8	2.7	17.6	13.3	6.8	6.2	6.4	3.7	107.2	15.3	5.0	44.2	7.7	5.7	10.2	9.1	5.8	4.0	7.6	29.6	5.3	3.4	12.1	11.4	5.4	7.5	6.8	7.0	4.6	7.5	10.6	9.8	10.9	6.9	10.0	24.7	6.2	7.2	8.3	7.3	5.1	31.0	13.9	31.7	2.6	6.1	12.0	14.5	9.7	4.5	11.4	5.9	10.3	11.7	8.9	5.6	4.9	8.5	10.9	9.2	7.9	17.9	7.5	7.4	16.5	8.1	16.9	3.8	81.8	9.3	3.8	6.7	82.7	12.7	20.9	10.3	26.1	9.0	5.3	18.5	20.1	6.6	174.6	16.8	12.8	139.9	14.9	4.5	2.5	7.3	5.2	4.9	31.4	17.3	10.6	5.3	8.5	8.2	1.5	2.9	2.2	3.4	1.2	4.5	4.5	1.9	2.4	5.0	4.8	1.8	3.5	0.1	9.4	1.7	5.7	1.8	2.5	4.2	3.6	4.2	4.7	3.4	3.6	3.7	3.8	2.7	3.7	4.0	3.4	4.6	7.2	6.4	13.1	3.6	6.2	2.9	13.1	10.1	6.8	5.3	49.9	40.1	2.0	7.2	20.3	1.8	2.1	12.9	5.6	3.6	9.8	14.0	0.4	10.6	5.2	6.9	9.0	8.6	0.4	13.3	17.0	4.8	10.7	13.5	5.7	8.7	4.2	14.2	5.4	0.0	0.4	56.9	6.1	7.5	2.0	0.6	7.2	5.1	5.4	0.0	2.8	6.6	8.2	1.5	2.2	7.9	4.3	2.2	5.3	49.3	4.0	4.1	16.6	8.8	19.7	3.1	5.0	7.4	10.6	6.3	3.0	4.2	4.5	7.6	10.9	7.0
CROCC2		ENSG00000226321	"Ciliary rootlet coiled-coil, rootletin family member 2"	H7BZ55	2	240906330-240993311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"choroid plexus: 19.1;fallopian tube: 7.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 9.7;Endometrial ciliated cells: 43.6;Respiratory ciliated cells: 13.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.0;RPMI-8226: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048678	Enhanced					NA	NA					"HPA048678: AB_2680491"	"unprognostic (4.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.68e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.75e-4)"	"unprognostic (2.84e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.90e-3)"	"unprognostic (7.19e-2)"	0.0	0.0	2.4	0.1	0.8	0.0	0.0	1.4	1.1	0.7	19.1	0.0	0.2	0.1	0.0	0.0	7.1	0.0	0.0	2.2	1.4	0.0	0.2	1.6	0.6	2.1	3.7	0.0	0.1	0.0	0.0	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	2.3	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.8	1.4	1.1	2.2	1.4	2.1	3.7	0.0	2.7	1.9	1.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0
DNAAF1	"CILD13, DAU1, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 22.9;testis: 45.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.2;Endometrial ciliated cells: 311.3;Plasma cells: 225.4;Respiratory ciliated cells: 494.5;Spermatocytes: 116.2"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 3.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.3;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;Karpas-707: 4.9;PC-3: 1.4;SK-BR-3: 1.4;U-266/70: 4.0;U-266/84: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: AB_2732250"	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.3	0.7	2.3	0.1	1.5	1.3	0.3	2.2	1.9	1.3	8.2	0.3	0.0	0.5	1.4	0.4	22.9	0.0	0.3	1.3	2.2	1.0	0.8	3.6	0.0	3.7	5.5	0.9	0.4	0.3	0.3	2.4	0.2	4.1	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	3.3	0.7	0.2	45.7	2.5	0.0	1.6	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	4.0	2.8	0.4	0.1	0.0	0.0	1.3	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.3	0.3	0.1	0.4	1.0	0.3	2.3	1.5	2.2	1.9	1.3	2.2	3.7	5.5	0.9	4.1	3.3	2.5	1.2	1.1	0.0	12.4	1.6	5.7	0.6	1.5	9.6	0.0	1.4	4.5	1.5	0.7	1.5	67.2	3.7	54.2	0.2	0.5	0.1	0.0	1.3	116.2	311.3	4.4	1.9	0.0	0.0	9.6	0.4	0.4	2.4	0.5	14.6	3.8	2.6	2.2	0.6	1.9	0.0	5.2	0.0	18.3	7.0	1.5	26.7	1.2	21.6	87.2	0.0	0.8	2.4	1.0	0.5	0.6	0.9	0.0	0.4	225.4	1.4	0.0	1.7	494.5	51.0	0.0	1.6	7.3	116.2	17.0	0.2	0.3	0.4	4.5	1.2	0.3	0.9
DNAI3	"DIC3, FLJ30067, NYD-SP29, WDR63"	ENSG00000162643	"Dynein axonemal intermediate chain 3"	Q8IWG1	1	84999147-85133138	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 22.1;choroid plexus: 20.3;fallopian tube: 14.6;testis: 19.0"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.3;melanoma: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.4;HBEC3-KT: 4.4;HSkMC: 5.6;hTCEpi: 6.9;LHCN-M2: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038526	Enhanced					NA	NA					"HPA038526: AB_2676063"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-4)"	"unprognostic (1.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.14e-5)"	"unprognostic (8.57e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	0.2	22.1	6.0	0.4	1.9	0.0	0.2	3.3	1.2	0.9	20.3	0.7	0.2	0.7	4.2	0.3	14.6	0.4	0.5	1.8	6.1	0.7	0.1	1.8	0.4	6.6	7.0	0.0	0.1	0.5	5.7	3.0	0.5	5.6	0.3	0.5	0.7	0.8	0.2	0.1	2.1	0.1	0.4	10.3	0.2	0.2	19.0	3.1	0.8	1.1	2.2	0.2	0.5	0.1	4.4	0.1	0.4	0.1	0.3	3.0	8.4	1.6	1.7	3.4	0.5	0.9	0.0	0.5	0.4	0.0	0.3	2.0	0.0	0.3	4.4	0.7	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	5.6	6.9	2.9	0.2	0.3	0.1	0.5	0.0	0.0	6.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.2	0.1	0.0	0.0	0.2	1.1	1.6	0.0	2.9	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.3	3.3	0.1	1.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	6.0	1.9	3.3	1.2	1.8	6.1	6.6	7.0	0.0	5.6	10.3	3.1	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"adrenal gland: 272.2;fallopian tube: 83.8;skeletal muscle: 187.7"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 108.0;Respiratory ciliated cells: 126.4"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045540	Enhanced					NA	NA					"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	5.3	272.2	4.0	0.0	1.5	0.0	2.5	2.4	1.4	2.1	7.2	0.3	0.0	1.3	9.0	0.6	83.8	0.1	0.5	1.2	2.9	0.7	0.6	4.2	0.1	3.8	5.6	0.4	0.3	0.2	0.1	0.4	0.0	4.4	0.4	0.2	0.1	0.7	0.6	187.7	0.6	0.6	0.1	6.1	0.2	0.4	0.2	2.8	0.0	0.3	18.5	0.3	0.2	0.2	2.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.5	2.4	1.4	1.2	2.9	3.8	5.6	0.4	4.4	6.1	2.8	2.8	0.3	0.0	0.5	0.0	0.0	4.7	1.2	9.2	2.2	0.0	0.3	2.4	0.3	0.0	10.1	0.0	2.1	0.2	0.3	0.0	0.0	0.2	0.3	108.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.1	0.4	0.5	0.1	0.0	0.1	0.0	24.4	0.0	0.7	0.3	0.3	0.3	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	3.3	126.4	0.2	0.0	3.1	3.3	0.2	0.2	2.0	2.0	0.0	0.3	2.1	0.2	0.5
FGF9		ENSG00000102678	"Fibroblast growth factor 9"	P31371	13	21671073-21704498	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9;kidney: 10.9;retina: 8.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Excitatory neurons: 36.7;Horizontal cells: 40.4;Inhibitory neurons: 54.7;Muller glia cells: 138.8"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 3.7;ovarian cancer: 1.2;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;HEK 293: 1.4;JURKAT: 2.1;RPMI-8226: 2.1;RPTEC TERT1: 3.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067007	Enhanced	Approved			"Secreted in other tissues"	NA	NA					"HPA067007: AB_2732755"	"unprognostic (6.59e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.42e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.38e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (1.70e-6)"	"unprognostic (5.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.92e-2)"	1.2	4.0	1.6	0.1	1.6	0.2	0.2	5.9	4.8	1.6	0.5	0.8	0.7	1.6	0.2	0.2	0.4	0.4	2.7	1.6	2.0	10.9	0.0	0.9	0.1	3.5	2.2	1.3	1.1	0.5	0.1	2.2	0.1	4.5	0.3	1.2	8.3	0.3	0.5	0.5	0.1	1.8	0.3	1.4	0.1	0.8	0.5	3.4	0.1	0.1	0.5	0.0	1.3	0.8	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.6	2.1	3.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	5.9	4.8	1.6	2.0	3.5	2.2	1.3	4.5	1.4	3.4	4.3	0.9	9.6	5.6	12.1	1.8	1.7	0.2	0.6	0.0	14.4	0.7	2.7	25.7	0.0	1.3	3.7	0.0	0.1	3.2	1.7	39.2	0.4	9.4	13.1	2.6	1.6	18.6	0.0	36.7	0.0	0.0	3.9	0.0	26.6	0.0	1.2	0.0	0.0	0.1	40.4	54.7	2.7	0.0	0.0	1.6	2.9	0.6	0.5	1.8	1.9	1.6	138.8	3.1	9.5	1.7	0.2	0.5	0.0	1.9	0.1	10.9	1.1	0.0	5.9	0.0	1.0	0.7	6.3	6.2	0.1	1.4	0.3	3.2	0.1	7.5	0.1
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493201	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Phagocytosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 261.6;Glandular and luminal cells: 116.5;granulocytes: 638.7;Syncytiotrophoblasts: 321.4"	"Group enriched"	"Detected in all"	5	"endometrial cancer: 12.7;prostate cancer: 36.7;urothelial cancer: 13.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	330	"basophil: 513.2"	"Lineage enriched"	"Detected in single"	4344	"granulocytes: 513.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 281.0;HEL: 360.7;HMC-1: 187.4;SH-SY5Y: 325.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (5.22e-5)"	15.1	9.9	8.2	2.8	4.2	5.1	12.9	3.5	4.8	31.7	4.0	6.0	4.4	43.0	7.2	4.9	50.1	10.8	15.1	3.6	2.9	18.1	1.3	35.1	2.8	6.9	6.2	1.6	4.3	13.8	7.0	9.8	22.7	8.0	54.8	2.9	0.1	4.9	52.7	6.5	8.1	8.6	10.9	3.5	11.5	6.7	2.8	7.0	0.8	7.4	5.3	1.3	34.1	24.1	5.6	24.4	5.9	1.3	15.9	2.0	0.6	281.0	53.8	45.2	18.0	6.5	10.0	10.7	0.5	14.8	31.9	1.5	25.5	14.7	0.0	7.6	0.0	8.3	360.7	42.9	16.0	4.0	36.8	187.4	0.3	0.3	0.7	0.3	2.9	28.6	0.2	96.7	0.5	0.4	9.0	0.1	74.2	1.0	0.2	1.8	0.1	7.0	0.4	0.5	21.5	21.8	325.9	13.6	70.1	2.4	14.4	13.5	15.0	52.0	1.2	0.7	12.7	7.4	0.1	0.0	0.2	0.6	2.5	3.7	513.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	8.2	4.2	3.5	4.8	3.6	2.9	6.9	6.2	1.6	8.0	3.5	7.0	5.6	69.0	6.4	27.7	0.0	0.9	4.8	25.5	0.0	1.2	0.2	1.5	1.5	5.7	0.0	1.8	75.4	0.0	63.4	2.3	0.5	1.9	0.2	10.1	74.2	43.2	75.4	3.0	62.4	0.0	14.2	261.6	8.8	0.5	116.5	638.7	0.9	57.5	0.2	10.8	0.0	0.0	0.3	0.0	0.3	4.6	6.4	0.6	7.9	8.8	15.9	0.7	0.1	0.0	0.0	0.0	0.9	0.0	0.4	5.4	29.5	0.0	0.2	0.7	0.2	0.0	2.2	11.0	0.6	4.7	0.9	2.4	321.4	14.0	0.2	0.3	10.5
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621156-48626358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 88.6;intestine: 26.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal enterocytes: 30.4;Distal tubular cells: 39.2;Enteroendocrine cells: 176.7;Intestinal goblet cells: 40.7;Undifferentiated cells: 45.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 56.0;endometrial cancer: 26.4"	"Group enriched"	"Detected in some"	14	"spinal cord: 2.3;white matter: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 339.3;HEK 293: 126.4;HMC-1: 127.7;K-562: 145.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	69	"spinal cord: 6.8"	HPA004928			Supported	Nucleoplasm		NA	No			Nucleoplasm		"HPA004928: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.4	1.0	0.0	4.7	0.0	0.0	0.5	0.0	0.0	11.5	0.0	26.5	0.0	0.9	88.6	0.0	0.3	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.4	22.5	0.0	0.0	16.0	0.1	0.1	13.5	1.3	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.3	1.0	18.0	5.8	0.0	32.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.6	7.0	0.1	34.6	0.9	3.9	0.1	5.5	0.0	0.0	339.3	126.4	59.1	2.3	0.0	2.3	1.1	127.7	0.1	0.2	0.1	3.3	9.8	0.0	2.7	145.7	0.1	5.5	0.3	0.0	0.4	0.0	8.0	5.4	0.3	21.9	1.9	57.1	0.2	0.0	0.0	4.4	0.0	37.4	0.5	0.6	0.3	0.4	0.1	32.1	0.2	10.4	0.2	0.4	0.2	0.1	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	1.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	58.8	0.0	0.0	0.5	30.4	39.2	0.0	0.1	5.5	0.4	3.0	176.7	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.3	6.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.0	0.4	0.0	45.5	0.2
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580302	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 70.5;testis: 25.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 78.0;Late spermatids: 140.7;Melanocytes: 119.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.5;lung cancer: 0.5;stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 12.0;naive B-cell: 14.8"	"Lineage enriched"	"Detected in many"	11	"B-cells: 14.8"	"Cell line enriched"	"Detected in some"	32	"REH: 787.7"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		48000000000	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.2	0.3	0.2	70.5	0.0	0.3	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	1.4	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.2	25.4	0.2	10.2	0.0	0.0	1.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	14.3	2.6	0.0	0.0	0.0	787.7	0.3	17.3	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.1	6.2	0.0	0.0	0.3	0.3	0.0	0.6	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.2	0.2	0.3	0.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.9	0.0	78.0	0.2	0.3	0.3	0.0	10.5	0.3	0.0	0.4	0.6	0.0	0.5	0.0	0.2	0.7	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	140.7	1.2	0.4	119.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	6.2	0.0	0.0	0.0	1.5	0.3	17.1	0.6	0.0	0.3	0.0	17.9	0.1	0.0	0.2
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831634-47837719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"fallopian tube: 79.1;testis: 54.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 143.1;Endometrial ciliated cells: 166.7;Late spermatids: 61.5;Respiratory ciliated cells: 225.8;Spermatocytes: 125.7"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 11.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA021882: AB_1853320, HPA074893: AB_2732271"	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.2	0.3	3.7	0.1	1.0	0.5	0.3	1.9	0.8	1.8	3.4	0.1	0.1	1.1	0.9	0.2	79.1	0.2	0.3	0.9	2.5	0.6	0.5	4.9	0.3	1.9	3.6	0.3	0.3	0.5	0.2	1.7	0.1	2.8	0.5	0.0	2.4	0.3	0.3	0.1	0.1	0.2	0.0	3.9	0.5	0.2	54.7	1.9	0.4	0.9	0.0	0.1	0.2	0.2	2.2	0.7	2.8	0.3	1.4	0.2	0.4	0.8	0.1	0.8	0.7	1.3	1.1	0.7	0.2	1.7	0.3	0.8	0.7	0.3	0.6	1.1	1.1	1.2	0.6	0.9	0.5	0.1	0.0	0.7	0.0	0.5	1.7	0.5	0.2	0.1	0.4	0.6	0.4	1.1	1.2	1.1	0.0	0.1	0.2	0.4	0.9	0.0	0.6	1.4	0.5	1.2	0.9	0.3	0.0	0.5	0.1	3.6	0.1	0.2	1.6	0.5	0.2	0.2	0.6	0.5	0.5	1.1	0.2	0.1	1.3	0.4	0.5	0.0	0.5	0.0	0.1	0.0	0.3	0.7	0.1	0.2	0.0	0.5	0.8	0.4	0.3	0.0	0.1	3.7	1.0	1.9	0.8	0.9	2.5	1.9	3.6	0.3	2.8	3.9	1.9	2.2	0.3	0.0	2.3	0.0	0.5	0.0	0.3	9.7	0.0	0.6	0.7	0.9	0.5	1.5	21.9	5.5	2.1	0.1	0.4	0.2	0.0	0.9	143.1	166.7	1.9	0.4	0.0	0.4	0.2	0.0	0.5	1.2	0.0	3.3	0.0	0.3	0.0	0.1	0.5	0.0	0.3	0.6	12.2	0.0	0.3	61.5	2.8	1.0	0.0	1.0	0.8	1.0	0.0	0.0	0.4	0.6	1.1	1.9	0.2	0.3	0.1	1.4	225.8	7.0	0.0	0.4	3.7	125.7	4.2	0.0	0.0	0.1	0.7	0.3	0.0	0.2
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 4295.9;salivary gland: 1172.0"	"Cell type enriched"	"Detected in many"	5	"Breast glandular cells: 1519.6"	"Group enriched"	"Detected in all"	5	"breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"neutrophil: 5.4;non-classical monocyte: 17.0"	"Group enriched"	"Detected in many"	23	"granulocytes: 5.4;monocytes: 17.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 43.2;TIME: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted to blood"	NA	NA		350000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	4.9	1.2	2.3	36.4	3.2	4295.9	336.8	6.5	4.2	663.9	2.5	2.8	1.2	4.2	158.8	23.2	4.4	7.6	4.2	3.0	6.8	102.3	3.3	29.7	8.7	4.6	20.2	0.7	0.5	18.8	6.2	7.0	3.1	10.5	155.5	2.2	0.9	1172.0	382.4	1.7	11.9	5.2	1.9	7.2	71.0	334.6	0.4	16.1	30.0	10.2	1.7	348.4	2.4	1.2	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.6	43.2	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	14.3	0.0	0.3	1.2	0.1	0.6	0.0	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	17.0	0.4	0.0	29.5	2.3	3.2	6.5	4.2	3.0	6.8	4.6	20.2	0.7	10.5	7.2	16.1	9.6	15.5	0.0	2.8	0.7	4.3	1.1	8.6	82.8	0.0	0.0	1519.6	198.4	1.0	2.8	298.0	71.7	0.0	0.0	6.2	0.1	0.0	1.4	1.2	0.3	0.2	8.8	0.0	3.0	0.1	0.9	0.2	2.5	56.1	2.3	1.3	0.1	5.0	0.0	0.0	0.0	0.0	0.2	14.2	0.0	0.7	1.5	5.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.1	78.6	0.0	18.6	14.9	0.0	0.0	0.3	9.9	0.2	0.1	15.4	0.1	0.1	4.0	0.1	0.1	101.7
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528962-31530232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	71	"kidney: 80.3"	"Group enriched"	"Detected in some"	44	"Distal tubular cells: 401.1;Proximal tubular cells: 414.8"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;endometrial cancer: 0.8;liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	80.3	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.2	0.4	0.2	0.1	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	401.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1
MEGF11	"DKFZp434L121, KIAA1781"	ENSG00000157890	"Multiple EGF like domains 11"	A6BM72	15	65895079-66253747	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.4;fallopian tube: 7.9;kidney: 8.2;retina: 14.4"	"Group enriched"	"Detected in many"	9	"Early spermatids: 175.8;Horizontal cells: 126.2;Late spermatids: 177.8;Oligodendrocyte precursor cells: 460.4"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.7;glioma: 2.3;renal cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;HEK 293: 2.7;RPTEC TERT1: 9.2;SCLC-21H: 7.2;U-698: 2.0"	"Region enriched"	"Detected in all"	4	"cerebellum: 35.0"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.8"							NA	NA						"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.84e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.81e-3)"	"unprognostic (5.71e-5)"	"unprognostic (7.94e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.89e-2)"	0.0	0.1	8.0	0.2	4.9	0.3	0.1	22.4	6.5	0.1	0.1	0.1	0.0	0.1	0.8	0.1	7.9	0.1	0.1	9.0	6.7	8.2	0.0	0.5	0.1	6.1	8.2	4.2	0.3	0.2	0.0	3.1	0.0	9.8	0.1	0.0	14.4	0.1	0.1	0.1	1.3	0.1	0.0	4.7	0.2	0.3	3.9	6.5	0.1	0.1	0.0	0.0	0.0	0.1	7.0	0.0	0.1	0.3	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.2	0.0	0.1	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	0.0	0.0	9.2	0.2	7.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.9	22.4	6.5	9.0	6.7	6.1	8.2	4.2	9.8	4.7	6.5	7.0	0.2	0.0	3.7	5.2	0.4	2.2	0.7	1.0	0.6	5.3	0.8	0.0	1.4	0.0	0.3	3.7	8.4	0.3	0.4	0.0	0.0	0.1	175.8	0.3	0.3	1.5	0.0	0.4	9.5	0.2	0.1	0.7	2.6	0.8	0.0	0.2	2.9	0.0	0.1	126.2	18.4	0.0	0.0	0.3	3.5	177.8	2.5	0.4	0.0	1.0	0.0	4.4	0.0	460.4	1.7	0.1	0.1	1.5	1.3	0.6	0.0	2.2	0.8	25.7	0.0	1.0	0.5	2.9	1.9	0.6	3.8	0.5	0.9	0.1	0.0	0.5
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206053173-206102449	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.6"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 202.9;Glandular and luminal cells: 337.5;granulocytes: 334.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 42.8;ovarian cancer: 41.1;renal cancer: 27.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	152	"basophil: 1312.1"	"Lineage enriched"	"Detected in single"	1544	"granulocytes: 1312.1"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 1562.9"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	3.2	0.4	0.0	3.0	0.0	1.4	4.7	0.0	0.0	24.6	0.0	7.6	3.3	12.9	16.4	7.8	5.4	16.4	0.9	0.0	0.0	14.2	1.0	10.8	4.2	0.0	0.1	0.0	0.2	1.4	0.3	0.4	0.6	0.0	2.9	7.5	0.0	2.8	20.2	1.0	4.1	6.7	7.4	0.0	3.0	6.5	1.0	0.2	3.1	2.0	2.6	4.6	7.8	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	143.8	0.0	0.9	0.0	75.2	1562.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	330.8	0.0	0.0	0.0	0.1	0.2	0.7	20.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.6	0.9	1.1	0.8	1312.1	0.0	8.6	0.0	0.1	0.1	0.5	0.2	0.0	0.6	0.2	0.1	0.2	0.5	0.0	0.2	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	13.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	20.2	0.0	2.3	0.7	0.0	1.9	3.6	0.0	202.9	17.6	1.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	337.5	334.3	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0
ROPN1L	"ASP, FLJ25776, RSPH11"	ENSG00000145491	"Rhophilin associated tail protein 1 like"	Q96C74	5	10441524-10472029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 325.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 3125.2;Late spermatids: 3173.9;Spermatocytes: 987.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 9.6;ovarian cancer: 3.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"basophil: 45.1;eosinophil: 55.0;neutrophil: 105.3"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 105.3"	"Cell line enriched"	"Detected in some"	5	"NB-4: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039193, HPA041830"	Enhanced					NA	NA					"HPA039193: AB_10673415, HPA041830: AB_2677695"	"unprognostic (2.39e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.22e-2)"	0.7	0.2	3.8	0.3	1.4	4.4	0.8	2.4	1.2	1.2	5.3	0.2	0.0	0.8	0.0	0.1	27.7	0.3	0.6	1.6	3.6	0.7	0.3	5.4	0.4	4.4	4.1	0.3	0.2	1.1	0.0	1.2	0.2	4.7	0.6	0.0	1.0	0.1	0.1	0.2	0.3	0.3	0.0	5.5	4.5	0.3	325.5	1.6	0.2	0.8	0.3	0.0	0.2	0.2	2.2	0.1	0.4	0.0	0.0	0.4	0.0	0.5	0.0	0.6	0.5	0.5	0.1	0.1	0.0	1.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.7	0.0	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.1	0.0	0.1	0.0	13.4	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.9	1.5	0.1	0.1	0.4	0.0	1.5	1.6	0.3	45.1	0.8	55.0	4.0	0.3	2.7	0.0	3.5	4.7	0.1	0.0	2.3	2.7	105.3	0.4	1.4	0.0	5.8	2.1	3.8	1.4	2.4	1.2	1.6	3.6	4.4	4.1	0.3	4.7	5.5	1.6	2.2	2.0	3.2	2.0	1.6	0.1	0.3	0.0	38.0	0.0	0.2	0.4	0.4	0.4	0.0	45.3	0.0	0.0	0.0	2.2	0.0	0.0	1.0	3125.2	311.3	2.0	4.0	0.0	0.0	5.4	0.0	0.1	0.9	0.0	3.4	1.3	0.0	7.5	0.2	0.1	3.3	4.0	0.0	38.7	0.6	0.3	3173.9	36.1	2.2	0.0	0.0	0.2	0.2	0.0	1.0	0.3	0.1	0.0	18.4	0.1	0.3	0.0	1.3	482.3	3.3	13.1	0.4	14.1	987.8	35.8	0.0	0.1	0.1	0.8	2.9	0.0	0.1
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208673-62213943	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 2037.7;epididymis: 1384.0"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 971.9"	"Region enriched"	"Detected in single"	5	"medulla oblongata: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 8.6"									HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (1.22e-4)"	"prognostic favorable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.1	0.0	0.2	0.2	0.5	0.0	58.4	0.1	0.1	2037.7	0.1	12.9	1.3	119.7	1384.0	4.2	240.5	13.6	0.1	0.2	0.4	1.7	0.1	2.4	0.0	3.4	0.4	0.0	0.7	17.3	1.1	5.1	0.1	0.7	6.9	16.5	0.0	29.8	15.7	0.0	7.1	1.0	2.2	0.7	0.0	46.3	0.0	0.7	2.7	5.8	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	1.6	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.2	0.4	3.4	0.4	0.0	0.7	0.7	0.7	0.2	0.6	0.0	4.8	0.0	0.4	0.1	3.8	4.8	0.0	0.0	123.6	71.0	0.0	48.6	10.1	16.5	0.0	0.2	1.6	9.7	3.9	6.6	0.0	2506.4	397.7	7.6	37.1	0.0	0.0	5.3	0.0	3.8	26.5	2597.0	0.0	0.3	0.0	0.1	4.9	0.0	0.0	59.9	10.2	0.3	0.0	0.0	0.0	14.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	15.3	10.8	0.0	0.0	27.0	0.7	0.1	109.3	0.0	0.0	0.0	8.5	0.0	0.0	1.7	0.4	0.0	13.7	0.1	7.0	16.6
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 20.7;testis: 21.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 34.9;Erythroid cells: 60.4;Late spermatids: 31.8;Spermatocytes: 43.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7;classical monocyte: 6.9"	"Group enriched"	"Detected in many"	56	"dendritic cells: 4.0;granulocytes: 5.7;monocytes: 6.9"	"Group enriched"	"Detected in some"	18	"NB-4: 16.9;REH: 14.6;THP-1: 53.1;U-937: 30.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	0.3	0.0	0.1	0.7	0.2	20.7	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.1	0.0	0.0	3.8	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	0.5	0.0	21.6	0.1	1.2	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	30.9	0.0	5.7	6.9	1.3	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.4	0.1	0.0	0.0	60.4	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	1.8	0.5	31.8	1.5	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	43.1	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 54.6;intestine: 65.8;kidney: 40.6;liver: 22.6"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047612	Enhanced					NA	NA					"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.1	0.1	0.2	1.2	0.5	2.8	0.2	1.0	0.3	1.7	0.1	3.3	26.6	0.7	0.0	0.3	54.6	2.4	0.1	0.3	0.4	40.6	22.6	0.9	1.7	0.8	2.1	0.0	0.4	1.2	0.3	0.2	0.1	0.7	6.3	1.5	0.6	3.2	0.6	0.4	1.9	65.8	0.2	0.2	1.3	1.5	0.2	0.8	5.5	0.2	0.0	1.3	0.4	0.3	0.6	0.3	2.1	0.4	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.4	1.3	5.8	3.0	0.0	0.1	0.3	0.0	0.0	0.1	8.3	0.1	0.2	0.8	13.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	15.5	0.1	10.9	0.0	0.2	5.7	1.0	0.1	0.8	0.1	6.8	0.3	10.9	0.5	0.4	0.3	0.3	0.3	1.9	0.0	0.7	5.0	0.1	0.3	0.3	0.3	0.1	0.0	16.6	2.2	7.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.2	0.5	1.0	0.3	0.3	0.4	0.8	2.1	0.0	0.7	0.2	0.8	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.3	1.5	2.0	0.0	4.2	0.4	0.4	1.9	5.9	0.2	0.0	65.2	0.7	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.5	0.0	0.1	0.4	19.3	0.1	0.0	1.2	3.6	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.1	3.1	0.0	0.4	0.9	131.7	27.0	13.4	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.2
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135704498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 29.1;choroid plexus: 12.1;testis: 17.0"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 78.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 2.3;endometrial cancer: 0.6;head and neck cancer: 2.3;lung cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 20.9;U-266/84: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA059439			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.1	0.0	13.4	0.0	15.7	0.0	0.0	12.8	29.1	0.0	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.1	12.7	0.0	0.0	0.0	0.0	16.4	13.4	14.5	0.1	0.0	0.1	3.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	12.3	0.1	0.1	17.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.7	12.8	29.1	15.1	12.7	16.4	13.4	14.5	16.8	12.3	12.8	18.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	15.9	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	78.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 120.9"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 191.1;Glandular and luminal cells: 249.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.84e-4)"	"prognostic favorable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.69e-4)"	10.3	16.1	8.6	11.0	9.7	12.1	11.0	9.1	10.5	120.9	13.5	13.0	18.3	54.4	8.3	10.8	49.0	14.1	13.1	8.5	9.7	29.5	15.9	10.9	13.3	10.2	9.1	7.9	11.4	22.7	17.0	14.7	12.9	9.8	10.7	13.5	8.4	12.2	9.0	16.6	12.1	15.8	15.9	7.9	10.7	18.6	30.7	9.8	9.5	11.4	10.0	12.5	11.1	11.9	9.7	26.6	16.7	19.3	20.0	16.2	23.7	26.1	30.1	26.9	27.6	22.8	35.5	37.3	35.1	69.7	27.1	24.9	13.9	34.6	17.2	27.0	15.1	18.6	22.0	22.3	43.4	24.2	38.6	17.8	22.2	14.7	23.4	16.9	15.4	23.5	27.5	21.7	30.0	19.9	14.0	35.6	27.2	26.0	21.3	36.1	31.4	14.6	28.2	28.2	15.6	24.7	22.0	22.2	14.7	26.4	16.5	21.6	18.3	27.2	16.7	18.4	15.4	32.1	21.6	35.4	40.1	20.4	29.3	21.0	10.6	15.6	10.8	15.1	16.0	18.2	16.7	14.0	13.7	23.8	14.4	11.7	13.4	3.1	16.9	20.6	37.6	14.3	14.0	8.6	9.7	9.1	10.5	8.5	9.7	10.2	9.1	7.9	9.8	7.9	9.8	9.7	17.5	32.1	9.0	52.5	15.8	7.9	8.3	20.3	9.6	39.3	14.4	11.6	20.4	18.6	25.3	20.2	20.9	31.0	27.9	33.8	70.5	32.5	80.6	191.1	38.4	14.8	4.9	15.6	40.2	27.9	19.0	18.5	23.9	249.4	8.2	21.6	6.8	10.8	28.1	10.1	48.0	22.8	32.6	13.7	12.4	76.5	14.0	21.3	14.2	48.7	26.5	25.8	16.5	37.7	56.4	36.5	28.8	14.7	20.4	15.7	32.8	25.2	34.5	17.7	6.6	13.1	18.1	94.9	35.7	13.1	9.7	31.7	18.9	27.2	20.0	13.9
TEKT4	MGC27019	ENSG00000163060	"Tektin 4"	Q8WW24	2	94871430-94876823	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 13.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 137.1;Endometrial ciliated cells: 49.0;Late spermatids: 129.3;Respiratory ciliated cells: 51.6"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 2.9"	"HPA048600, HPA053929, HPA069872"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: "	"unprognostic (1.49e-2)"	"unprognostic (4.00e-1)"		"prognostic favorable (1.29e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-3)"	"unprognostic (5.45e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.56e-3)"	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.4	0.1	0.0	0.6	0.5	0.8	0.0	0.5	0.5	0.4	0.3	3.6	0.0	1.5	2.9	0.4	1.5	0.1	1.9	0.0	0.0	0.7	0.6	0.5	7.2	4.7	1.8	0.0	0.5	0.1	0.3	1.9	1.9	137.1	49.0	1.3	1.3	0.0	0.0	1.3	0.4	0.5	1.1	0.0	0.9	1.3	0.1	1.8	1.5	0.2	0.0	0.9	0.2	0.0	1.6	0.5	129.3	2.8	0.8	0.0	1.0	2.6	0.0	0.0	2.0	2.3	0.8	0.0	1.2	0.0	0.4	0.0	8.3	51.6	0.0	6.6	0.6	0.9	12.4	2.4	0.0	1.3	0.5	0.5	0.0	0.2	0.4
TMEM211	bA9F11.1	ENSG00000206069	"Transmembrane protein 211"	Q6ICI0	22	24934954-24946695	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 2.6;salivary gland: 5.8;stomach 1: 3.2"	"Cell type enriched"	"Detected in some"	19	"Ionocytes: 36.7"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 4.8;endometrial cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066784	Uncertain					NA	NA					"HPA066784: AB_2685722"	"unprognostic (7.89e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.09e-2)"		"unprognostic (5.97e-3)"		"unprognostic (5.88e-2)"		"unprognostic (1.31e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.1	0.3	0.3	0.0	0.5	0.4	0.2	2.6	0.0	0.3	0.0	0.6	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	5.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.3	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974688-129977935	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 110.9;cervix: 26.2;retina: 35.5"	"Cell type enriched"	"Detected in some"	10	"Muller glia cells: 234.5"	"Group enriched"	"Detected in some"	5	"breast cancer: 13.3;endometrial cancer: 10.2;glioma: 4.3"	"Group enriched"	"Detected in many"	5	"hypothalamus: 28.6;medulla oblongata: 110.9;pons: 41.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.0"	"Group enriched"	"Detected in many"	5	"hypothalamus: 175.6;olfactory bulb: 148.0"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"	NA	NA					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.2	0.0	11.2	0.1	3.1	3.8	1.9	1.9	0.9	26.2	0.2	0.0	0.1	18.9	0.0	0.0	2.5	0.0	0.3	2.2	28.6	0.1	0.0	0.6	0.0	110.9	4.5	0.6	3.9	0.0	0.0	0.2	0.2	41.3	0.1	0.0	35.5	0.5	0.1	0.1	0.5	0.0	0.3	1.7	0.1	0.0	1.3	10.1	0.4	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	3.1	1.9	0.9	2.2	28.6	110.9	4.5	0.6	41.3	1.7	10.1	2.7	0.3	0.0	0.0	0.3	0.2	0.8	0.7	0.0	0.0	10.4	1.6	1.4	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	9.0	0.8	0.7	0.0	0.0	0.2	0.0	0.1	0.2	0.0	22.5	0.0	0.1	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	11.5	2.7	0.0	2.0	0.0	0.0	0.0	234.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.7	1.6	0.0	0.1	0.1	0.2	0.1	0.0	4.3
WIF1		ENSG00000156076	"WNT inhibitory factor 1"	Q9Y5W5	12	65050626-65121305	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 232.4;retina: 605.0"	"Cell type enriched"	"Detected in many"	13	"Muller glia cells: 2736.1"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 16.9;lung cancer: 14.6"	"Region enriched"	"Detected in all"	5	"hypothalamus: 232.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.2;LHCN-M2: 1.0;NTERA-2: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (5.96e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.29e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.30e-5)"	"unprognostic (3.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.24e-3)"	0.6	2.7	21.6	0.3	31.6	0.0	23.1	14.2	45.0	1.6	13.7	0.3	0.0	8.7	24.0	4.7	1.6	0.0	0.3	23.5	232.4	0.7	0.0	118.5	0.1	17.4	14.4	21.9	1.2	0.3	0.0	46.8	0.0	18.9	14.4	0.3	605.0	45.5	2.8	0.1	6.6	2.2	0.9	13.6	0.1	1.4	0.7	18.5	0.2	0.0	0.7	0.0	1.7	2.2	18.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	31.6	14.2	45.0	23.5	232.4	17.4	14.4	21.9	18.9	13.6	18.5	18.7	0.0	35.3	197.8	186.1	0.0	12.6	34.5	0.0	2.2	25.0	0.7	13.7	1.6	0.0	26.6	1.8	8.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	4.7	0.0	0.0	0.6	0.0	0.0	27.8	0.5	0.1	7.6	1.0	0.0	0.0	0.0	15.2	46.5	0.0	0.0	0.0	20.4	0.0	0.0	0.8	23.2	12.2	0.0	2736.1	0.0	1.5	0.9	0.0	0.0	0.4	0.2	25.5	0.0	1.2	34.2	80.8	0.0	1.8	1.5	2.5	2.0	0.4	10.5	0.0	1.2	0.0	0.0	0.8
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 subunit sigma 2"	P56377	X	15825806-15854931	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 669.1"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 221.1;monocytes: 326.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 298.0;SK-MEL-30: 442.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	28.6	21.6	31.6	37.0	33.6	38.6	15.2	35.7	37.2	31.8	31.4	34.0	12.0	52.7	669.1	21.6	13.6	20.3	75.5	28.0	51.7	13.3	16.0	26.0	33.5	43.8	40.2	30.1	8.9	7.9	16.8	19.6	42.3	48.5	11.7	22.3	44.1	9.5	30.8	70.7	14.1	20.3	77.0	37.4	43.3	19.6	23.7	35.1	29.0	12.6	94.6	29.0	26.3	12.8	61.3	12.0	14.2	130.1	78.4	29.5	19.1	5.0	47.1	22.7	31.1	41.1	9.6	11.1	22.6	183.0	72.6	50.4	16.1	31.7	10.8	57.0	30.1	64.9	15.3	16.7	14.7	24.2	63.1	16.9	12.2	11.2	36.0	33.1	50.4	78.1	19.1	14.3	298.0	72.4	8.7	12.9	39.5	171.0	6.4	42.5	29.5	116.7	50.6	37.4	2.5	14.8	69.2	18.4	4.8	442.2	84.1	52.7	69.2	43.9	67.8	21.2	92.5	41.9	25.5	58.7	37.3	33.6	28.0	159.7	50.9	326.8	34.6	21.1	325.0	24.8	30.8	25.5	20.6	221.1	28.0	18.5	18.1	52.8	27.9	175.4	82.2	38.1	228.0	31.6	33.6	35.7	37.2	28.0	51.7	43.8	40.2	30.1	48.5	37.4	35.1	61.3	130.8	3.2	13.1	37.2	77.0	55.2	12.7	9.1	8.6	34.7	12.0	11.4	195.6	12.8	3.2	9.2	12.5	5.3	114.2	9.2	33.2	13.7	5.1	50.4	32.6	166.3	26.9	32.6	15.1	6.4	18.9	38.0	7.7	78.0	78.6	15.6	147.4	8.6	259.8	11.8	73.2	8.4	12.2	392.6	609.2	17.5	17.4	362.7	149.4	31.9	630.0	21.1	62.8	19.1	85.0	10.3	14.0	7.2	26.0	19.0	6.5	9.0	1.6	39.3	39.5	26.7	39.1	55.7	28.8	10.6	51.6	5.6	58.3	4.0	8.5	6.7
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810024-24949101	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 58.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.8;monocytes: 17.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		97000			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	6.7	5.9	5.2	7.1	7.1	2.4	2.1	9.8	9.7	3.7	1.0	2.8	0.8	8.7	1.0	2.0	7.3	4.5	1.5	2.5	15.1	1.2	1.3	9.7	6.4	17.0	18.2	2.3	7.3	58.7	0.4	6.6	15.3	19.4	0.9	2.6	14.6	1.7	0.8	0.7	0.6	3.6	5.8	6.6	2.0	1.8	7.1	13.6	5.3	1.2	2.0	5.3	4.2	1.3	23.1	30.3	12.1	106.8	0.2	30.5	59.0	54.9	60.9	40.6	33.4	55.2	67.1	83.1	114.0	0.3	100.7	6.5	12.0	77.2	0.5	88.2	261.3	15.4	91.1	2.0	37.3	112.3	105.9	31.6	77.4	2.0	85.1	17.8	73.0	114.3	56.9	88.5	1.1	28.7	0.6	65.2	30.1	287.4	0.0	8.1	0.1	310.3	1.4	0.1	10.4	0.1	60.1	0.1	0.2	0.5	114.8	0.2	45.2	150.8	19.7	72.9	80.4	58.1	13.2	13.9	152.7	69.9	62.4	0.3	0.0	2.3	0.0	0.0	3.6	0.1	1.1	0.0	0.1	5.8	0.0	0.0	0.0	1.0	0.1	17.1	3.4	0.2	1.0	5.2	7.1	9.8	9.7	2.5	15.1	17.0	18.2	2.3	19.4	6.6	13.6	23.1	1.7	16.0	26.0	1.6	1.3	8.7	0.1	2.5	0.0	203.2	0.3	0.3	1.6	1.5	2.2	0.0	2.1	61.2	4.3	0.0	1.9	1.8	161.4	41.5	92.6	16.8	0.0	20.8	39.6	139.9	23.2	27.6	0.0	89.1	11.4	117.4	7.9	0.3	72.3	42.1	81.8	0.0	14.2	87.1	265.8	370.3	7.2	59.9	7.2	38.4	22.3	7.1	0.0	84.4	57.4	49.6	0.0	4.1	0.7	0.2	0.0	0.1	3.3	12.2	6.6	14.9	17.4	1.9	1.6	0.5	7.2	22.4	2.8	41.3	0.1	0.1
BEX5	NGFRAP1L1	ENSG00000184515	"Brain expressed X-linked 5"	Q5H9J7	X	102153708-102155977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 127.6;pituitary gland: 78.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 171.6;Distal tubular cells: 137.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 45.7;thyroid cancer: 14.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 6.2;MAIT T-cell: 15.5;memory CD4 T-cell: 11.6;memory CD8 T-cell: 8.1;naive CD4 T-cell: 16.4;naive CD8 T-cell: 10.1;NK-cell: 10.1;T-reg: 11.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 10.1;T-cells: 16.4"	"Group enriched"	"Detected in some"	4	"HAP1: 16.4;Karpas-707: 61.9"					"Low region specificity"	"Detected in all"			HPA059058	Enhanced					NA	NA					"HPA059058: AB_2683894"	"unprognostic (1.88e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.79e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-2)"	3.2	15.7	72.1	3.7	77.3	2.1	7.8	58.9	127.6	4.1	51.0	5.2	4.0	6.3	33.6	1.9	5.0	13.1	3.8	80.8	101.0	20.1	3.5	13.8	4.9	77.6	80.6	76.9	13.8	26.5	33.9	78.1	0.0	77.6	6.6	6.1	31.0	7.6	3.7	0.5	3.4	3.4	3.4	62.9	4.4	8.3	13.2	81.9	1.1	26.0	0.5	7.8	2.1	3.4	113.5	0.0	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	0.3	1.4	16.4	0.3	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	2.4	0.4	0.1	6.0	2.5	61.9	0.3	7.1	0.4	0.1	7.3	0.0	2.6	0.0	0.0	0.2	5.8	0.0	8.9	0.9	0.1	0.1	0.0	1.2	1.6	0.0	6.0	0.4	4.2	0.5	0.0	7.1	4.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	6.2	0.0	15.5	2.1	11.6	8.1	0.1	0.9	16.4	10.1	0.0	10.1	0.0	0.8	11.9	2.9	72.1	77.3	58.9	127.6	80.8	101.0	77.6	80.6	76.9	77.6	62.9	81.9	113.5	9.0	3.2	5.6	4.2	12.2	14.9	24.2	0.1	10.2	53.2	25.9	32.1	19.4	171.6	7.4	38.6	0.0	0.0	13.4	2.1	137.0	16.5	1.3	6.7	0.7	16.3	35.9	1.7	18.1	22.8	0.1	5.8	2.6	8.4	22.8	25.1	26.7	18.2	0.3	57.2	14.0	31.9	0.0	0.8	6.2	7.0	2.5	1.3	30.2	6.5	6.0	55.5	7.2	6.6	3.5	8.5	2.5	0.4	24.5	16.4	0.5	23.2	6.8	25.4	0.0	8.8	2.3	2.1	1.2	4.3	11.2	0.0	13.4	21.5	6.2	11.0
C20orf85	"bA196N14.1, LLC1"	ENSG00000124237	"Chromosome 20 open reading frame 85"	Q9H1P6	20	58150902-58161150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"fallopian tube: 459.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 412.1;Endometrial ciliated cells: 1096.5;Late spermatids: 413.4;Respiratory ciliated cells: 1504.4"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 57.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.6"	"Region enhanced"	"Detected in many"		"midbrain: 20.0"	"HPA058271, HPA065540"	Enhanced					NA	NA					"HPA058271: AB_2683661, HPA065540: AB_2685510"				"unprognostic (4.50e-3)"				"unprognostic (1.87e-1)"		"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.46e-2)"		"unprognostic (3.62e-1)"	"unprognostic (2.79e-2)"			0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.4	0.0	8.6	1.1	0.0	0.0	5.1	0.2	0.0	459.2	0.0	0.0	0.1	0.9	0.1	0.0	25.7	0.0	2.0	2.0	0.0	0.3	0.0	0.0	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.8	0.1	0.1	78.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.4	0.0	0.1	0.9	2.0	2.0	0.0	1.0	2.8	0.9	0.1	0.0	0.0	9.9	0.0	0.0	0.0	0.0	98.3	0.0	0.0	0.0	0.0	0.0	0.0	122.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	412.1	1096.5	6.2	0.9	0.0	0.0	0.1	0.0	0.0	1.2	0.0	11.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	120.1	0.0	0.0	413.4	3.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.1	1504.4	0.0	0.0	0.0	34.5	95.9	3.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3
C22orf15	"FLJ36561, N27C7-3"	ENSG00000169314	"Chromosome 22 open reading frame 15"	Q8WYQ4	22	23762990-23765863	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"fallopian tube: 18.4"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 198.2"	"Cancer enriched"	"Detected in single"	4	"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BJ: 1.2;BJ hTERT+: 2.3;hTERT-RPE1: 3.2;MOLT-4: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted in female reproductive system"	NA	NA						"unprognostic (2.37e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.53e-5)"	"unprognostic (1.86e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.08e-3)"	0.0	0.0	0.8	0.0	0.2	0.3	0.1	0.4	0.2	0.4	0.4	0.1	0.0	0.2	0.0	0.0	18.4	0.2	0.0	0.2	1.1	0.1	0.0	1.8	0.1	1.0	1.1	0.1	0.5	0.0	0.0	1.1	0.2	1.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	1.1	0.2	0.1	2.8	0.5	1.1	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	1.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.8	0.2	0.4	0.2	0.2	1.1	1.0	1.1	0.1	1.0	1.1	0.5	0.3	0.0	0.0	1.8	1.3	0.0	0.1	0.0	9.1	0.0	0.5	0.0	0.5	0.1	0.0	15.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.0	35.8	0.2	0.2	0.0	0.4	2.3	0.0	0.0	1.4	0.0	0.3	2.5	0.1	0.7	0.1	0.0	0.0	2.0	0.0	16.2	0.3	0.4	3.5	0.0	0.3	0.0	1.0	0.1	0.2	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	198.2	1.9	0.0	0.1	3.5	10.9	4.2	0.0	0.3	0.0	1.0	0.5	0.0	0.1
C2orf88	"MGC13057, smAKAP"	ENSG00000187699	"Chromosome 2 open reading frame 88"	Q9BSF0	2	189879609-190203484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 496.6;Early spermatids: 1138.7;Late spermatids: 1344.3;Proximal enterocytes: 462.3"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 16.2;glioma: 4.8;ovarian cancer: 14.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.7;naive B-cell: 2.8;neutrophil: 7.1;plasmacytoid DC: 3.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.8;dendritic cells: 3.0;granulocytes: 7.1"	"Group enriched"	"Detected in many"	6	"HEL: 108.4;K-562: 92.2;RT4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049549	Approved					NA	NA		160000			"HPA049549: AB_2680812"	"unprognostic (1.20e-4)"	"unprognostic (9.17e-2)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (6.09e-3)"	"unprognostic (4.55e-2)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (5.29e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.64e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-3)"	4.2	6.6	11.3	4.5	12.6	9.9	9.3	11.6	13.7	48.7	3.6	36.4	35.0	16.0	2.2	2.7	21.1	2.8	11.7	11.2	11.8	6.5	4.7	3.6	3.3	10.9	11.4	7.8	1.9	12.9	35.4	2.7	1.7	12.2	7.2	39.0	4.5	14.2	9.5	13.6	5.7	44.8	3.9	13.2	4.9	5.1	73.7	10.7	0.5	3.6	29.1	5.4	4.8	11.9	20.5	0.1	0.3	0.9	0.3	3.6	11.7	0.8	0.4	0.5	0.2	1.1	3.5	0.2	0.7	14.2	1.1	5.9	0.3	3.0	0.0	1.4	0.6	1.9	108.4	0.4	6.9	0.3	0.7	0.0	5.4	0.3	5.8	0.3	0.2	0.3	0.4	92.2	7.1	1.6	0.4	0.3	0.8	0.4	0.3	0.1	0.4	4.2	0.5	2.2	58.8	0.9	2.2	0.2	0.2	11.6	2.0	0.0	1.1	0.8	0.7	0.7	0.3	0.3	0.5	2.0	2.1	1.0	0.5	0.1	0.0	0.5	0.9	0.0	0.0	0.0	2.7	0.0	0.1	0.1	2.8	0.0	0.0	7.1	0.1	0.0	3.0	0.0	16.5	11.3	12.6	11.6	13.7	11.2	11.8	10.9	11.4	7.8	12.2	13.2	10.7	20.5	4.1	3.2	0.5	15.3	6.4	1.5	12.9	0.6	2.2	9.1	25.0	36.4	41.5	1.5	0.0	3.7	25.0	0.1	1.1	496.6	19.6	0.5	1138.7	164.4	23.8	21.0	4.2	51.8	28.1	15.3	0.5	7.8	2.6	228.4	0.0	21.7	83.9	3.8	0.2	8.4	26.9	67.9	0.0	5.9	1.8	1344.3	9.9	57.9	26.6	12.2	4.2	2.7	7.2	22.1	44.9	3.9	227.4	6.0	27.8	3.2	462.3	33.2	0.0	12.4	0.0	9.2	3.9	37.9	6.0	2.5	2.3	0.4	3.8	6.1	35.0	3.3
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904288-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"fallopian tube: 111.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 167.1;Endometrial ciliated cells: 400.1;Late spermatids: 148.9;Respiratory ciliated cells: 709.5"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 14.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.7;REH: 8.0;U-698: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules		No	No			"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.0	0.0	10.1	0.0	3.0	0.2	0.1	3.8	2.1	2.3	21.6	0.0	0.0	2.0	8.5	0.0	111.9	0.0	0.0	1.8	6.6	0.6	0.0	7.7	0.0	9.4	7.3	0.9	0.1	0.5	1.2	13.7	0.0	7.4	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	11.1	0.0	0.1	10.0	3.3	6.7	5.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.3	6.2	0.0	0.0	2.2	0.0	1.0	0.1	0.0	0.1	0.0	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	1.2	2.1	0.0	0.5	0.0	0.0	19.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.0	3.8	2.1	1.8	6.6	9.4	7.3	0.9	7.4	11.1	3.3	8.2	0.0	3.2	7.3	0.3	0.0	0.0	0.1	58.0	0.0	0.0	0.2	0.0	0.0	0.0	66.2	1.8	0.0	0.0	0.0	0.0	1.9	0.1	167.1	400.1	2.4	0.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	4.7	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	65.1	0.0	0.0	148.9	0.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.0	1.6	709.5	0.0	0.0	0.0	19.2	21.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1
CCDC146	"KIAA1505, MBO2"	ENSG00000135205	"Coiled-coil domain containing 146"	Q8IYE0	7	77122434-77329533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.3;Endometrial ciliated cells: 460.8;Oligodendrocyte precursor cells: 151.3;Respiratory ciliated cells: 417.9;Spermatocytes: 149.4"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 8.8;ovarian cancer: 13.6;renal cancer: 15.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 14.3;neutrophil: 15.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;NK-cells: 5.3;T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA020082, HPA020105"	Uncertain					NA	NA					"HPA020082: AB_1852410, HPA020105: AB_2072056"	"unprognostic (3.07e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.02e-3)"	"unprognostic (4.05e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.58e-3)"	2.2	1.1	11.0	2.5	4.0	1.7	2.4	4.1	2.6	4.1	15.8	3.4	2.5	4.6	2.5	3.6	34.3	3.2	1.8	2.2	7.3	4.2	1.8	5.3	3.0	10.4	9.1	1.0	3.3	2.5	4.0	3.9	1.9	7.3	3.7	2.8	14.6	4.2	2.3	1.1	9.5	2.8	3.0	11.4	3.7	3.4	21.7	5.4	3.1	7.7	1.6	2.7	3.1	3.9	6.8	0.6	0.9	2.7	1.4	1.7	1.7	0.3	0.7	0.6	0.7	1.1	0.0	4.6	1.4	0.1	0.2	2.6	0.9	0.4	0.8	1.1	1.9	0.3	1.8	1.5	0.8	0.5	1.8	1.3	0.8	1.3	1.2	0.2	2.2	0.6	1.4	0.0	1.4	0.1	0.2	1.5	2.9	0.3	0.6	0.6	4.0	0.4	0.2	2.8	0.5	2.0	1.3	1.0	0.9	0.6	0.8	0.8	0.6	0.9	1.0	0.4	1.4	0.4	2.7	4.5	1.2	2.3	2.7	2.3	0.9	0.6	14.3	4.4	0.9	3.0	1.2	1.9	3.1	0.8	0.2	1.2	2.0	15.4	5.3	0.4	2.0	1.6	0.8	11.0	4.0	4.1	2.6	2.2	7.3	10.4	9.1	1.0	7.3	11.4	5.4	6.8	6.9	3.2	9.7	34.0	3.6	7.1	2.6	16.9	6.2	8.6	2.7	4.6	32.0	2.8	56.9	5.5	62.6	1.2	9.3	2.8	21.5	3.2	308.3	460.8	11.1	4.8	1.8	0.4	49.0	1.6	0.7	15.4	6.1	106.0	6.3	6.1	23.6	0.8	1.6	5.0	48.8	1.4	24.4	3.5	7.1	52.4	12.2	4.5	5.4	50.6	2.0	12.1	20.6	151.3	62.8	1.7	5.2	6.4	3.7	5.8	2.9	30.1	417.9	55.1	6.6	15.6	11.6	149.4	10.8	5.5	3.4	2.5	8.6	7.2	4.0	5.4
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442870	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.4;testis: 82.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	103	"basophil: 49.2"	"Lineage enriched"	"Detected in single"	301	"granulocytes: 49.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.9	7.0	0.5	6.6	2.1	0.7	3.2	7.6	5.9	4.1	0.5	0.4	3.8	7.1	0.4	18.2	0.7	0.3	6.0	7.5	0.5	0.1	1.4	0.3	5.6	6.5	6.4	0.5	0.1	22.4	8.2	0.0	8.6	0.5	0.1	1.0	0.6	0.1	1.2	0.3	0.3	8.2	4.5	0.6	0.4	82.1	5.6	0.4	0.6	0.4	0.6	0.6	1.1	6.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	15.2	0.1	15.5	1.2	12.9	1.4	0.1	0.0	0.7	0.0	0.4	0.0	0.6	8.0	350.9	0.3	34.1	0.7	2.8	5.5	0.9	1.7	0.0	0.5	0.2	4.4	0.4	71.4	2.5	0.0	8.8	0.0	8.3	0.0	2.3	0.0	2.5	5.8	0.0	8.4	0.2	1.8	0.0	71.5	4.5	0.0	0.0	0.1	2.9	0.8	0.0	0.0	0.3	90.3	0.6	49.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.0	6.6	3.2	7.6	6.0	7.5	5.6	6.5	6.4	8.6	4.5	5.6	6.1	0.1	0.0	0.6	0.3	0.3	0.6	0.6	19.1	0.0	0.4	0.5	1.4	0.4	0.0	10.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	162.4	119.1	1.8	0.4	0.0	0.0	3.5	0.0	0.8	1.1	0.0	31.9	5.1	2.2	0.0	0.0	0.2	0.0	3.0	0.0	6.1	0.0	1.8	91.1	3.1	1.1	0.0	0.0	0.0	1.4	0.0	0.5	0.4	0.0	0.0	2.6	0.0	0.7	0.0	0.1	29.3	0.8	6.6	0.5	1.5	285.7	2.4	0.0	0.4	0.3	0.9	0.0	0.1	1.1
CFAP161	"C15orf26, FLJ38615"	ENSG00000156206	"Cilia and flagella associated protein 161"	Q6P656	15	81007033-81149179	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 26.4;fallopian tube: 16.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 18.1;Endometrial ciliated cells: 26.5;Late spermatids: 5.4;Respiratory ciliated cells: 23.3;Spermatocytes: 15.6"	"Cancer enriched"	"Detected in some"	4	"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HEL: 84.4;K-562: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076975	Supported					NA	NA					"HPA076975: "	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (1.57e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.22e-2)"	0.4	0.1	2.3	0.1	1.1	0.6	0.2	4.3	0.9	0.4	26.4	0.1	0.0	0.6	0.6	0.1	16.0	0.2	0.6	1.2	1.8	0.2	0.2	2.7	0.1	2.0	2.8	0.1	0.1	0.2	0.3	1.7	1.3	1.7	0.1	0.0	1.3	0.2	0.2	0.2	0.5	0.1	0.2	3.0	0.5	0.2	6.5	2.0	0.0	0.6	0.8	0.2	0.2	0.1	0.9	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.3	0.0	84.4	0.2	0.2	0.0	0.0	11.0	0.0	0.0	0.3	1.0	0.0	1.7	0.0	29.2	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	1.2	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.4	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	3.4	2.3	1.1	4.3	0.9	1.2	1.8	2.0	2.8	0.1	1.7	3.0	2.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	26.5	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	23.3	0.6	0.0	0.0	0.0	15.6	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 45.2;testis: 28.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;HEL: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.5	0.1	8.2	0.4	1.7	0.8	0.6	2.6	1.1	1.7	11.2	0.2	0.2	1.5	0.0	0.4	45.2	0.2	0.6	1.2	7.0	0.4	0.1	5.0	0.2	6.4	6.5	0.1	0.3	0.2	0.1	0.4	0.4	4.6	0.4	0.1	0.0	0.3	0.4	0.2	0.5	0.3	0.4	8.8	0.7	0.6	28.6	2.8	0.3	0.7	0.1	0.3	0.5	0.3	4.4	2.1	0.4	0.0	0.0	0.1	0.2	9.0	1.1	1.3	1.9	0.8	1.5	2.7	0.8	0.4	0.3	1.0	1.3	0.2	0.3	1.1	0.3	0.2	12.2	0.5	0.0	0.4	1.1	0.4	0.8	0.6	2.1	0.7	2.8	1.4	0.2	1.3	0.4	0.3	3.0	0.2	0.9	0.5	1.7	1.0	0.0	0.9	0.4	0.1	0.5	0.8	0.1	1.0	3.2	0.3	2.6	3.1	0.2	1.8	0.8	2.4	1.6	2.0	0.8	0.0	0.2	4.3	0.3	0.7	0.0	0.1	3.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.0	0.2	2.4	0.0	0.0	0.1	0.0	0.1	8.2	1.7	2.6	1.1	1.2	7.0	6.4	6.5	0.1	4.6	8.8	2.8	4.4	2.0	0.0	4.8	0.0	0.4	0.0	0.9	0.0	0.6	0.1	1.4	0.9	5.5	0.0	29.7	5.5	0.0	1.6	0.6	0.0	0.0	1.9	256.4	98.2	1.3	3.2	0.0	0.0	0.1	2.2	7.4	1.2	0.0	3.2	3.8	0.1	1.4	0.0	0.4	0.0	0.1	0.1	0.0	0.6	0.0	57.4	2.1	4.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	1.6	0.0	1.5	3.2	1.3	0.1	0.4	166.9	0.0	0.0	0.7	0.9	43.7	3.1	1.2	0.0	0.8	1.2	0.6	0.1	1.1
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 15.0;fallopian tube: 58.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.0	0.3	8.1	0.0	4.2	0.0	0.1	4.4	3.9	1.3	15.0	0.1	0.7	1.1	0.1	0.2	58.3	0.2	0.0	2.8	6.4	0.3	0.2	4.4	0.0	9.2	8.6	1.9	0.2	0.2	0.3	3.2	0.2	8.0	0.3	0.0	2.4	1.3	0.2	0.0	0.2	0.7	0.0	11.4	0.0	0.1	12.3	4.8	0.3	0.6	0.3	0.0	0.1	0.1	6.6	0.8	0.8	0.0	0.3	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.3	0.1	2.7	0.0	1.4	0.0	0.0	0.2	0.4	0.3	0.0	0.3	0.5	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	4.2	4.4	3.9	2.8	6.4	9.2	8.6	1.9	8.0	11.4	4.8	6.6	0.2	0.0	2.3	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.3	0.0	9.9	0.0	6.2	0.8	0.0	0.0	1.9	0.1	32.4	99.6	0.9	0.3	0.0	0.0	9.7	0.2	0.2	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	6.4	1.8	0.0	0.0	1.0	0.0	0.7	0.0	7.1	1.1	0.1	0.0	1.9	0.0	0.3	0.0	0.5	81.6	3.1	0.0	0.1	0.2	33.9	0.8	0.0	0.0	1.0	0.1	0.1	0.0	0.1
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924491-7926135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 226.7;endometrium 1: 86.4"	"Cell type enriched"	"Detected in many"	4	"Endometrial ciliated cells: 127.7"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	4.0	12.6	171.8	0.9	226.7	0.1	3.2	0.0	174.4	32.8	0.0	39.6	0.9	86.4	2.9	2.6	43.4	0.2	1.0	201.2	27.3	10.7	0.4	7.0	0.0	91.0	17.7	137.0	6.3	2.2	1.1	57.4	0.3	150.1	16.4	0.4	0.2	6.5	12.5	0.5	4.0	4.8	4.9	0.0	1.4	8.9	28.0	43.6	0.3	2.8	0.1	0.0	21.4	13.3	52.9	33.5	8.1	20.5	96.4	0.0	0.3	4.8	8.5	2.3	4.1	2.4	2.4	5.0	0.2	16.2	2.0	2.2	35.9	4.7	0.9	0.2	3.0	67.5	0.7	5.3	1.5	0.9	1.8	1.9	0.0	2.7	1.4	0.9	9.8	5.4	9.1	21.3	0.3	0.5	40.5	18.5	13.6	72.4	2.4	34.1	57.3	0.0	6.4	15.0	1.4	56.2	94.5	5.2	2.8	9.9	1.7	21.2	0.6	8.3	2.1	33.1	3.9	4.8	0.7	1.0	4.8	8.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.8	226.7	0.0	174.4	201.2	27.3	91.0	17.7	137.0	150.1	0.0	43.6	52.9	0.6	0.0	0.0	3.3	0.7	1.1	4.1	1.5	2.2	0.3	15.3	6.7	0.4	1.5	1.0	9.2	4.2	0.2	0.2	0.5	3.9	7.8	9.5	127.7	22.4	1.6	9.1	0.0	20.6	0.4	0.4	3.0	0.0	7.9	0.0	13.3	0.7	0.1	0.3	0.0	3.5	0.5	2.0	0.3	0.5	27.1	1.2	0.5	1.8	4.7	0.0	0.6	0.0	1.5	2.9	1.7	1.2	1.9	0.0	19.9	0.0	11.9	21.0	0.4	0.0	0.2	17.7	6.0	16.0	0.3	2.0	0.3	0.6	3.2	0.2	6.4
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045886-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.5;ovary: 60.7;pituitary gland: 53.0"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 64.6;Theca cells: 206.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 4.3;glioma: 16.3;pancreatic cancer: 5.6;thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 8.2;HSkMC: 17.2;TIME: 11.2;U-251 MG: 9.1;U-87 MG: 16.9"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favorable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.3	20.3	30.5	0.5	19.1	0.1	5.1	2.6	10.3	4.7	3.0	2.6	7.5	2.6	10.7	1.7	3.4	10.3	11.4	7.1	97.5	7.0	9.6	5.2	0.2	36.5	47.1	6.1	60.7	20.1	7.6	53.0	0.6	17.2	3.0	0.8	4.0	2.4	2.6	1.1	2.1	1.4	1.2	8.0	2.6	4.3	5.5	69.1	1.6	3.8	1.9	0.3	3.1	6.5	11.2	0.0	1.5	1.6	0.0	5.2	3.9	0.6	4.6	1.6	0.3	1.2	0.0	0.8	0.0	0.2	4.8	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.6	0.0	8.2	0.0	0.0	17.2	0.1	0.7	0.0	0.0	1.0	0.2	0.3	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.1	0.5	0.1	0.0	11.2	0.0	0.5	0.2	9.1	2.7	0.0	0.0	16.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	30.5	19.1	2.6	10.3	7.1	97.5	36.5	47.1	6.1	17.2	8.0	69.1	11.2	0.3	0.0	1.8	5.2	0.0	3.2	25.0	0.6	0.6	1.1	5.4	6.5	5.9	7.2	2.5	3.7	10.4	1.1	0.0	0.4	64.6	3.7	0.1	0.7	0.7	1.7	16.2	0.0	2.2	18.7	0.1	10.3	4.1	1.8	0.0	0.8	3.3	3.9	0.1	0.0	8.8	2.3	0.0	0.0	4.8	0.8	6.8	0.3	5.4	0.0	0.0	0.7	1.0	5.0	0.2	2.9	0.1	1.5	0.0	5.3	0.1	11.1	0.9	6.1	0.0	16.9	1.7	0.0	1.4	1.7	2.8	0.4	0.7	206.2	0.7	2.4
DNAH9	"DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357"	ENSG00000007174	"Dynein axonemal heavy chain 9"	Q9NYC9	17	11598470-11969748	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;choroid plexus: 23.3;fallopian tube: 35.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.7;Endometrial ciliated cells: 97.5;Excitatory neurons: 26.8;Late spermatids: 56.5;Respiratory ciliated cells: 110.5"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.1;glioma: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.1;WM-115: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052641	Enhanced					NA	NA					"HPA052641: AB_2681895"	"unprognostic (4.16e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.31e-2)"	"prognostic favorable (6.79e-5)"	"unprognostic (8.37e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-3)"	"unprognostic (5.31e-2)"	2.1	0.8	22.0	0.3	8.9	0.0	1.5	13.8	8.1	1.2	23.3	0.1	0.0	1.4	2.2	0.1	35.7	0.4	0.1	11.3	18.6	1.5	0.1	2.8	0.0	21.2	23.1	6.3	1.4	1.9	3.6	3.3	0.3	18.0	0.8	0.0	6.6	0.3	2.0	0.2	0.3	0.1	0.5	26.0	0.1	0.3	6.3	13.6	0.1	0.9	0.0	0.0	0.3	0.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	8.9	13.8	8.1	11.3	18.6	21.2	23.1	6.3	18.0	26.0	13.6	11.4	0.1	3.2	1.1	8.5	0.0	0.8	0.9	3.6	1.2	2.0	0.2	0.4	1.7	0.0	6.1	3.7	2.1	0.0	0.0	0.6	1.9	1.4	48.7	97.5	2.0	0.3	0.0	0.0	26.8	0.2	0.0	1.5	0.0	2.1	1.3	1.2	0.0	0.0	0.1	0.0	17.6	0.2	2.0	0.0	0.4	56.5	0.6	0.2	0.0	3.7	0.0	1.8	0.0	11.1	8.3	0.1	0.0	3.0	0.1	0.6	0.0	0.2	110.5	8.2	0.0	1.5	2.5	5.3	2.4	0.6	1.1	0.1	0.3	1.4	0.0	0.6
DNAI2	"CILD9, DIC2"	ENSG00000171595	"Dynein axonemal intermediate chain 2"	Q9GZS0	17	74274234-74314884	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 30.7;testis: 19.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 21.7;Endometrial ciliated cells: 51.3;Late spermatids: 16.4;Respiratory ciliated cells: 68.1;Spermatocytes: 41.7"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.2;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.8"	"Cell line enriched"	"Detected in single"	4	"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB006245, HPA050565"	Enhanced					NA	NA					"CAB006245: AB_426059, HPA050565: AB_2681177"	"unprognostic (6.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.62e-3)"	0.0	0.0	1.8	0.1	0.7	0.0	0.0	1.0	0.6	0.9	5.4	0.0	0.0	0.3	0.0	0.0	30.7	0.0	0.0	0.5	1.5	0.0	0.0	3.0	0.0	2.5	2.7	0.0	0.0	0.0	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	19.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	1.8	0.7	1.0	0.6	0.5	1.5	2.5	2.7	0.0	2.0	2.7	1.2	0.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.7	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	21.7	51.3	0.4	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.0	4.4	16.4	0.6	0.3	0.0	1.0	0.6	0.0	1.0	1.0	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	68.1	0.0	0.0	0.0	0.9	41.7	0.5	0.0	0.0	0.0	0.4	0.6	0.2	0.0
EMID1	"EMI5, EMU1, hEmu1"	ENSG00000186998	"EMI domain containing 1"	Q96A84	22	29205896-29259597	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;lymphoid tissue: 55.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.1;Granulosa cells: 32.7;Oligodendrocyte precursor cells: 51.8;Theca cells: 151.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 23.1;glioma: 7.8;ovarian cancer: 10.9;thyroid cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HEL: 28.8;NB-4: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000592	Uncertain				"Secreted in other tissues"	NA	NA					"HPA000592: AB_1078737"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-1)"	2.6	29.3	31.2	4.3	31.6	14.9	2.5	24.6	49.9	5.9	21.5	5.8	5.1	10.1	1.7	1.3	10.5	4.8	1.7	33.5	26.2	14.8	3.4	13.1	7.6	27.3	27.9	31.5	7.1	14.1	12.5	2.1	4.9	26.0	6.1	3.5	0.3	3.7	3.9	0.9	5.4	8.4	2.3	23.4	55.2	7.8	2.3	24.6	4.8	13.3	0.3	2.4	5.0	2.2	29.8	0.0	0.2	4.9	10.5	0.0	0.0	0.7	0.0	0.0	0.4	0.3	5.7	0.7	0.0	4.7	0.1	0.0	0.0	2.5	0.1	0.0	11.5	8.6	28.8	0.1	1.1	0.7	4.1	2.2	0.3	0.2	0.2	0.0	0.0	0.0	6.4	2.5	0.0	0.0	8.0	0.2	102.0	1.1	0.1	0.4	0.0	0.2	11.3	0.0	0.1	13.2	6.3	0.4	0.1	0.2	0.8	4.2	5.4	0.0	0.0	8.0	0.0	0.1	0.5	0.0	0.0	0.0	14.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.2	31.6	24.6	49.9	33.5	26.2	27.3	27.9	31.5	26.0	23.4	24.6	29.8	0.4	0.0	2.5	92.1	0.1	2.8	1.0	0.1	0.0	1.7	5.3	3.9	0.7	4.3	0.6	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.2	10.8	22.6	6.2	0.0	18.5	5.6	1.3	0.1	11.8	0.5	20.0	11.4	32.7	11.4	2.1	0.3	0.0	6.2	0.4	0.0	0.3	5.2	0.5	3.1	0.6	0.0	10.3	0.6	1.1	0.0	51.8	1.0	0.4	0.0	1.9	1.0	1.9	0.1	1.9	0.0	0.4	0.0	17.5	4.0	0.1	1.5	0.0	2.0	0.3	1.1	151.0	0.3	0.4
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;fallopian tube: 11.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.2	0.4	10.3	0.0	13.4	0.0	5.6	10.5	11.3	3.0	0.0	0.0	0.0	0.2	0.0	0.1	11.3	0.0	3.0	9.6	28.6	5.2	0.0	0.9	0.0	6.8	15.4	9.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.8	1.2	1.5	0.3	0.0	0.0	2.2	0.0	0.4	3.3	7.1	0.0	1.6	1.7	0.0	0.1	0.1	9.0	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	13.4	10.5	11.3	9.6	28.6	6.8	15.4	9.9	7.6	2.2	7.1	9.0	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor subunit pi"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 153.9;esophagus: 173.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 11.8;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain					NA	NA					"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	4.5	3.6	13.5	7.3	13.5	10.0	153.9	21.1	19.6	8.7	5.4	4.3	15.5	49.1	19.2	173.1	13.0	27.5	5.4	12.5	12.4	6.1	7.2	14.8	5.7	13.2	9.6	5.5	3.9	24.0	2.0	2.0	9.1	15.5	12.8	5.0	42.5	36.0	16.8	13.8	19.1	16.3	2.7	3.3	7.4	27.6	8.3	14.1	4.7	6.2	2.7	42.6	5.4	29.7	22.3	215.1	9.9	10.1	7.0	0.7	4.3	23.8	3.8	1.5	0.5	0.6	38.1	23.6	3.3	236.8	1.1	2.3	75.7	6.4	0.5	0.6	3.5	7.6	14.1	166.8	5.7	0.8	5.1	11.2	1.6	3.0	2.8	1.8	8.0	1.4	13.4	57.6	26.5	0.4	6.7	9.5	4.7	84.5	3.7	331.3	13.7	6.6	8.2	13.8	11.6	8.2	4.0	76.5	3.9	2.2	418.8	4.2	2.4	8.8	19.1	69.3	15.7	15.7	10.0	6.7	6.3	2.6	13.9	2.9	11.8	1.9	6.1	0.4	1.5	1.1	0.3	0.4	0.3	0.6	0.7	0.5	0.5	4.5	0.2	5.7	0.9	0.6	2.3	13.5	13.5	21.1	19.6	12.5	12.4	13.2	9.6	5.5	15.5	3.3	14.1	22.3	1.1	3.2	0.6	0.0	0.9	0.0	14.9	44.4	0.0	0.0	169.0	113.2	0.7	51.5	83.1	1.8	0.0	5.2	2.3	0.0	0.0	10.4	0.0	146.0	48.8	3.8	0.0	0.0	0.3	13.8	0.6	2.4	2.0	464.0	0.0	0.0	0.0	0.1	2.3	0.0	0.2	0.3	12.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.6	0.1	0.0	0.0	24.2	0.1	0.1	34.0	0.0	0.0	0.2	5.9	0.0	0.0	4.5	0.0	5.7	2.7	0.0	0.6	146.6
GAS2L2	GAR17	ENSG00000270765	"Growth arrest specific 2 like 2"	Q8NHY3	17	35744511-35753239	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.4;fallopian tube: 16.5"	"Group enriched"	"Detected in some"	6	"Endometrial ciliated cells: 23.0;Respiratory ciliated cells: 32.8"	"Cancer enriched"	"Detected in some"	4	"endometrial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HaCaT: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044370	Enhanced					NA	NA					"HPA044370: AB_2678915"	"unprognostic (3.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.54e-3)"	"prognostic favorable (7.00e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-1)"		"unprognostic (6.67e-2)"		"unprognostic (4.42e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.92e-2)"	0.6	0.0	2.3	0.0	1.1	0.0	0.5	1.0	1.0	0.5	5.4	0.1	0.0	0.2	1.9	0.0	16.5	0.0	0.1	0.9	1.2	0.1	0.0	2.0	0.0	1.7	2.2	0.7	0.0	0.1	0.1	0.0	0.0	1.6	0.1	0.0	0.2	0.1	1.2	2.8	0.3	0.1	0.0	2.5	0.0	0.1	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	1.0	1.0	0.9	1.2	1.7	2.2	0.7	1.6	2.5	1.0	1.2	0.1	0.0	1.1	1.0	0.1	0.6	0.0	1.3	0.0	0.1	0.6	0.3	0.5	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	23.0	0.2	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.8	0.0	0.0	0.0	0.5	0.2	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 12.1;cervix: 20.1;salivary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.8;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 3.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 16.7;endometrial cancer: 15.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HAP1: 6.0;SK-BR-3: 14.1;U-2197: 6.6"					"Low region specificity"	"Detected in many"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favorable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.1	0.1	0.3	0.1	0.3	0.1	12.1	0.3	0.5	20.1	0.1	0.1	0.3	0.4	0.3	0.9	0.1	7.6	0.3	0.2	0.4	0.2	0.1	0.0	0.3	0.6	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.9	0.2	0.3	33.7	0.1	0.0	1.1	0.1	0.3	0.9	0.3	0.1	0.0	0.3	0.1	0.1	0.5	0.4	0.1	0.3	1.1	0.0	0.0	0.4	0.0	0.7	2.6	0.0	1.7	5.3	2.3	3.7	0.0	0.0	0.1	0.0	1.4	1.0	0.4	6.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.2	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	14.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	6.6	2.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.5	0.2	0.4	0.6	0.4	0.2	0.6	0.9	0.3	1.1	0.2	0.0	0.0	0.0	0.0	1.0	2.3	1.4	0.0	0.5	14.8	2.2	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	1.1	0.0	0.0	1.5	1.4	0.0	0.5	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	3.0	0.4	0.1	0.0	0.0	0.0	3.6	0.0	0.2	0.1	0.1	6.6	0.2	0.6	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.9
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 24541.9"	"Cell type enriched"	"Detected in many"	51	"Erythroid cells: 224916.4"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 142.6;plasmacytoid DC: 101.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.1;granulocytes: 142.6"	"Group enriched"	"Detected in some"	36	"HEL: 3355.8;K-562: 2416.8"									"CAB032534, HPA043780"	Enhanced					NA	NA		14000000000			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	563.6	184.5	89.5	82.7	213.9	24541.9	319.3	152.8	802.0	157.9	2244.8	128.0	10.7	41.8	2.4	246.9	353.9	60.6	1410.3	51.0	108.5	1386.9	1109.3	2221.0	5.0	164.5	327.4	35.4	161.1	101.4	5.2	469.4	2009.5	282.8	171.6	11.6	3.1	139.4	44.1	235.9	193.3	85.8	7.1	198.0	5572.2	137.1	105.6	283.2	20.9	614.3	1133.1	3.6	168.6	354.2	403.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	58.1	0.0	5.7	2.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.2	3355.8	0.0	37.1	0.0	1.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.7	2416.8	0.0	0.0	14.7	0.5	0.3	0.4	1.0	0.0	0.1	1.4	79.1	0.0	1.0	7.4	5.3	2.8	0.0	0.0	0.0	1.1	0.0	8.3	0.0	0.0	0.9	0.0	0.0	0.4	0.8	0.0	0.2	0.0	8.5	7.4	48.2	26.3	0.2	0.7	7.5	3.1	8.7	10.0	4.5	8.3	25.7	142.6	13.4	0.8	101.1	0.3	2806.3	89.5	213.9	152.8	802.0	51.0	108.5	164.5	327.4	35.4	282.8	198.0	283.2	403.4	72.7	0.0	0.0	0.0	56.8	10.6	0.1	0.0	0.0	0.4	11.3	12.3	1.8	55.8	0.1	0.0	0.0	0.0	93.2	3.2	7.9	0.0	6.0	0.5	0.5	20.4	1.2	224916.4	0.0	0.0	0.0	57.9	0.0	0.4	0.0	0.1	151.0	78.8	0.0	0.0	0.0	5.7	0.0	436.7	64.1	22.4	0.0	234.0	4338.2	0.0	12.7	1.3	1166.9	0.0	0.0	0.1	2.8	0.4	0.5	0.2	0.2	11.1	0.0	16.5	0.0	8.7	58.7	1.5	7.6	0.0	13.2	0.0	155.7	0.0	3.2	0.0
IGHD7-27	"DHQ52, IGHD727"	ENSG00000236597	"Immunoglobulin heavy diversity 7-27"		14	105865551-105865561	"Immunoglobulin genes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"endometrial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JSRP1	"FLJ32416, JP-45"	ENSG00000167476	"Junctional sarcoplasmic reticulum protein 1"	Q96MG2	19	2252252-2269759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"skeletal muscle: 338.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.7;Melanocytes: 46.2;Plasma cells: 139.4;Skeletal myocytes: 132.6"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	10	"B-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 164.1;RPMI-8226: 109.8;U-266/70: 444.1;U-266/84: 57.8"	"Group enriched"	"Detected in many"	6	"amygdala: 8.4;basal ganglia: 11.6;cerebral cortex: 9.9;hippocampal formation: 4.4;white matter: 5.1"	"Not detected"	"Not detected"			HPA044741	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		13000	"Endoplasmic reticulum"		"HPA044741: AB_10794295"	"unprognostic (9.41e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.64e-5)"	"unprognostic (3.63e-1)"	"unprognostic (4.43e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.71e-1)"	0.2	0.1	0.3	1.0	0.3	0.4	0.5	0.3	0.4	0.3	0.1	1.0	2.9	0.1	0.0	0.3	0.3	0.1	0.0	0.3	0.2	0.5	0.3	0.7	0.5	0.3	0.2	0.2	0.1	0.5	0.0	0.3	0.0	0.2	1.9	0.1	0.0	9.0	0.0	338.6	0.2	1.4	0.0	0.2	5.5	1.8	1.9	0.3	0.1	0.6	18.8	0.6	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	26.8	0.0	0.0	0.2	0.0	0.0	0.0	46.6	0.1	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	7.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	26.7	109.8	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	444.1	57.8	2.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.0	5.3	0.0	31.7	0.5	0.3	0.2	0.6	0.8	0.6	0.4	0.6	1.5	0.1	0.0	2.1	0.2	0.7	1.7	0.0	1.8	19.0	0.7	0.3	0.3	5.4	1.3	0.2	1.0	0.6	1.1	1.5	1.1	6.3	2.9	0.7	0.6	0.5	0.0	0.1	2.3	2.0	1.3	2.2	18.2	0.6	1.1	46.2	0.0	0.0	0.5	1.0	0.0	0.1	1.0	0.3	0.0	139.4	0.3	0.6	0.4	1.7	0.5	0.0	132.6	0.6	7.6	1.9	0.2	1.0	0.3	5.0	0.5	0.7	0.2
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Metabolic proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 58.9;pancreas: 97.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 201.5;Glandular and luminal cells: 175.0;Intestinal goblet cells: 86.1;Paneth cells: 228.9;Undifferentiated cells: 301.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 44.8;endometrial cancer: 36.2;pancreatic cancer: 13.8;testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"basophil: 17.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 17.0"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 50.2"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.3	0.2	2.0	7.9	2.1	0.0	0.4	1.7	2.7	1.4	1.3	58.9	0.2	0.5	7.0	0.1	0.6	0.0	0.3	2.1	1.8	1.7	0.9	0.4	0.0	1.7	1.6	2.1	4.1	97.7	0.0	1.0	0.2	1.8	0.9	32.7	0.8	1.5	3.3	0.4	0.2	2.9	0.9	1.8	0.3	1.4	0.8	1.7	0.0	0.1	0.1	0.1	1.5	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.3	0.0	0.0	0.0	4.5	0.1	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	5.4	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	2.0	2.1	1.7	2.7	2.1	1.8	1.7	1.6	2.1	1.8	1.8	1.7	1.9	0.2	0.0	0.0	0.7	1.0	0.4	1.6	0.0	0.0	1.8	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.0	0.0	51.7	1.9	20.1	1.8	201.5	9.9	0.3	31.5	0.0	2.3	29.6	0.1	1.6	0.0	175.0	0.0	1.6	0.0	0.2	0.0	0.0	2.3	86.1	0.0	0.0	0.0	3.9	1.5	2.1	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.5	228.9	1.9	0.0	0.8	0.7	6.0	0.0	1.4	0.0	0.0	0.6	2.5	4.2	0.0	0.0	0.0	1.0	1.3	301.0	1.3
LKAAEAR1	C20orf201	ENSG00000171695	"LKAAEAR motif containing 1"	Q8TD35	20	64083380-64084359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 32.6"	"Group enriched"	"Detected in some"	14	"Early spermatids: 496.7;Late spermatids: 694.8"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;glioma: 1.2;ovarian cancer: 1.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 8.6;non-classical monocyte: 13.5"	"Lineage enriched"	"Detected in many"	13	"monocytes: 13.5"	"Group enriched"	"Detected in some"	4	"REH: 5.6;SCLC-21H: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056463			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056463: AB_2683139"	"unprognostic (5.47e-3)"	"unprognostic (1.18e-1)"		"unprognostic (1.20e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.78e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.16e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.30e-2)"	0.1	0.1	1.5	0.0	0.8	0.1	0.1	0.3	1.9	0.2	0.0	0.0	0.1	0.1	0.0	0.0	2.6	0.0	0.1	1.1	1.5	0.0	0.0	0.6	0.0	1.2	0.9	1.5	0.0	0.2	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	32.6	1.4	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.4	0.2	0.0	0.9	5.6	0.0	0.1	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.1	8.6	0.6	0.1	0.6	0.1	1.0	0.0	0.7	0.2	0.0	0.0	13.5	0.2	0.0	0.9	1.5	0.8	0.3	1.9	1.1	1.5	1.2	0.9	1.5	0.9	0.5	1.4	1.4	0.5	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	1.1	0.6	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	496.7	40.3	1.3	0.5	0.0	0.8	1.1	0.0	0.0	0.6	0.0	0.5	0.0	0.1	1.4	0.1	1.6	0.0	0.9	0.0	0.0	1.8	0.0	694.8	3.7	2.2	0.0	0.0	1.4	0.7	0.0	1.0	0.5	0.1	0.0	3.0	0.4	0.2	0.0	0.2	0.0	1.0	13.1	0.3	0.4	24.0	6.6	0.1	0.0	0.1	0.8	0.1	0.0	0.2
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610582	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"epididymis: 50.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 33.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;liver cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA						"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.2	50.5	0.1	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.1	3.3	33.2	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	1.5	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.0
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856717-46918642	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 44.0;skin 1: 31.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3"	"Group enriched"	"Detected in all"	4	"colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 21.3;SuSa: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	0.7	1.4	20.7	1.0	28.8	0.0	1.6	20.8	21.1	2.3	0.0	4.8	3.4	1.7	0.9	1.9	1.4	2.0	7.0	22.0	15.8	0.7	0.2	2.9	0.1	44.0	21.9	13.0	4.6	2.2	5.7	2.6	2.6	24.8	2.1	3.5	7.9	1.7	2.3	4.5	31.8	4.9	1.5	19.9	3.9	7.9	1.1	29.6	1.5	2.4	7.7	0.3	0.9	1.4	25.1	0.1	9.6	21.3	6.5	13.4	3.7	4.9	1.0	1.9	2.8	3.2	2.8	0.0	0.0	1.4	11.4	3.1	3.9	12.0	7.5	2.2	0.0	10.3	1.0	3.8	6.8	2.8	0.1	1.9	4.5	4.2	4.4	1.1	2.5	2.5	2.6	0.9	0.0	1.6	0.8	0.2	0.3	11.9	0.0	0.9	1.6	7.3	0.0	0.3	2.8	0.1	14.2	1.2	0.0	3.4	16.2	0.3	0.5	0.2	5.7	3.5	6.5	2.1	0.0	0.0	0.4	4.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	28.8	20.8	21.1	22.0	15.8	44.0	21.9	13.0	24.8	19.9	29.6	25.1	0.2	0.0	1.9	123.1	0.0	8.2	2.7	2.4	10.8	0.5	0.3	1.9	6.2	0.0	1.9	1.8	41.7	2.6	0.0	31.1	1.9	0.0	0.5	1.0	4.7	1.0	0.0	0.0	19.7	0.4	0.4	5.0	3.1	4.4	5.1	1.6	1.8	0.4	0.2	0.0	18.6	2.8	0.0	0.0	0.4	0.0	1.8	0.2	1.8	15.0	0.6	9.3	0.0	137.2	31.3	0.3	3.0	1.2	0.0	1.0	8.0	0.3	1.1	2.7	0.0	12.4	0.9	0.2	0.8	2.3	10.9	1.4	0.2	8.4	3.3	0.8
MMP26	"endometase, MGC126590, MGC126592"	ENSG00000167346	"Matrix metallopeptidase 26"	Q9NRE1	11	4704927-4992429	"Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"endometrium 1: 13.2"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 44.8;Glandular and luminal cells: 171.1"	"Cancer enriched"	"Detected in some"	4	"endometrial cancer: 8.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to extracellular matrix"	NA	NA									"unprognostic (4.21e-3)"								"unprognostic (2.63e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	44.8	14.6	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	171.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
MORN5	"C9orf113, C9orf18, FLJ46909"	ENSG00000185681	"MORN repeat containing 5"	Q5VZ52	9	122159908-122200088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 112.0;testis: 82.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 490.3;Endometrial ciliated cells: 240.0;Late spermatids: 692.9;Respiratory ciliated cells: 454.7;Spermatocytes: 142.1"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 9.2;glioma: 4.0;ovarian cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.6;U-87 MG: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.24e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.12e-1)"			"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-1)"	0.0	0.1	10.5	0.6	8.3	0.0	0.2	8.6	8.8	2.7	14.6	17.1	0.9	6.2	2.3	2.2	112.0	0.6	0.0	7.7	11.5	1.3	0.0	5.8	0.0	12.5	11.2	6.8	0.5	0.3	2.8	3.9	0.0	11.5	0.8	5.5	10.0	1.0	3.7	0.0	0.0	2.3	17.2	10.9	0.0	3.9	82.3	8.7	0.1	0.0	0.0	0.0	2.3	0.5	9.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	8.3	8.6	8.8	7.7	11.5	12.5	11.2	6.8	11.5	10.9	8.7	9.6	0.1	0.0	3.6	0.3	0.0	0.0	0.2	30.3	0.0	1.1	0.1	0.5	0.1	0.0	36.9	3.7	2.1	0.0	0.0	0.0	0.0	0.1	490.3	240.0	1.6	0.7	0.0	0.0	1.8	0.0	0.0	0.7	0.0	3.0	0.0	0.2	0.0	0.0	0.1	1.7	1.5	0.0	63.1	0.0	0.0	692.9	6.5	0.7	0.0	0.0	0.0	5.6	0.0	1.0	0.3	0.0	0.0	4.1	0.0	1.2	0.0	4.9	454.7	8.1	0.0	0.0	8.4	142.1	6.4	0.0	0.0	0.0	0.3	0.1	0.0	0.1
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4 X-linked"	Q8N0W4	X	5840637-6228867	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.5;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7"									HPA001651	Approved					NA	NA					"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	3.4	1.3	8.2	1.9	11.2	0.0	2.2	11.1	13.5	5.1	0.0	2.8	1.3	2.3	0.4	0.7	2.1	2.6	3.1	15.9	19.5	0.3	1.3	1.1	0.8	7.7	5.8	10.9	11.7	0.4	5.2	1.7	3.7	6.0	1.1	1.9	9.3	0.8	1.9	0.3	0.6	2.6	3.7	1.5	2.2	1.1	2.6	8.5	14.4	0.7	0.2	0.5	2.2	1.4	5.5	0.0	0.0	55.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.4	0.0	44.1	0.0	0.1	0.0	0.0	0.1	4.1	11.5	2.7	3.5	0.0	0.1	0.0	42.7	5.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	11.2	11.1	13.5	15.9	19.5	7.7	5.8	10.9	6.0	1.5	8.5	5.5	12.1	0.0	0.5	113.9	0.3	0.3	0.1	0.2	0.0	15.0	5.2	3.4	2.8	0.0	0.1	0.0	25.0	3.7	0.1	0.0	0.0	0.0	0.1	19.7	69.5	2.5	0.0	0.0	162.2	0.0	2.4	9.6	0.0	33.2	0.0	2.2	1.8	0.0	0.6	0.0	236.8	0.0	0.0	0.3	0.5	0.7	18.0	0.3	14.2	4.7	0.0	12.5	0.0	702.7	68.3	0.0	0.0	29.7	0.1	0.0	0.0	0.1	0.7	3.3	13.1	18.4	5.0	2.0	5.5	0.2	0.6	3.6	0.5	8.8	0.0	0.3
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934396-33820863	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in many"	6	"Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075337	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	0.7	0.8	17.5	0.1	19.3	0.0	0.9	16.8	14.3	6.0	0.0	1.1	0.3	3.9	0.9	0.3	4.0	0.7	0.4	15.0	14.5	0.7	0.1	0.2	0.1	23.5	15.7	10.9	2.7	0.4	0.5	1.0	0.5	15.7	0.8	0.3	1.4	0.8	1.3	0.2	0.2	0.4	0.7	17.2	1.1	1.0	1.4	15.2	0.4	1.9	0.2	0.2	0.5	0.5	19.2	0.0	0.0	9.3	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	23.6	7.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	19.3	16.8	14.3	15.0	14.5	23.5	15.7	10.9	15.7	17.2	15.2	19.2	5.1	0.0	0.0	3405.1	0.1	1.0	1.0	0.0	0.6	8.9	3.8	5.1	2.1	0.0	0.1	1.8	0.0	1.5	0.1	0.1	1.9	0.1	22.2	24.6	5.7	3.2	1.2	0.0	341.9	0.0	0.1	3.5	0.0	72.3	0.0	0.7	4.2	0.1	0.5	10.1	1408.3	0.0	0.0	0.0	1.4	17.0	7.2	0.7	0.0	116.2	0.0	7.4	0.0	1893.0	1772.0	0.2	0.0	5.3	0.1	0.5	0.0	0.5	1.8	0.7	0.0	11.5	3.1	0.2	0.8	0.1	0.4	0.3	1.0	1.1	0.0	0.5
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.7;intestine: 17.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 327.5;Late spermatids: 920.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5"	"Region enhanced"	"Detected in many"		"pons: 53.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 367.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.4;pons and medulla: 35.1"	"Region enriched"	"Detected in many"	8	"spinal cord: 256.8"	"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA					"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	3.0	14.6	2.2	7.6	4.3	0.0	1.8	0.5	7.2	3.1	0.3	17.5	4.8	0.8	0.1	0.5	3.1	0.6	0.8	0.8	4.5	0.3	0.1	0.9	0.2	37.9	5.2	0.9	0.7	1.3	0.1	2.9	0.3	53.7	2.3	2.1	1.5	0.5	1.5	0.4	0.9	9.0	2.0	9.2	1.2	5.2	13.3	1.9	0.1	0.5	0.2	0.1	1.5	8.4	18.0	0.0	0.7	0.0	367.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.7	1.6	0.4	1.3	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.7	0.0	0.2	2.0	0.0	2.2	0.4	0.0	1.6	86.6	1.5	0.2	0.8	0.0	0.0	1.7	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.3	0.5	7.2	0.8	4.5	37.9	5.2	0.9	53.7	9.2	1.9	18.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.3	0.8	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	327.5	0.5	0.1	1.4	92.3	0.0	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.2	0.1	1.0	0.0	0.0	0.9	920.2	5.9	0.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.8	0.1	38.1	0.0	0.1	14.1	96.1	19.4	0.3	0.4	0.0	0.1	0.0	0.5	0.2
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520388-232525716	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 3.1;retina: 5.3;skeletal muscle: 9.8"	"Group enriched"	"Detected in some"	10	"Early spermatids: 29.0;Muller glia cells: 45.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.2;colorectal cancer: 2.5;endometrial cancer: 1.4;melanoma: 2.1;urothelial cancer: 4.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Daudi: 1.0"	"Group enriched"	"Detected in some"	10	"basal ganglia: 1.8;olfactory bulb: 4.2"	"Region enhanced"	"Detected in many"		"olfactory bulb: 14.9"							NA	NA								"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.0	0.0	1.0	0.0	0.8	0.0	0.0	1.6	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	2.8	1.2	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.0	9.8	0.0	0.0	0.0	1.0	0.0	0.0	0.8	1.2	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	1.6	3.1	0.1	2.4	2.8	1.2	0.2	3.1	1.0	1.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	3.6	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489526	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 27.6"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 16.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 1.8;glioma: 5.9"	"Region enhanced"	"Detected in many"		"midbrain: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7"	HPA028835	Uncertain	Supported				NA	NA					"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.1	2.7	0.6	0.2	1.7	1.1	0.1	0.0	3.6	0.6	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	7.2	0.1	0.1	0.2	0.0	6.4	27.6	0.3	0.1	0.1	0.0	6.8	0.0	15.5	0.2	0.1	0.1	1.4	0.0	0.1	0.1	0.4	0.1	1.1	0.1	0.5	0.4	8.9	0.0	0.4	0.0	0.0	0.1	0.6	5.4	0.0	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	9.2	0.0	0.1	0.0	2.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	32.1	0.4	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	3.6	0.1	7.2	6.4	27.6	0.3	15.5	1.1	8.9	5.4	0.4	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.2	0.4	0.0	3.0	0.6	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	16.2	0.0	0.0	0.0	0.4	2.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.7	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SOX17		ENSG00000164736	"SRY-box transcription factor 17"	Q9H6I2	8	54457935-54460892	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 38.4;breast: 32.9"	"Group enriched"	"Detected in many"	8	"Adipocytes: 464.9;Endometrial ciliated cells: 377.3;Endothelial cells: 171.5;Glandular and luminal cells: 520.0"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 122.8;ovarian cancer: 96.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"EFO-21: 108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025594, HPA068399"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025594: , HPA068399: AB_2685981"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.76e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.98e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.88e-1)"	38.4	1.6	3.1	1.4	2.3	0.0	32.9	2.6	2.9	20.6	2.2	7.1	0.7	19.0	1.2	3.7	23.2	7.8	14.4	2.2	2.6	3.1	1.3	10.0	0.7	2.9	2.6	1.6	4.2	1.9	0.8	2.3	5.7	3.5	6.1	0.8	0.1	4.0	1.1	10.4	5.1	5.0	4.4	2.5	13.3	5.8	3.4	2.8	0.4	5.8	5.9	0.4	8.5	9.5	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.3	2.6	2.9	2.2	2.6	2.9	2.6	1.6	3.5	2.5	2.8	2.7	464.9	0.0	0.0	0.0	0.2	13.9	0.3	0.0	0.0	0.1	0.7	1.3	2.1	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	2.6	377.3	44.5	171.5	0.0	2.7	0.0	0.2	0.1	7.7	0.0	520.0	0.0	0.0	46.8	0.1	0.1	0.0	0.0	0.0	0.0	0.9	16.6	1.8	2.5	3.5	19.6	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	7.3	5.1	3.2	6.4	0.3	13.5	0.0	4.5	0.2	0.0	3.7
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.4;breast: 5.2;choroid plexus: 5.5"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 25.0;Distal tubular cells: 90.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 7.7;endometrial cancer: 2.2;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	13	"Hep G2: 7.9;SK-BR-3: 13.6;T-47d: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favorable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.1	0.2	10.3	0.2	8.2	0.7	5.2	7.9	11.4	2.3	5.5	0.1	0.2	1.2	0.1	0.2	0.1	0.2	0.5	7.8	8.2	1.5	0.1	0.1	0.3	8.8	8.5	6.5	0.2	0.2	0.0	0.0	0.1	8.9	0.7	0.0	0.8	3.1	0.0	0.2	0.6	0.1	0.0	7.5	0.2	0.3	0.2	9.5	0.0	1.2	0.0	0.0	0.1	0.0	9.5	0.3	0.1	0.3	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.6	7.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.6	0.5	0.0	0.4	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.4	0.6	0.3	13.6	0.2	0.4	4.3	0.4	0.2	0.4	0.3	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.6	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.8	0.3	0.1	0.1	0.0	0.0	10.3	8.2	7.9	11.4	7.8	8.2	8.8	8.5	6.5	8.9	7.5	9.5	9.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	1.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38990859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 35.2"	"Group enriched"	"Detected in some"	19	"Endometrial ciliated cells: 75.5;Respiratory ciliated cells: 109.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.4;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"AF22: 17.5"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 23.6"					"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.0	0.0	2.1	0.0	1.0	0.0	0.0	1.8	0.7	0.7	1.1	0.1	0.0	0.6	0.0	0.0	35.2	0.0	0.0	0.7	3.2	0.0	0.0	2.1	0.0	4.7	4.1	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.0	1.8	0.7	0.7	3.2	4.7	4.1	0.0	4.5	2.5	1.8	1.4	0.0	0.0	1.5	0.0	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.4	0.1	0.0	4.8	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.4	75.5	0.4	0.3	0.0	0.0	0.1	0.0	1.1	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	109.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.1
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 143.7;choroid plexus: 48.1"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 138.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	5.1	7.7	67.5	0.6	79.4	0.2	6.3	143.7	91.3	4.0	48.1	7.1	2.0	3.6	1.5	1.8	6.4	2.8	4.2	81.0	62.2	42.6	10.0	6.7	0.5	74.6	68.0	75.3	5.9	4.6	2.3	13.0	3.2	88.1	11.7	1.7	15.8	22.1	1.6	2.8	3.2	3.3	2.4	79.0	2.6	8.7	2.2	64.0	0.5	12.4	1.9	0.5	3.9	3.1	119.0	0.0	0.0	138.7	0.1	0.1	3.3	0.2	0.6	0.1	0.0	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.3	4.5	0.0	0.5	0.3	0.1	0.0	0.0	0.4	1.1	0.1	0.0	2.6	0.3	0.0	0.4	4.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	17.7	0.2	0.1	1.7	0.0	0.0	1.0	0.2	25.7	0.6	0.0	0.6	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.5	79.4	143.7	91.3	81.0	62.2	74.6	68.0	75.3	88.1	79.0	64.0	119.0	3.2	0.0	2.0	14.7	0.0	0.4	0.5	0.6	1.8	9.1	1.1	32.4	3.9	0.0	1.3	12.9	6.2	0.3	0.1	0.8	0.0	0.2	0.4	3.0	1.2	4.3	16.1	0.0	109.1	0.2	0.0	2.6	0.0	6.5	0.0	1.4	0.7	0.5	0.2	1.7	109.2	0.4	2.0	0.0	0.4	0.1	0.0	0.2	1.8	7.5	0.0	1.1	0.0	33.7	19.3	0.4	0.3	0.0	0.0	3.7	0.5	0.7	4.3	6.1	0.0	0.9	0.6	0.2	0.5	0.1	0.6	0.5	0.1	0.5	0.4	0.3
TMEM190	MDAC1	ENSG00000160472	"Transmembrane protein 190"	Q8WZ59	19	55376826-55378246	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 139.3;testis: 58.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 556.2;Endometrial ciliated cells: 307.5;Late spermatids: 179.0;Respiratory ciliated cells: 1386.5"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 11.5"	"Region enhanced"	"Detected in many"		"cerebellum: 6.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 10.6;SCLC-21H: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-3)"	"unprognostic (3.97e-2)"		"unprognostic (1.42e-1)"	"unprognostic (5.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.38e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.93e-1)"	0.1	1.6	0.4	0.2	0.7	0.2	0.0	6.6	0.9	4.1	0.0	0.2	0.2	0.4	0.0	0.1	139.3	0.2	0.0	0.5	0.1	0.8	0.0	18.3	0.1	1.2	1.0	0.0	0.2	0.1	0.0	7.5	0.6	2.6	0.5	0.0	0.2	0.1	0.5	0.0	1.3	0.1	0.1	0.1	0.1	1.0	58.1	2.4	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.0	1.8	0.0	0.4	0.0	0.0	0.2	0.5	0.2	0.4	0.1	1.3	1.1	1.8	0.1	0.5	0.2	3.3	0.0	0.0	0.0	3.2	0.1	0.0	2.2	10.6	0.6	0.0	0.0	0.2	0.0	0.1	0.0	3.4	0.0	0.1	0.0	2.5	0.0	1.5	0.2	0.0	0.4	1.3	0.5	0.1	1.2	1.1	0.0	0.9	5.0	0.9	1.0	1.3	0.4	0.9	0.5	0.0	0.0	0.1	0.8	0.1	0.5	0.3	2.5	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	6.6	0.9	0.5	0.1	1.2	1.0	0.0	2.6	0.1	2.4	0.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	63.5	0.0	0.6	0.0	0.0	0.0	0.0	66.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	556.2	307.5	1.8	0.4	8.9	0.0	0.0	0.0	0.1	1.8	0.0	3.7	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	91.6	0.0	0.0	179.0	5.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.2	0.0	0.0	1386.5	0.1	0.0	0.0	28.6	3.4	1.8	0.0	0.0	0.4	0.2	0.0	0.0	0.3
TMEM26	"Em:AC068892.1, MGC35010"	ENSG00000196932	"Transmembrane protein 26"	Q6ZUK4	10	61406642-61453381	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.2;Endometrial stromal cells: 5.4;Excitatory neurons: 5.3;Hepatic stellate cells: 4.6;Inhibitory neurons: 4.8;Kupffer cells: 12.2;Late spermatids: 5.6;Theca cells: 15.0"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.5;endometrial cancer: 1.0;prostate cancer: 1.8;renal cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.7;fHDF/TERT166: 1.1;HSkMC: 2.0;HUVEC TERT2: 1.5;MOLT-4: 2.3"	"Region enhanced"	"Detected in some"		"hypothalamus: 2.3"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.21e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.34e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.29e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.95e-1)"	0.4	0.5	1.3	0.9	1.6	0.1	5.3	0.3	1.0	2.3	0.2	0.7	1.4	4.0	0.1	0.6	0.4	1.0	0.1	1.1	0.7	2.2	2.5	1.4	0.7	1.8	1.0	0.9	0.5	0.0	1.4	0.2	1.5	0.6	2.6	0.9	0.0	0.0	2.4	0.8	0.0	0.8	2.0	0.3	8.9	0.2	3.7	1.2	2.1	0.4	0.2	0.2	0.7	0.5	0.8	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	4.7	0.4	0.6	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.5	0.0	0.5	1.5	0.5	0.0	0.0	0.1	0.0	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.3	1.0	1.1	0.7	1.8	1.0	0.9	0.6	0.3	1.2	0.8	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.7	5.4	1.7	0.0	0.0	5.3	0.0	0.0	1.4	0.0	1.6	0.0	0.1	4.6	0.2	0.3	0.0	4.8	0.0	0.0	12.2	0.0	5.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.1	1.2	0.5	0.2	0.0	0.1	0.0	0.1	15.0	0.0	0.0
VWA3A	"FLJ40941, FLJ46765"	ENSG00000175267	"Von Willebrand factor A domain containing 3A"	A6NCI4	16	22092538-22156964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.8;choroid plexus: 45.1;fallopian tube: 40.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Club cells: 16.7;Endometrial ciliated cells: 45.6;Excitatory neurons: 33.8;Late spermatids: 15.2;Respiratory ciliated cells: 88.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 3.2;glioma: 1.4;ovarian cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041696, HPA042044"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041696: AB_10964202, HPA042044: AB_10968997"	"unprognostic (2.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.75e-4)"	"prognostic favorable (8.15e-4)"	"unprognostic (2.70e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.79e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.06e-4)"	0.3	0.3	24.8	0.0	11.8	0.4	0.4	8.2	13.3	6.2	45.1	0.3	0.1	2.5	0.1	0.1	40.0	0.0	0.5	6.8	14.5	0.5	0.1	8.9	0.1	17.3	23.3	6.5	0.5	0.4	0.1	16.7	0.1	13.0	0.4	0.1	0.3	0.1	0.1	0.1	2.0	0.3	0.1	20.5	0.3	0.2	8.3	9.9	0.1	0.5	0.2	0.2	0.1	0.1	10.8	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	11.8	8.2	13.3	6.8	14.5	17.3	23.3	6.5	13.0	20.5	9.9	10.8	0.3	0.0	1.1	25.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	45.6	0.3	0.0	0.0	0.0	33.8	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	15.2	0.3	0.2	0.0	3.7	0.0	0.0	0.0	4.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	88.0	0.0	0.0	0.0	1.2	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469753-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 5255.3;salivary gland: 2005.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4507.8;Club cells: 6299.8;Collecting duct cells: 1988.1;Endometrial ciliated cells: 3253.3;Glandular and luminal cells: 4817.5;Respiratory ciliated cells: 2935.3;Urothelial cells: 3783.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 1815.6;ovarian cancer: 1086.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"A-431: 115.8;CAPAN-2: 210.6;EFO-21: 171.3;HaCaT: 151.9;RPTEC TERT1: 165.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042302	Enhanced				"Secreted in other tissues"	NA	NA		1600000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	11.8	1.6	6.6	11.1	12.0	0.0	81.9	6.2	9.4	5255.3	18.8	165.2	9.7	242.3	950.2	55.3	682.5	167.6	3.9	6.8	7.2	907.9	23.8	145.9	0.9	7.3	7.4	6.6	10.5	30.7	82.6	153.5	0.7	7.0	223.6	227.0	6.9	2005.6	832.7	2.0	30.9	60.6	29.2	6.4	0.7	44.5	15.0	7.1	12.4	255.9	0.5	8.9	162.5	25.2	6.9	115.8	0.0	0.3	0.4	0.0	0.1	4.7	0.0	0.0	0.0	0.0	4.9	210.6	0.0	171.3	0.0	0.7	151.9	0.0	0.0	0.0	0.8	1.9	0.0	1.2	0.3	0.0	0.2	0.7	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	6.7	0.3	2.7	18.4	0.6	0.0	0.1	0.0	0.0	165.6	1.3	5.0	1.0	10.6	0.0	1.1	2.0	3.1	0.6	0.0	0.3	2.8	0.6	0.5	0.7	0.6	1.6	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	12.0	6.2	9.4	6.8	7.2	7.3	7.4	6.6	7.0	6.4	7.1	6.9	2.8	169.9	273.8	2.6	4.2	8.9	1190.9	4507.8	35.3	30.3	340.4	238.5	2.0	94.4	6299.8	1988.1	22.9	1.0	4.3	239.8	221.1	308.2	1.6	3253.3	359.3	21.7	422.7	0.0	4.7	129.2	0.8	23.4	31.6	4817.5	10.1	12.5	3.9	3.3	1.9	0.0	7.6	1764.7	1328.5	0.6	1.1	5.0	36.1	26.8	10.6	1.9	5.7	31.3	0.0	2.0	3.4	179.0	424.6	0.0	0.8	1169.7	1.7	113.9	2935.3	6.1	6.6	1.1	319.1	12.4	11.9	110.2	14.1	0.7	36.8	0.0	318.2	3783.3
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"		5	129460281-129738683	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"cervix: 10.2;endometrium 1: 9.9;smooth muscle: 6.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7;testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 15.9;SH-SY5Y: 34.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA			"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.0	0.7	0.6	0.0	2.1	0.0	0.0	0.0	1.7	10.2	0.1	0.2	0.1	9.9	0.0	0.2	0.2	0.0	0.2	0.8	0.4	0.3	0.0	0.0	0.0	0.8	0.5	1.2	0.4	0.0	0.1	0.0	3.8	1.3	0.1	0.3	0.5	0.3	0.0	0.5	0.0	0.1	6.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	15.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	34.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	1.7	0.8	0.4	0.8	0.5	1.2	1.3	0.0	0.3	1.1	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.4	0.0	0.0	1.8	0.0	15.6	0.0	0.3	0.0	0.0	1.5	0.5	8.9	0.2	0.0	0.0	82.6	0.2	0.7	1.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	79.7	0.1	0.0	0.0	0.3	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	12.5	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.1	0.1	0.0	5.2	0.1	0.1	0.3	0.0
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404923-130428609	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.8"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 14.5;Endometrial stromal cells: 30.9;Glandular and luminal cells: 37.7;Skeletal myocytes: 26.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;HeLa: 1.3;HMC-1: 4.4;NTERA-2: 2.2;U-2 OS: 9.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066349	Approved				"Secreted to extracellular matrix"	NA	NA		3600000			"HPA066349: AB_2685662"	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	1.8	0.1	1.4	10.2	1.7	0.0	0.7	0.0	3.4	1.5	0.0	5.2	1.1	3.1	1.0	3.0	2.2	1.6	1.4	2.9	0.5	0.2	0.0	27.8	0.1	1.2	0.2	3.1	0.4	0.7	0.0	0.2	2.7	0.7	2.7	0.5	0.0	0.5	5.0	0.5	0.3	2.1	4.2	0.0	0.4	5.4	0.3	0.5	0.0	0.2	0.5	0.0	4.3	0.9	1.8	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.7	0.0	3.4	2.9	0.5	1.2	0.2	3.1	0.7	0.0	0.5	1.8	1.3	0.0	0.6	1.0	0.0	0.4	0.4	0.1	0.0	2.4	2.3	3.9	9.1	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	14.5	30.9	0.6	0.0	0.0	7.4	0.0	0.0	6.6	0.0	37.7	1.3	1.3	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.7	0.5	0.0	0.1	1.8	2.8	0.0	0.1	1.0	0.5	5.9	0.0	0.0	1.5	0.0	0.5	0.0	0.1	2.6	0.2	0.0	26.9	5.7	0.1	0.3	0.1	0.1	0.0	0.6	0.1	0.0	0.0
AKAP14	AKAP28	ENSG00000186471	"A-kinase anchoring protein 14"	Q86UN6	X	119895837-119920716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 44.4;testis: 84.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 485.6;Late spermatids: 1648.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.6;SCLC-21H: 2.4;SuSa: 1.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA060999	Enhanced					NA	NA					"HPA060999: AB_2684407"	"unprognostic (1.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.68e-2)"		"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.80e-1)"	0.0	0.0	2.2	0.0	1.0	0.2	0.1	1.2	0.8	1.2	13.2	0.1	0.3	0.7	0.1	0.0	44.4	0.0	0.0	1.4	2.7	0.0	0.1	3.3	0.0	3.2	2.3	0.7	0.1	0.0	0.0	0.7	0.0	2.2	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.4	0.0	1.6	0.0	0.0	84.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.0	1.2	0.8	1.4	2.7	3.2	2.3	0.7	2.2	1.6	2.3	0.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	18.7	0.0	0.5	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	485.6	133.5	1.1	0.3	0.0	0.0	0.6	0.0	0.3	0.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	22.4	0.0	0.0	1648.3	2.5	0.8	0.0	1.0	0.0	0.2	0.0	1.5	0.2	0.0	0.1	7.2	0.0	0.0	0.1	0.1	224.1	0.1	13.1	0.0	4.9	14.0	2.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1
ALPG	"ALPPL2, GCAP"	ENSG00000163286	"Alkaline phosphatase, germ cell"	P10696	2	232406844-232410714	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 33.9;HaCaT: 24.9;SuSa: 38.3"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.7	33.9	0.0	0.0	0.0	0.0	24.9	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ALPP	"PALP, PLAP"	ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378724-232382889	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 18.0;placenta: 34.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 12.8;Glandular and luminal cells: 5.0;Syncytiotrophoblasts: 6.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 381.0;SiHa: 103.6"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	18.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	42.9	0.0	0.1	0.0	0.1	381.0	0.0	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	103.6	35.3	0.0	3.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	6.7	0.1	0.2	0.0	0.0
APOBEC4	"C1orf169, FLJ25691, MGC26594, RP1-127C7.4"	ENSG00000173627	"Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4"	Q8WW27	1	183646275-183653316	"Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 11.7;testis: 10.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 131.4;Endometrial ciliated cells: 31.0;Late spermatids: 86.7;Respiratory ciliated cells: 63.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA								"unprognostic (2.27e-1)"	"prognostic favorable (2.65e-4)"				"unprognostic (2.61e-1)"		"unprognostic (3.84e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.73e-1)"		"unprognostic (7.10e-2)"	"unprognostic (4.00e-2)"			0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.7	0.1	0.8	0.0	0.1	0.2	0.0	0.0	11.7	0.0	0.0	0.6	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	10.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.7	0.6	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	11.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	131.4	31.0	0.2	0.1	3.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	86.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.2	0.0	63.3	0.0	0.0	0.0	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961872-49965682	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"salivary gland: 628.0;testis: 223.8"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1542.9;Late spermatids: 4265.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 223.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	1.8	0.8	2.5	0.1	3.3	0.2	17.3	3.2	2.7	13.0	1.3	0.3	15.5	2.7	0.2	16.6	0.7	2.9	2.3	2.2	2.7	1.2	0.1	7.7	0.0	3.1	3.6	1.9	0.2	2.0	3.1	1.2	0.0	3.1	1.3	0.0	1.0	628.0	1.0	0.2	97.3	0.1	0.3	2.3	0.4	52.8	223.8	3.3	0.0	1.7	0.0	0.1	0.3	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.7	223.2	0.0	10.1	0.0	0.0	0.3	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.3	3.2	2.7	2.2	2.7	3.1	3.6	1.9	3.1	2.3	3.3	2.4	0.5	57.7	3.1	0.0	0.1	1.3	0.5	18.3	0.0	0.8	53.9	48.0	0.3	0.0	56.4	7.3	0.0	0.0	0.1	0.0	0.0	0.1	1542.9	1.5	0.1	1.8	0.0	0.0	0.0	0.2	0.0	1.4	34.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.4	0.0	1.6	4265.6	28.6	1.7	295.3	0.0	0.0	53.7	0.0	3.0	0.1	7.2	0.0	19.2	0.3	1.6	0.0	0.0	9.7	1.7	19.7	0.0	1.8	403.9	15.9	1.3	0.9	0.0	0.6	18.7	0.0	0.6
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224194-64230607	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	33	"skeletal muscle: 91.4;tongue: 52.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 21.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;THP-1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049542	Uncertain					NA	NA					"HPA049542: AB_2680810"	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.2	0.3	0.3	0.1	0.3	0.2	0.2	0.3	0.4	0.3	0.3	0.4	0.0	0.4	0.5	0.9	1.4	0.2	2.1	0.3	0.3	0.3	0.1	0.2	0.1	0.3	0.2	0.3	0.6	0.2	0.3	0.2	0.0	0.3	0.4	0.5	0.2	0.7	0.6	91.4	0.3	0.2	0.3	0.2	0.2	0.3	1.7	0.2	0.1	0.2	52.6	0.2	0.6	0.3	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.6	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.2	0.7	0.7	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	4.6	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	21.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1
ASIC2	"ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG"	ENSG00000108684	"Acid sensing ion channel subunit 2"	Q16515	17	33013087-34174964	"Plasma proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.7;cervix: 3.1;endometrium 1: 3.4;retina: 4.6"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 1786.2;Inhibitory neurons: 666.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;RPTEC TERT1: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052112	Enhanced					NA	NA					"HPA052112: AB_2681733"	"unprognostic (3.40e-1)"	"unprognostic (2.45e-2)"	"unprognostic (8.50e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	0.0	0.6	9.2	0.0	11.6	0.0	0.1	4.7	10.4	3.1	0.1	0.1	0.4	3.4	0.0	0.0	0.6	0.0	0.0	12.7	6.6	0.5	0.0	0.0	0.0	6.8	5.1	10.1	0.0	0.0	0.0	0.5	0.0	3.0	0.1	0.1	4.6	0.0	0.5	0.0	0.1	0.3	1.4	2.9	0.0	0.0	0.3	5.5	0.0	0.0	0.0	0.0	0.0	0.1	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	11.6	4.7	10.4	12.7	6.6	6.8	5.1	10.1	3.0	2.9	5.5	8.7	0.0	0.0	0.0	17.0	0.0	0.3	0.0	0.0	0.0	25.7	0.0	0.0	1.3	0.0	0.0	9.2	2.1	0.0	0.0	0.1	0.0	0.1	16.3	0.1	0.8	0.1	6.0	0.0	1786.2	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	10.1	666.4	1.3	0.0	0.0	0.0	47.1	0.3	0.1	1.8	26.2	0.0	0.5	0.0	144.3	22.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase and isoaspartyl peptidase 1"	Q7L266	11	62337448-62393412	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.3;cervix: 122.7;testis: 101.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 277.9;eosinophil: 269.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 277.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	14.0	3.7	89.3	6.6	89.9	14.5	12.1	89.9	104.3	122.7	67.3	14.3	6.9	26.7	3.1	2.1	68.7	11.3	5.8	83.1	88.0	42.8	10.3	26.0	5.6	93.2	96.5	79.1	1.9	13.5	2.3	21.4	3.3	96.8	24.0	17.3	18.0	13.4	7.2	7.4	2.5	9.6	4.5	76.5	4.8	15.2	101.2	101.0	10.4	6.7	3.0	4.8	4.3	2.0	86.9	2.4	19.5	20.9	27.2	0.1	0.0	16.4	2.3	0.8	3.6	3.5	32.0	8.5	1.9	85.2	0.3	9.3	1.8	83.9	0.7	4.2	2.6	34.4	1.2	28.1	23.5	0.6	24.0	30.8	0.8	0.2	1.6	0.4	1.3	39.4	47.8	24.5	21.5	0.9	37.5	65.3	15.9	28.5	13.6	15.2	26.1	12.5	11.8	73.3	5.9	112.3	16.1	16.4	28.2	14.4	21.2	15.0	12.1	2.0	0.4	15.4	1.2	9.5	32.8	33.6	3.0	0.8	12.3	9.7	277.9	68.6	269.5	2.8	50.8	1.9	2.4	1.0	3.3	39.7	1.5	2.3	3.4	16.3	11.5	38.5	7.2	0.8	24.2	89.3	89.9	89.9	104.3	83.1	88.0	93.2	96.5	79.1	96.8	76.5	101.0	86.9	29.2	6.4	27.8	56.8	5.2	3.4	2.5	2.2	0.6	24.4	13.8	6.6	2.4	42.9	4.1	22.0	33.3	2.3	3.2	14.0	133.1	30.3	372.5	414.6	39.9	31.2	47.2	14.1	13.9	22.3	2.4	4.0	19.9	437.1	80.9	16.6	49.2	3.7	25.0	16.8	18.6	67.4	6.1	11.4	6.4	597.6	8.7	26.9	1.8	9.4	10.5	80.8	4.1	15.1	22.0	7.8	7.5	7.2	13.9	35.4	2.9	214.1	5.4	37.1	13.1	7.7	6.1	534.3	48.6	0.1	1.3	0.8	7.8	10.8	36.0	15.9
C11orf16		ENSG00000176029	"Chromosome 11 open reading frame 16"	Q9NQ32	11	8920076-8933006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.0;fallopian tube: 13.0;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	8	"Endometrial ciliated cells: 40.8;Ionocytes: 28.5;Respiratory ciliated cells: 110.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA040644			Uncertain	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA040644: "	"unprognostic (5.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.09e-3)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.94e-5)"	"unprognostic (6.40e-4)"	"unprognostic (1.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.13e-3)"	0.0	0.1	1.1	0.0	0.3	0.0	0.1	0.5	0.2	0.5	5.0	0.0	0.0	0.3	0.0	0.0	13.0	0.0	0.0	0.3	0.8	0.2	0.0	2.7	0.0	1.0	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	2.2	0.4	6.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.5	0.2	0.3	0.8	1.0	1.3	0.0	0.8	1.2	0.4	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.1	0.0	0.0	7.1	5.5	0.0	0.1	0.0	0.0	0.0	0.0	1.6	40.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	28.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	110.8	0.0	0.0	0.0	1.5	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C11orf97	LINC01171	ENSG00000257057	"Chromosome 11 open reading frame 97"	A0A1B0GVM6	11	94512461-94532123	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 19.3;testis: 18.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 239.3;Endometrial ciliated cells: 258.2;Respiratory ciliated cells: 109.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (3.62e-3)"	"unprognostic (1.29e-1)"		"unprognostic (1.22e-1)"	"unprognostic (4.18e-1)"		"unprognostic (4.70e-1)"	"unprognostic (9.64e-3)"		"unprognostic (9.44e-3)"	"unprognostic (3.86e-3)"				0.0	0.0	2.6	0.0	2.7	0.3	0.0	0.6	1.7	0.7	3.3	0.0	0.0	0.5	0.1	0.0	19.3	0.1	0.0	1.6	1.2	0.9	1.4	2.5	0.0	2.1	2.1	1.4	0.0	0.5	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	18.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	0.6	1.7	1.6	1.2	2.1	2.1	1.4	1.4	2.3	1.7	1.4	0.0	3.2	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	11.2	0.0	0.0	0.3	0.0	0.1	0.0	0.4	239.3	258.2	1.4	0.6	0.0	0.0	3.4	0.2	0.0	0.5	0.0	3.2	0.0	0.0	0.0	4.5	0.1	0.0	2.0	0.0	0.0	0.0	0.0	34.4	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	18.1	109.3	0.0	0.0	0.0	0.0	37.9	9.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1
C1orf189		ENSG00000163263	"Chromosome 1 open reading frame 189"	Q5VU69	1	154199085-154206333	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"fallopian tube: 30.8;testis: 19.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 88.7;Endometrial ciliated cells: 30.7;Late spermatids: 19.6;Respiratory ciliated cells: 25.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045779			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"HPA045779: AB_2679448"	"unprognostic (8.23e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.01e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.05e-2)"	0.1	0.0	0.9	0.1	0.4	0.5	0.1	0.6	0.4	1.7	0.5	0.0	0.0	0.5	0.3	0.1	30.8	0.0	0.1	0.2	0.3	0.1	0.3	1.8	0.1	1.6	0.8	0.0	0.1	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.0	1.1	0.0	0.1	19.8	1.2	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.4	0.2	0.4	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.5	0.1	0.1	0.5	0.2	0.5	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.3	0.0	0.4	0.2	0.2	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.9	0.4	0.6	0.4	0.2	0.3	1.6	0.8	0.0	1.3	1.1	1.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	30.7	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	19.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	25.1	0.0	0.0	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C1orf87	"CREF, MGC34837"	ENSG00000162598	"Chromosome 1 open reading frame 87"	Q8N0U7	1	59987269-60073770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.2;fallopian tube: 30.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 113.0;Endometrial ciliated cells: 63.0;Late spermatids: 25.4;Respiratory ciliated cells: 101.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031366, HPA031368"	Enhanced					NA	NA					"HPA031366: AB_2673847, HPA031368: AB_10600795"				"unprognostic (1.16e-2)"	"unprognostic (9.87e-2)"			"unprognostic (3.83e-2)"		"unprognostic (1.92e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.11e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"			0.0	0.0	6.2	0.0	1.8	0.0	0.0	1.8	1.1	0.7	2.9	0.0	0.0	0.5	0.0	0.0	30.2	0.0	0.0	1.1	5.2	0.1	0.0	3.2	0.0	8.2	5.2	0.6	0.0	0.0	0.6	0.3	0.0	5.6	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.9	2.9	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.2	1.8	1.8	1.1	1.1	5.2	8.2	5.2	0.6	5.6	7.4	2.9	2.8	0.0	0.0	1.5	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	11.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	113.0	63.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	25.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.7	0.0	0.0	0.0	0.7	11.4	0.9	0.0	0.1	0.0	0.1	0.2	0.0	0.0
C4orf54	"FOPV, LOC285556"	ENSG00000248713	"Chromosome 4 open reading frame 54"	D6RIA3	4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 73.4"	"Cell type enriched"	"Detected in single"	17	"Endometrial ciliated cells: 14.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.6;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"							HPA079091			Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA079091: "	"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	5.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.0	73.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.7	0.0	14.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C5orf49	LOC134121	ENSG00000215217	"Chromosome 5 open reading frame 49"	A4QMS7	5	7830378-7851151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.6;fallopian tube: 76.4;testis: 37.4"	"Group enriched"	"Detected in many"	11	"Early spermatids: 821.2;Endometrial ciliated cells: 353.9;Late spermatids: 410.2;Respiratory ciliated cells: 502.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043759	Enhanced					NA	NA					"HPA043759: AB_2678655"	"unprognostic (1.55e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.93e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.20e-2)"	0.2	0.5	19.8	0.1	15.8	0.0	0.9	14.4	16.6	2.9	23.7	0.1	0.1	1.4	1.7	0.0	76.4	0.5	0.1	14.4	30.6	3.9	3.3	6.1	0.0	20.1	20.3	12.0	1.0	2.7	6.3	10.5	0.1	19.8	3.5	0.0	1.4	0.3	1.3	0.0	0.6	0.1	0.3	20.1	0.1	0.6	37.4	15.1	0.7	0.8	0.0	0.0	0.2	0.8	17.3	0.0	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	15.8	14.4	16.6	14.4	30.6	20.1	20.3	12.0	19.8	20.1	15.1	17.3	0.1	0.0	5.4	2.3	1.0	0.0	2.6	32.0	0.0	0.4	4.7	3.0	0.4	1.5	41.4	9.2	0.0	0.2	0.0	0.0	3.9	5.6	821.2	353.9	4.3	1.2	5.4	0.0	2.8	0.9	2.9	1.7	0.0	5.8	1.3	0.2	0.4	0.8	0.1	1.7	3.5	0.2	46.8	0.0	0.4	410.2	8.7	0.8	3.6	1.0	0.0	2.3	0.0	1.5	0.2	1.6	0.0	3.8	0.0	4.1	0.0	39.9	502.4	3.6	6.6	0.8	13.4	41.1	8.4	0.0	0.6	0.3	0.9	0.1	0.0	1.5
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 9.1;choroid plexus: 25.4;fallopian tube: 16.6;testis: 7.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 145.5;Endometrial ciliated cells: 140.4;Late spermatids: 57.6;Respiratory ciliated cells: 243.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 2.7;SCLC-21H: 1.6"	"Low region specificity"	"Detected in many"							"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.0	0.0	8.7	0.0	2.5	0.0	0.0	3.0	1.2	0.4	25.4	0.0	0.0	0.5	0.0	0.0	16.6	0.0	0.0	4.5	7.1	0.0	0.0	2.1	0.0	6.6	8.8	0.6	0.0	0.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	7.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.2	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	2.5	3.0	1.2	4.5	7.1	6.6	8.8	0.6	5.3	9.1	3.5	4.1	0.0	0.0	1.5	0.3	0.0	0.0	0.2	6.6	0.0	0.0	0.0	0.1	0.4	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.5	140.4	1.4	0.1	0.0	0.0	0.4	0.0	0.0	1.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	10.2	0.0	0.0	57.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	243.9	0.0	0.0	0.0	1.8	16.8	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 98.1;testis: 62.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 520.9;Endometrial ciliated cells: 442.5;Late spermatids: 579.4;Respiratory ciliated cells: 610.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.3;T-47d: 41.9;U-2197: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	2.6	16.4	14.6	0.8	12.1	0.9	3.1	11.8	13.1	5.5	20.9	1.8	1.0	4.2	26.0	1.9	98.1	2.8	1.9	12.6	16.7	9.6	3.5	9.3	0.7	14.5	14.3	10.2	2.9	6.5	6.9	17.0	1.6	14.5	4.3	1.3	10.1	3.4	6.4	1.5	1.8	1.4	1.2	15.9	1.9	3.1	62.9	11.7	0.6	8.2	0.9	1.2	2.8	1.5	12.2	11.0	18.7	8.1	12.7	3.5	7.4	1.6	7.3	5.1	8.7	5.9	7.1	10.9	1.9	9.5	4.9	4.7	7.4	9.1	4.1	7.4	0.5	8.0	0.0	21.0	22.1	9.7	1.5	5.0	5.2	3.2	4.4	1.4	7.1	4.2	8.6	10.3	1.4	4.2	41.3	5.7	1.9	17.1	17.2	21.5	8.7	3.9	6.9	21.0	7.7	7.9	8.3	10.3	4.4	1.2	3.7	41.9	1.8	2.1	5.0	6.5	42.9	2.9	4.7	12.6	1.8	14.7	0.7	1.5	0.0	0.8	0.0	0.5	0.5	1.2	0.2	0.4	0.4	0.3	0.4	0.7	0.5	0.0	0.6	0.1	0.1	0.5	0.3	14.6	12.1	11.8	13.1	12.6	16.7	14.5	14.3	10.2	14.5	15.9	11.7	12.2	1.2	9.6	7.8	2.3	1.9	0.9	1.8	39.7	2.2	5.0	11.7	9.8	1.7	15.7	46.3	14.7	14.6	11.5	0.7	0.5	11.7	26.0	520.9	442.5	6.6	2.1	1.2	1.3	2.1	7.8	3.4	5.2	4.6	23.9	1.3	12.0	0.7	1.6	3.6	3.3	2.2	1.0	38.7	1.2	1.4	579.4	8.1	1.3	0.0	0.0	2.0	13.2	0.0	1.0	0.2	6.9	1.7	7.5	3.6	2.4	1.3	58.8	610.3	19.9	0.0	1.4	15.0	133.8	20.0	1.3	0.3	4.5	1.6	41.4	1.7	3.1
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397810	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.3;choroid plexus: 86.7;fallopian tube: 109.6;testis: 91.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 744.6;Endometrial ciliated cells: 841.0;Late spermatids: 3115.3;Respiratory ciliated cells: 1312.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.2	0.6	28.7	0.3	21.6	0.0	0.7	21.0	30.0	4.5	86.7	2.8	1.9	0.7	0.1	0.4	109.6	0.3	15.5	16.9	27.1	3.2	0.3	18.6	0.2	31.3	25.9	14.7	0.4	1.0	0.1	10.7	0.2	25.6	1.6	0.7	1.2	1.9	0.4	1.4	0.6	5.5	0.5	30.8	0.2	1.4	91.3	20.7	0.3	0.6	1.7	0.3	0.9	0.4	22.4	0.2	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.3	0.0	0.4	1.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.2	0.6	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.4	0.1	28.7	21.6	21.0	30.0	16.9	27.1	31.3	25.9	14.7	25.6	30.8	20.7	22.4	0.4	6.4	15.1	11.4	0.3	2.2	3.3	67.3	2.2	1.4	1.6	1.8	37.0	1.5	116.4	7.3	0.0	0.6	0.1	11.3	72.4	1.1	744.6	841.0	6.1	2.1	12.1	0.0	11.3	1.5	0.3	3.5	0.5	9.8	8.8	0.2	1.4	4.1	0.4	0.0	12.6	13.4	81.4	1.0	1.0	3115.3	10.5	2.7	0.0	1.0	0.0	2.2	1.0	4.0	5.4	0.2	7.3	7.2	0.5	4.5	142.5	13.7	1312.6	0.9	32.9	0.5	25.5	21.0	6.9	0.4	1.0	0.5	1.6	0.0	20.5	2.4
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60185412-60281400	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;parathyroid gland: 40.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Enteroendocrine cells: 35.2;Gastric mucus-secreting cells: 40.2;Oligodendrocyte precursor cells: 129.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	24	"basophil: 76.2"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 76.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.1;JURKAT: 11.0;K-562: 20.3;NB-4: 12.3;OE19: 17.4"	"Region enriched"	"Detected in all"	38	"cerebellum: 1260.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 86.3"	"HPA024748, CAB025545, CAB047309"	Enhanced					NA	NA					"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	1.4	0.9	5.1	0.3	4.8	0.5	4.6	18.6	5.6	4.3	2.2	1.3	1.0	1.9	10.2	0.2	1.5	0.3	3.8	4.4	5.7	5.2	0.0	1.0	0.4	4.7	4.7	4.0	0.2	2.0	40.4	8.5	6.2	10.4	1.5	2.0	2.3	3.8	0.2	1.2	0.3	1.0	0.5	3.2	0.8	4.4	4.2	5.1	1.3	0.3	2.3	0.3	0.6	0.3	4.5	0.0	2.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	10.1	4.5	0.0	0.0	3.6	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	11.0	20.3	0.2	0.0	0.0	3.3	12.3	0.2	17.4	0.0	0.0	0.0	0.2	0.4	0.8	5.1	0.0	0.0	1.1	0.0	2.0	4.5	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	76.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.1	5.1	4.8	18.6	5.6	4.4	5.7	4.7	4.7	4.0	10.4	3.2	5.1	4.5	22.0	0.0	4.8	92.7	1.6	1.0	0.4	4.1	0.0	8.2	15.6	10.3	4.7	0.0	5.7	3.7	0.0	8.3	10.9	2.0	3.9	8.1	9.9	9.8	2.4	16.7	35.2	13.5	4.7	6.0	0.3	4.0	40.2	26.2	0.0	1.1	0.0	0.0	9.9	0.0	25.6	25.0	6.1	1.9	1.1	4.9	1.5	1.1	7.2	18.7	0.0	2.6	1.0	129.7	0.4	1.6	3.5	1.5	14.0	2.1	0.3	0.0	1.2	1.0	0.0	0.8	2.3	3.8	5.5	0.2	0.4	1.4	0.7	3.1	3.3	1.5
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53991637-54012666	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 91.5;tongue: 30.2"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	107	"basophil: 13.3;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in some"		"A549: 12.7;EFO-21: 23.6;HHSteC: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA056615: AB_2683192"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.9	0.1	0.5	0.0	0.0	0.4	1.0	0.2	0.2	0.1	0.2	0.2	0.0	0.3	8.8	0.0	0.0	0.6	0.8	0.0	0.0	2.2	0.0	0.8	1.1	0.2	0.0	0.0	2.9	1.9	0.0	0.8	0.4	0.0	0.2	1.0	0.0	91.5	0.0	0.2	0.0	1.2	0.1	0.3	2.4	0.4	0.0	0.0	30.2	0.1	0.0	0.0	0.5	0.0	12.7	0.2	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	23.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.6	0.0	0.1	0.1	0.0	0.0	0.0	1.9	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.1	1.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.2	0.0	2.8	0.0	0.0	0.0	3.5	0.1	0.2	0.0	0.0	13.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.4	1.0	0.6	0.8	0.8	1.1	0.2	0.8	1.2	0.4	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.1	0.0	0.0	2.3	0.1	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.4;stomach 1: 28.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 76.6;Gastric mucus-secreting cells: 50.0;Proximal enterocytes: 35.2;Undifferentiated cells: 18.1;Urothelial cells: 19.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 9.3;SK-BR-3: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.0	0.0	0.8	0.0	1.3	0.0	7.2	0.9	1.2	9.8	0.9	11.5	21.0	0.2	0.3	0.9	1.1	2.9	0.0	0.7	0.8	2.5	0.2	7.3	0.0	1.2	1.2	0.6	0.0	3.6	0.4	0.2	0.0	1.2	3.9	24.8	0.0	1.2	0.2	0.0	0.1	29.4	0.2	0.8	0.1	28.8	0.1	1.1	0.0	0.0	0.0	0.6	4.2	0.5	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	9.3	0.1	0.4	0.0	21.9	0.0	0.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.9	1.2	0.7	0.8	1.2	1.2	0.6	1.2	0.8	1.1	2.4	0.0	6.4	3.1	0.3	0.0	0.0	10.2	3.5	4.0	0.0	4.2	1.8	1.3	0.0	76.6	1.8	0.0	0.0	0.0	16.9	0.0	1.3	0.8	2.0	0.0	0.1	15.0	0.0	0.3	5.3	0.0	0.6	50.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	1.5	12.0	6.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.4	1.9	6.2	0.0	0.0	2.7	35.2	0.2	12.4	0.0	0.0	0.0	6.1	0.0	0.1	1.4	0.0	0.0	0.1	0.0	18.1	19.4
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245099-111270483	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 214.5;placenta: 83.8;seminal vesicle: 73.1"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 198.5;Syncytiotrophoblasts: 140.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.8;NTERA-2: 16.3;SuSa: 14.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 9.6"	HPA040259			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	2.1	0.0	0.0	7.3	0.0	0.0	12.8	0.0	0.0	12.0	0.0	5.6	1.9	22.7	214.5	2.3	3.2	8.4	0.3	0.0	0.0	6.5	0.3	0.5	2.8	0.0	0.0	0.0	2.6	7.5	0.1	0.2	83.8	0.0	10.7	8.7	0.0	14.3	73.1	3.0	0.9	1.7	8.3	0.0	1.7	13.0	2.0	0.0	1.9	1.5	9.1	4.7	3.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.3	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.3	0.4	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.1	0.0	1.2	0.0	0.6	2.0	0.3	7.2	0.0	7.3	0.0	39.9	0.1	0.1	3.9	8.3	0.0	18.0	4.3	0.4	0.0	0.0	0.0	0.7	198.5	12.9	6.6	40.1	0.0	0.0	0.0	0.0	7.6	0.0	0.1	1.2	0.0	0.0	0.3	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	22.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	1.0	0.5	0.1	0.1	0.9	0.0	140.5	0.3	0.9	0.5	0.3
CATSPERD	"MGC39581, TMEM146"	ENSG00000174898	"Cation channel sperm associated auxiliary subunit delta"	Q86XM0	19	5720637-5778734	"Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 120.2;Endometrial ciliated cells: 67.5;Late spermatids: 165.8;Respiratory ciliated cells: 149.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"HEL: 7.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA024056	Enhanced					NA	NA					"HPA024056: AB_1858093"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"		"unprognostic (3.77e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.74e-2)"		"unprognostic (6.85e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.95e-8)"	"unprognostic (2.54e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.74e-2)"	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.0	2.2	0.7	0.0	0.4	0.2	4.7	0.0	0.0	0.3	0.6	0.5	0.0	6.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	120.2	67.5	0.7	0.5	0.0	0.0	1.3	0.2	0.1	0.4	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	8.2	0.3	0.0	165.8	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	149.9	0.0	0.0	0.5	2.0	18.7	1.2	0.0	1.4	0.3	0.1	0.0	0.0	0.1
CCDC114	"CILD20, FLJ32926"	ENSG00000105479	"Coiled-coil domain containing 114"	Q96M63	19	48296457-48321971	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 7.3;choroid plexus: 23.9;fallopian tube: 25.7;testis: 13.4"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 106.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;U-266/70: 1.7"									HPA042524	Approved					NA	NA					"HPA042524: AB_10795706"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.70e-5)"	"unprognostic (1.54e-2)"	"unprognostic (5.09e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.50e-3)"	"unprognostic (4.35e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.15e-2)"	0.0	0.1	5.6	0.0	2.2	0.5	0.1	3.0	1.9	0.7	23.9	0.0	0.0	0.7	0.1	0.0	25.7	0.0	0.1	1.8	3.2	0.1	0.0	3.0	0.1	6.5	7.3	0.2	0.8	0.1	0.7	0.4	0.0	5.0	0.1	0.0	0.4	0.0	0.5	0.0	0.5	0.0	0.0	6.4	0.1	0.2	13.4	2.6	0.2	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.1	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.4	0.0	0.6	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.5	0.0	0.6	0.0	0.1	0.0	0.2	1.7	0.8	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.6	2.2	3.0	1.9	1.8	3.2	6.5	7.3	0.2	5.0	6.4	2.6	2.1	0.1	0.0	3.4	0.7	0.1	0.1	0.2	4.7	0.0	0.7	0.6	0.4	0.5	0.0	9.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.9	60.4	0.6	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.0	1.5	3.8	0.2	0.0	0.2	0.0	1.7	0.4	0.3	6.1	0.0	0.3	6.5	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	106.5	0.6	0.0	0.2	1.4	20.8	2.2	0.1	0.1	0.0	1.0	0.5	0.2	0.1
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"fallopian tube: 36.3"	"Cell type enriched"	"Detected in many"	5	"Respiratory ciliated cells: 374.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA028338	Enhanced					NA	NA					"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.8	1.1	0.1	0.1	0.2	0.1	0.0	0.0	36.3	0.0	0.1	0.1	0.2	0.1	0.2	3.4	0.1	0.6	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.8	0.1	0.2	0.6	0.4	0.1	0.5	0.2	0.3	0.2	3.1	3.2	4.1	1.0	0.4	1.1	0.3	14.2	0.6	0.1	2.4	1.7	1.6	0.0	23.4	0.0	0.0	0.6	2.0	4.6	5.9	0.5	0.0	74.5	1.1	2.1	1.2	0.4	0.1	0.9	0.2	1.9	1.1	3.2	1.3	0.3	1.1	0.9	0.6	0.0	0.1	2.3	10.2	0.6	1.4	0.4	1.2	1.8	0.0	1.0	1.0	0.4	0.0	0.0	1.7	1.3	3.2	2.2	0.3	0.6	4.2	1.1	374.1	0.5	0.0	0.9	5.2	0.8	0.7	0.9	0.6	0.5	0.8	0.7	2.6	0.4
CCDC78	"C16orf25, FLJ34512"	ENSG00000162004	"Coiled-coil domain containing 78"	A2IDD5	16	722582-726954	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"fallopian tube: 50.7"	"Group enriched"	"Detected in some"	11	"Endometrial ciliated cells: 179.7;Respiratory ciliated cells: 240.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.2;U-266/70: 9.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.82e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-3)"	0.3	1.1	3.2	1.7	3.4	1.5	0.4	4.7	4.4	1.9	3.1	0.2	0.3	1.7	0.1	0.5	50.7	0.9	0.6	4.1	5.1	0.9	0.1	10.1	2.2	6.3	5.2	2.1	0.5	1.0	0.7	5.0	0.5	4.4	0.6	0.3	0.8	1.2	0.7	0.5	0.7	1.9	0.1	5.3	2.2	1.1	0.6	4.0	0.9	0.6	0.2	0.8	0.9	0.3	5.9	1.8	3.1	1.1	5.4	1.1	1.2	2.8	1.1	2.2	0.5	0.1	0.8	2.8	2.0	0.4	0.3	1.0	1.7	2.8	1.1	0.1	9.0	2.1	2.3	4.8	1.4	0.8	1.5	1.5	2.5	0.4	0.1	3.3	2.4	0.2	3.7	1.4	2.4	0.8	8.6	0.0	4.5	1.5	1.3	0.8	2.1	0.9	6.6	2.5	1.7	12.2	2.1	0.9	3.6	0.9	0.9	4.5	1.7	0.9	1.5	0.5	0.4	0.3	9.9	4.7	1.9	0.8	3.2	2.6	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.2	3.4	4.7	4.4	4.1	5.1	6.3	5.2	2.1	4.4	5.3	4.0	5.9	0.1	0.0	0.0	2.6	1.9	0.0	0.1	17.9	0.0	3.5	0.7	0.6	0.5	0.0	17.7	0.0	0.0	0.0	3.4	0.2	1.9	0.0	0.0	179.7	2.1	0.1	0.0	0.4	1.4	0.2	0.1	0.2	1.1	2.4	0.0	0.0	0.0	0.0	0.9	3.3	1.0	0.0	18.3	0.6	0.0	0.1	0.3	0.5	0.0	1.0	0.1	0.7	2.1	1.0	2.0	0.3	0.0	0.0	0.2	0.6	0.0	0.2	240.7	0.2	0.0	0.0	7.6	0.8	0.9	0.0	0.1	0.0	1.4	0.1	0.1	0.2
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112971-55173177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 2.1;kidney: 1.1;testis: 2.6"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 18.8;Ionocytes: 12.2;Respiratory ciliated cells: 24.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053900	Uncertain					NA	NA					"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.3	2.4	1.2	0.0	0.9	2.3	0.5	0.0	2.1	0.0	0.0	0.1	0.2	1.6	0.0	0.1	0.3	18.8	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.7	3.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.5	12.2	0.6	4.1	0.0	0.0	0.7	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.7	0.9	2.7	0.8	24.5	0.0	0.0	0.5	0.5	1.3	0.8	0.7	0.1	0.1	0.3	0.1	0.7	0.1
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"CEA cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 10.3"	"Cell type enriched"	"Detected in some"	10	"Granulosa cells: 150.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8"									HPA043411	Uncertain					NA	NA					"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.1	0.7	1.4	2.2	0.9	17.6	0.8	0.9	1.3	2.2	0.7	0.7	0.6	2.7	0.3	0.5	0.7	0.5	0.5	0.9	2.3	0.7	1.2	3.8	5.3	1.9	2.5	0.8	0.4	0.2	0.1	0.4	1.5	1.9	0.6	0.6	0.0	0.5	3.6	0.1	0.1	2.6	0.5	1.5	10.3	0.9	1.1	3.1	2.2	0.6	0.1	3.5	0.8	0.3	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.8	1.0	1.0	0.0	5.8	0.0	0.1	6.0	27.3	29.7	11.7	20.1	10.8	25.6	20.8	6.9	15.1	21.3	21.0	30.2	19.2	7.0	12.4	26.6	17.9	1.4	0.9	0.9	1.3	0.9	2.3	1.9	2.5	0.8	1.9	1.5	3.1	1.7	1.5	0.0	0.0	0.3	5.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.6	1.8	0.0	0.1	7.2	0.0	0.0	0.0	5.4	7.3	0.1	2.0	0.0	5.7	0.1	0.0	0.1	0.3	0.0	2.2	4.5	150.8	10.0	0.3	9.4	0.0	0.7	0.0	0.0	9.0	0.6	10.3	0.0	6.2	1.8	15.0	1.0	0.0	9.2	0.0	0.1	0.0	0.0	0.4	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.6	0.0	0.0	0.3	8.8	0.0	0.0	0.0
CFAP100	"CCDC37, FLJ40083, MIA1"	ENSG00000163885	"Cilia and flagella associated protein 100"	Q494V2	3	126394909-126436556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.6;choroid plexus: 25.7;fallopian tube: 27.3;testis: 32.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 316.1;Late spermatids: 703.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046354	Enhanced					NA	NA					"HPA046354: AB_2679634"	"unprognostic (1.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (7.17e-5)"	"unprognostic (1.61e-3)"	"unprognostic (6.75e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-5)"	"unprognostic (3.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.58e-4)"	0.0	0.0	21.6	0.0	5.1	0.0	0.0	6.0	2.8	1.7	25.7	0.0	0.0	1.0	0.0	0.0	27.3	0.0	0.0	4.2	11.0	0.1	0.0	6.3	0.1	12.5	19.1	1.2	0.1	0.0	0.0	0.3	0.0	9.8	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	32.6	8.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	5.1	6.0	2.8	4.2	11.0	12.5	19.1	1.2	9.8	17.8	8.0	7.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	316.1	60.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	703.3	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.8	48.1	0.0	6.6	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706988-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 29.2;fallopian tube: 60.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 56.8;Endometrial ciliated cells: 153.5;Late spermatids: 85.0;Respiratory ciliated cells: 189.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 7.3;HeLa: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.2	0.3	8.5	0.1	3.2	0.1	0.2	3.5	2.0	5.0	29.2	0.1	0.0	1.2	1.8	0.9	60.0	0.6	0.3	2.1	9.0	0.5	0.1	11.3	0.4	9.9	13.9	0.0	0.4	1.1	0.2	4.7	0.2	7.0	0.3	0.0	0.1	0.6	0.2	0.3	0.6	0.1	0.1	10.6	0.3	0.2	10.2	4.4	0.1	0.4	0.0	0.0	0.4	0.1	2.0	1.4	7.3	0.9	1.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.8	0.8	1.4	1.0	0.0	1.6	3.6	0.0	0.0	0.0	2.8	1.2	0.8	6.2	1.7	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.5	0.0	2.1	2.9	0.4	0.0	5.0	1.1	0.4	0.7	1.5	3.6	2.0	1.1	1.2	0.0	0.3	5.1	1.0	1.7	2.9	0.4	0.1	2.4	0.4	1.5	1.6	1.4	4.1	0.8	0.7	2.3	0.9	0.7	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	3.2	3.5	2.0	2.1	9.0	9.9	13.9	0.0	7.0	10.6	4.4	2.0	0.2	9.6	10.5	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.3	0.6	0.0	0.0	27.9	0.0	0.0	0.1	0.1	0.2	1.9	0.3	56.8	153.5	1.9	0.8	0.0	0.0	0.0	0.0	0.1	1.0	0.0	4.8	2.5	0.1	0.4	0.2	0.2	0.0	0.0	0.6	0.0	0.6	0.0	85.0	0.3	0.5	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.1	0.7	0.1	0.4	0.5	0.4	189.5	0.4	0.0	0.4	0.3	14.3	0.9	0.0	0.0	0.0	0.3	1.4	0.3	0.2
CFAP43	"bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96"	ENSG00000197748	"Cilia and flagella associated protein 43"	Q8NDM7	10	104129888-104232364	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 32.4;choroid plexus: 68.2;fallopian tube: 49.4;testis: 57.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.0;Endometrial ciliated cells: 161.0;Late spermatids: 58.4;Respiratory ciliated cells: 231.0;Spermatocytes: 53.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.3;U-266/70: 3.3;U-266/84: 2.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 5.9"							NA	NA						"unprognostic (1.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.46e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.11e-4)"	"unprognostic (6.67e-2)"	0.2	1.0	26.7	0.2	8.7	0.2	2.6	12.1	5.2	3.8	68.2	0.3	0.4	2.9	7.8	0.2	49.4	0.9	0.2	9.0	19.2	4.0	0.4	8.3	0.3	29.1	26.0	3.1	1.9	2.2	3.8	10.2	0.3	23.3	1.5	0.2	10.8	0.9	1.3	0.1	1.0	0.6	0.2	32.4	0.2	0.6	57.8	12.7	0.4	5.4	0.0	0.2	0.2	0.5	16.1	1.7	0.6	0.6	1.1	0.0	0.3	0.1	0.0	0.5	0.3	0.2	0.0	4.3	0.0	0.0	0.0	1.5	0.6	0.1	0.6	0.7	0.2	0.7	0.0	0.3	0.2	0.1	0.0	0.1	0.4	0.5	0.4	0.3	0.9	0.1	0.3	1.2	0.1	0.0	1.1	0.1	0.2	0.1	0.4	0.2	0.1	0.0	0.0	1.5	0.0	0.9	0.9	0.4	0.0	0.8	0.5	0.5	0.0	0.0	0.1	0.3	0.5	0.2	3.3	2.9	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.7	8.7	12.1	5.2	9.0	19.2	29.1	26.0	3.1	23.3	32.4	12.7	16.1	0.3	3.2	8.4	16.6	0.1	0.0	0.6	0.0	0.6	0.8	1.9	1.7	0.8	0.0	38.4	1.8	10.4	0.1	0.0	0.0	0.0	1.2	103.0	161.0	2.1	1.0	3.6	0.8	16.6	0.0	0.2	1.2	1.1	3.6	6.3	0.6	0.4	0.1	0.1	0.0	23.5	0.1	0.0	0.0	0.0	58.4	1.5	0.7	0.0	1.9	0.6	1.3	0.0	1.5	6.1	0.2	0.1	2.2	0.2	0.6	0.1	1.2	231.0	8.8	0.0	0.6	0.1	53.7	4.4	0.3	0.0	0.0	0.7	0.4	0.2	0.3
CFAP47	"CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1"	ENSG00000165164	"Cilia and flagella associated protein 47"	Q6ZTR5	X	35919734-36385317	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;choroid plexus: 6.1;fallopian tube: 4.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 45.4;Endometrial ciliated cells: 66.2;Respiratory ciliated cells: 20.4;Rod photoreceptor cells: 14.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Karpas-707: 1.6;U-266/70: 3.0"									"HPA044633, HPA054859"	Uncertain					NA	NA					"HPA044633: AB_10960684, HPA054859: AB_2682627"	"unprognostic (1.88e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.50e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.19e-3)"	0.0	0.0	6.8	0.0	2.4	0.0	0.0	2.1	1.3	0.2	6.1	0.0	0.0	0.1	0.4	0.0	4.8	0.0	0.0	1.5	6.5	0.0	0.1	0.5	0.0	7.6	4.7	0.4	0.0	0.0	0.4	1.8	0.0	4.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.7	2.8	0.0	0.3	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	2.4	2.1	1.3	1.5	6.5	7.6	4.7	0.4	4.1	5.7	2.8	5.6	0.1	0.0	0.0	45.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	2.5	1.8	8.4	0.2	0.0	0.0	0.0	0.0	6.0	66.2	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	2.1	0.3	0.1	0.0	1.9	0.0	0.6	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	20.4	14.7	0.0	0.0	0.1	2.2	4.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172330-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 8.9;fallopian tube: 23.6;testis: 15.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 38.6;Endometrial ciliated cells: 62.4;Late spermatids: 26.7;Respiratory ciliated cells: 85.2;Spermatocytes: 25.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.8;HDLM-2: 1.8;TIME: 1.5"	"Low region specificity"	"Detected in many"							"HPA002736, HPA028623"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.3	0.1	2.5	0.0	1.3	0.0	0.3	1.4	1.0	0.9	8.9	0.0	0.0	0.6	2.8	0.1	23.6	0.2	0.1	1.3	3.8	1.0	2.8	2.5	0.0	3.4	2.9	0.3	0.2	0.6	0.1	2.0	0.2	2.4	0.4	0.1	1.5	0.1	0.2	0.1	0.6	0.0	0.1	3.1	0.0	0.1	15.9	1.2	0.2	1.0	0.0	0.1	0.2	0.1	1.3	0.9	0.3	0.2	0.1	0.0	0.0	0.2	0.3	0.7	0.5	0.5	0.3	0.3	0.0	0.3	1.0	0.3	2.8	0.2	0.3	1.1	1.8	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.1	0.7	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.2	0.2	0.3	0.1	0.3	0.0	0.3	0.3	0.6	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	2.5	1.3	1.4	1.0	1.3	3.8	3.4	2.9	0.3	2.4	3.1	1.2	1.3	0.2	6.4	0.5	1.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.5	0.0	5.6	0.0	6.2	0.9	0.0	0.2	0.0	0.2	38.6	62.4	0.6	0.3	0.0	0.0	3.5	0.2	0.1	0.6	0.0	1.2	0.0	0.1	1.1	0.5	0.1	1.7	1.2	0.0	0.0	0.0	0.0	26.7	0.9	0.2	0.0	0.0	2.1	0.6	0.0	0.0	1.1	0.3	0.0	0.7	0.0	0.1	0.7	1.9	85.2	1.2	0.0	0.0	0.1	25.4	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 11.4;fallopian tube: 25.9;retina: 9.3;testis: 9.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 204.5;Late spermatids: 164.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 10.8"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.0	0.1	7.6	0.0	2.5	0.0	0.1	3.1	2.1	0.7	11.4	0.1	0.0	0.5	1.8	0.0	25.9	0.4	0.0	1.9	6.0	0.4	0.0	2.7	0.0	7.0	8.2	0.6	0.0	0.3	0.1	3.5	0.0	6.0	0.1	0.2	9.3	0.1	0.1	0.0	0.0	0.4	0.0	7.4	0.0	0.3	9.5	3.3	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	2.5	3.1	2.1	1.9	6.0	7.0	8.2	0.6	6.0	7.4	3.3	3.4	0.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.8	7.7	8.8	0.0	4.3	6.8	0.0	12.5	0.0	0.1	1.1	0.0	0.6	204.5	45.1	0.5	0.2	29.1	0.0	0.0	1.5	0.0	0.2	2.0	1.8	0.0	0.2	0.0	0.1	0.1	0.0	0.0	25.2	0.0	0.0	0.0	164.3	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.8	0.7	0.0	1.1	1.9	1.1	29.2	19.5	0.0	0.1	0.0	14.4	5.7	0.0	0.0	0.0	0.2	0.1	5.1	0.1
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;choroid plexus: 23.3;fallopian tube: 42.6"	"Cell type enriched"	"Detected in some"	4	"Endometrial ciliated cells: 110.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;REH: 2.2;T-47d: 2.5;U-698: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.4	15.7	0.4	5.5	2.1	0.3	5.4	2.4	2.1	23.3	0.2	0.3	0.5	0.3	0.5	42.6	0.2	0.1	4.0	14.3	1.0	0.5	7.2	0.7	13.8	14.6	0.8	0.4	0.4	0.1	1.2	0.0	11.7	0.6	0.0	0.2	2.3	0.7	0.3	4.8	0.5	0.0	19.0	0.6	4.0	0.5	6.2	0.0	0.8	0.0	1.2	0.2	0.2	3.7	0.2	0.0	0.2	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	2.0	4.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.2	1.7	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.7	0.2	0.7	0.3	0.8	0.1	2.2	0.0	0.3	0.5	0.5	0.4	0.1	0.0	0.6	0.0	0.2	2.5	0.0	0.1	0.1	0.7	0.2	0.1	0.4	0.1	9.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	5.5	5.4	2.4	4.0	14.3	13.8	14.6	0.8	11.7	19.0	6.2	3.7	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	6.2	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	110.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.6	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	23.3	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.2
CFAP74	"C1orf222, FLJ45476, KIAA1751"	ENSG00000142609	"Cilia and flagella associated protein 74"	Q9C0B2	1	1921951-2003837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.2;testis: 5.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 11.5;Endometrial ciliated cells: 36.0;Excitatory neurons: 11.6;Late spermatids: 20.3;Respiratory ciliated cells: 18.2;Spermatocytes: 16.4;Spermatogonia: 10.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028521, HPA029274, HPA030240"	Enhanced					NA	NA					"HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455"	"unprognostic (5.41e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	0.2	1.3	1.5	0.4	0.6	0.9	0.2	2.4	1.3	0.2	2.4	0.2	0.3	0.5	0.2	0.9	7.2	0.8	0.2	1.0	0.4	0.1	0.6	1.5	0.7	1.3	1.4	0.1	0.2	0.0	0.1	0.5	0.3	1.8	0.2	0.2	0.8	0.4	0.4	0.8	3.3	0.2	0.1	0.5	0.3	0.2	5.3	0.9	0.1	1.1	0.0	0.1	0.3	0.0	2.2	0.7	0.0	0.9	0.7	0.0	0.9	1.0	0.1	0.0	0.0	0.4	1.7	0.1	1.0	1.4	0.3	0.7	0.2	0.0	0.3	0.2	0.9	1.4	2.1	2.6	1.1	0.3	1.6	0.6	0.7	1.0	0.0	0.0	0.4	0.0	0.7	3.0	0.5	0.5	0.3	0.8	0.3	0.9	0.1	1.2	0.8	0.3	0.5	0.0	1.4	1.5	0.5	0.3	0.1	0.0	0.3	0.3	0.4	1.7	0.9	0.9	0.4	1.1	1.0	0.4	1.1	0.1	1.6	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	1.5	0.6	2.4	1.3	1.0	0.4	1.3	1.4	0.1	1.8	0.5	0.9	2.2	0.2	0.0	1.8	0.7	0.1	0.0	1.0	0.0	0.0	1.5	0.2	0.4	1.9	0.0	4.3	0.0	8.4	1.1	0.2	0.0	0.0	0.0	11.5	36.0	0.4	0.6	0.0	0.0	11.6	0.0	3.3	0.9	0.0	0.7	0.0	0.3	3.6	1.0	0.1	0.0	5.9	0.0	0.0	1.0	0.0	20.3	1.2	0.6	0.0	9.4	0.0	0.3	1.0	1.0	1.0	0.0	0.0	0.0	0.0	1.1	1.6	0.2	18.2	2.4	0.0	1.5	1.1	16.4	10.1	0.0	0.0	0.8	0.7	0.8	0.1	0.5
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 9.5;fallopian tube: 30.0;testis: 19.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 127.1;Endometrial ciliated cells: 58.4;Late spermatids: 47.6;Respiratory ciliated cells: 36.5;Spermatocytes: 25.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657"	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	3.7	0.0	1.1	0.0	0.0	2.2	0.7	0.6	9.5	0.0	0.0	0.5	0.2	0.0	30.0	0.0	2.1	0.7	3.7	0.1	0.0	2.1	0.0	3.3	4.1	0.0	0.0	0.1	0.0	0.6	0.0	3.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	19.5	1.5	0.2	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.1	2.2	0.7	0.7	3.7	3.3	4.1	0.0	3.0	4.2	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	58.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.3	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	36.5	3.8	0.0	0.0	0.0	25.5	3.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70216040-70303084	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 57.0;prostate: 15.4"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 310.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 25.7;NTERA-2: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074749	Enhanced				"Secreted to extracellular matrix"	NA	NA		120000			"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.1	0.0	5.1	0.1	5.0	0.0	0.1	4.4	5.6	0.4	57.0	1.0	0.8	0.3	0.1	0.1	0.2	0.4	5.0	5.5	4.9	0.3	0.0	0.0	0.0	6.8	5.3	3.8	0.0	0.3	0.1	5.2	0.0	6.1	15.4	0.5	9.6	1.5	0.3	0.0	0.0	0.9	0.2	4.8	0.0	1.5	4.1	5.2	0.1	0.4	0.3	0.0	1.3	2.9	6.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.0	4.4	5.6	5.5	4.9	6.8	5.3	3.8	6.1	4.8	5.2	6.0	0.6	0.0	0.0	2.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	3.7	0.0	0.0	0.0	4.2	0.0	0.0	1.0	1.9	0.0	21.4	1.2	0.1	0.8	1.2	0.0	1.4	0.2	0.0	0.5	0.0	1.7	0.0	1.0	0.0	0.0	0.1	35.3	6.7	0.5	0.0	0.0	0.0	11.6	0.0	0.1	0.0	2.8	0.1	68.5	0.0	310.1	0.6	0.0	0.8	0.4	0.0	2.3	0.0	0.1	0.0	3.2	0.0	0.3	4.2	0.6	2.3	0.1	0.0	0.0	0.0	0.1	0.8	0.1
CRYBA4		ENSG00000196431	"Crystallin beta A4"	P53673	22	26621963-26630669	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.3;NK-cells: 1.0;Spermatogonia: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 4.3;hippocampal formation: 4.0"	HPA071178	Supported					NA	NA					"HPA071178: AB_2686354"	"unprognostic (6.69e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.61e-5)"	"unprognostic (1.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.05e-6)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.3	0.1	0.0	0.5	0.1
CRYBB2	"CCA2, CRYB2, CRYB2A"	ENSG00000244752	"Crystallin beta B2"	P43320	22	25212564-25231870	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 10.6;Breast myoepithelial cells: 12.8;Distal tubular cells: 27.4;Melanocytes: 12.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.1"	"Region enhanced"	"Detected in some"		"hippocampal formation: 1.7"	"Low region specificity"	"Detected in many"			HPA043749	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043749: AB_2678652"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.57e-3)"	"unprognostic (9.51e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-3)"	0.2	0.4	2.4	0.0	2.4	0.0	0.3	1.8	4.6	0.3	1.8	0.3	0.2	0.1	0.3	0.4	0.1	0.1	0.2	2.5	2.1	0.4	0.3	0.3	0.0	2.0	2.0	2.4	0.1	0.2	0.0	1.4	0.0	2.1	0.6	0.3	0.4	0.3	0.1	0.5	0.4	0.3	0.2	1.9	0.1	0.2	1.7	2.4	0.0	1.0	0.0	0.0	0.2	0.4	2.6	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.9	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	2.4	2.4	1.8	4.6	2.5	2.1	2.0	2.0	2.4	2.1	1.9	2.4	2.6	0.9	0.0	0.0	2.0	1.0	5.4	0.6	6.7	0.6	0.3	10.6	12.8	1.4	1.5	1.5	1.8	0.0	0.1	0.9	1.7	27.4	0.1	3.0	1.7	1.2	2.9	0.0	8.0	2.4	0.2	0.1	3.4	0.0	2.5	0.0	3.1	4.6	3.2	0.2	0.0	0.4	0.3	0.0	1.2	3.1	9.6	2.5	0.8	12.4	1.9	0.0	0.4	0.0	0.5	0.3	0.5	0.1	8.2	0.0	0.4	0.0	9.7	0.6	0.1	0.0	6.2	2.1	2.6	3.3	0.4	3.8	0.1	1.3	7.6	0.2	0.6
CRYGC	CRYG3	ENSG00000163254	"Crystallin gamma C"	P07315	2	208128137-208129828	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 1.9;Granulosa cells: 3.7;Late spermatids: 3.2;Spermatocytes: 2.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8;ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"hippocampal formation: 3.2;hypothalamus: 1.5;thalamus: 1.2"	"Group enriched"	"Detected in some"	14	"cerebral cortex: 1.2;hippocampal formation: 1.5"	HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (1.89e-1)"					"unprognostic (2.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST4		ENSG00000101441	"Cystatin S"	P01036	20	23685640-23689038	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	514	"salivary gland: 29298.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.7;Collecting duct cells: 9.2;Glandular and luminal cells: 3.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.5;RT4: 13.6"									"HPA043706, HPA044763"	Supported				"Secreted to digestive system"	NA	NA		2800000			"HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (2.80e-1)"		"unprognostic (7.88e-2)"	"unprognostic (2.48e-1)"		"unprognostic (1.09e-1)"		"unprognostic (2.59e-1)"		"prognostic unfavorable (4.98e-5)"	"unprognostic (1.00e-2)"	"unprognostic (9.52e-2)"		"unprognostic (2.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.95e-2)"	"prognostic favorable (2.88e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	56.9	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	30.2	0.0	0.0	3.8	0.0	2.4	0.0	0.0	29298.9	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	13.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4;placenta: 13.0"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 58.2;Syncytiotrophoblasts: 216.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;CACO-2: 2.7;hTCEpi: 1.8;NTERA-2: 2.2;OE19: 11.2;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basal ganglia: 16.9;cerebral cortex: 21.4;hippocampal formation: 16.8"	HPA030251	Enhanced	Supported				NA	NA					"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	1.5	3.3	3.7	0.4	16.4	0.0	0.6	2.6	4.7	1.7	1.1	0.9	0.8	2.8	0.1	1.5	1.7	0.4	3.6	2.5	3.2	3.6	5.8	1.6	0.4	5.9	3.1	1.8	0.1	2.9	0.0	0.6	13.0	7.8	7.4	0.3	5.9	6.5	0.4	0.2	5.7	0.6	0.2	2.4	0.0	0.7	1.0	4.8	1.9	0.3	0.0	0.6	1.1	1.2	2.9	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	16.4	2.6	4.7	2.5	3.2	5.9	3.1	1.8	7.8	2.4	4.8	2.9	0.0	0.0	2.0	0.0	0.0	3.1	1.9	0.8	0.0	10.7	0.1	3.0	0.6	1.5	1.3	1.8	0.0	58.2	0.0	0.1	0.0	1.3	0.0	11.8	0.5	0.7	5.3	0.0	0.1	0.2	6.1	3.4	0.0	11.0	0.0	3.3	0.0	0.3	5.3	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	3.6	6.5	0.0	26.3	0.0	0.0	0.1	0.3	1.2	0.0	0.0	1.1	0.0	5.7	0.0	0.9	0.0	0.5	0.1	0.0	0.3	0.0	1.4	216.3	0.2	0.0	1.9	0.1
DNAAF3	"C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22"	ENSG00000167646	"Dynein axonemal assembly factor 3"	Q8N9W5	19	55158661-55166722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"fallopian tube: 41.1;testis: 65.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 395.2;Late spermatids: 722.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 26.2;HEL: 31.6;K-562: 25.3;U-937: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056220			Approved	"Nuclear bodies,Mitochondria"		No	No			Mitochondria	"Nuclear bodies"	"HPA056220: AB_2683071"	"unprognostic (1.71e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.03e-2)"	0.2	1.8	3.4	0.0	1.2	0.0	0.6	2.2	1.2	2.0	5.0	0.3	0.1	0.9	3.4	0.6	41.1	0.6	5.0	0.9	2.8	2.1	0.6	4.4	0.1	3.1	4.0	0.3	0.2	1.6	3.5	0.7	0.1	4.4	0.3	0.1	0.4	0.4	0.9	0.1	0.8	0.3	0.2	4.1	0.3	0.4	65.9	1.5	0.5	2.3	0.0	0.1	0.1	0.4	2.0	8.8	6.6	0.6	6.7	0.1	0.0	0.6	0.1	0.2	1.0	0.7	0.3	4.0	10.5	2.5	0.3	1.9	10.1	1.5	3.0	0.4	0.0	26.2	31.6	0.5	0.5	0.2	13.6	3.1	0.2	4.0	1.7	2.2	0.9	0.5	4.7	25.3	13.9	0.4	5.9	0.4	0.3	0.5	9.5	15.0	16.5	1.0	3.2	5.4	0.2	0.8	2.6	1.1	1.1	1.6	0.2	8.3	0.4	1.0	0.8	3.9	4.0	0.2	0.4	2.5	0.6	4.9	18.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	1.2	2.2	1.2	0.9	2.8	3.1	4.0	0.3	4.4	4.1	1.5	2.0	0.2	0.0	0.5	0.0	0.0	3.2	0.0	4.7	4.6	0.0	1.1	0.6	3.0	1.5	7.5	7.3	0.0	0.0	0.0	0.3	7.9	2.7	395.2	55.8	0.5	0.6	0.0	0.0	0.5	1.0	0.1	1.2	0.0	1.3	0.0	1.9	0.7	0.4	0.2	0.0	0.5	0.5	12.2	0.0	0.4	722.0	4.4	4.2	0.0	0.0	0.0	2.1	0.0	0.5	0.1	0.2	0.1	3.0	0.0	0.1	0.0	5.1	75.2	0.0	0.0	0.0	2.3	104.8	18.6	0.3	1.3	0.0	0.1	1.1	0.4	0.2
DNAAF6	"CXorf41, MGC35261, NYSAR97, PIH1D3, TWISTER"	ENSG00000080572	"Dynein axonemal assembly factor 6"	Q9NQM4	X	107206611-107244247	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 12.2;testis: 12.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"midbrain: 3.0"	HPA072496	Enhanced					NA	NA					"HPA072496: AB_2732202"	"unprognostic (8.66e-2)"	"unprognostic (2.75e-3)"		"unprognostic (7.73e-4)"	"unprognostic (3.37e-1)"			"unprognostic (8.61e-2)"		"unprognostic (4.27e-1)"			"unprognostic (3.37e-2)"			"unprognostic (1.77e-2)"		0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.3	0.2	0.2	0.8	0.0	0.0	0.1	0.6	0.0	12.2	0.0	0.0	0.2	0.9	0.1	0.0	1.5	0.0	1.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	12.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.9	1.4	0.8	0.1	0.7	1.0	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 3.9;choroid plexus: 5.9;fallopian tube: 10.4;lung: 3.5;testis: 8.9"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 230.5;Respiratory ciliated cells: 318.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 9.6"	"HPA037493, HPA058203, HPA061365"	Enhanced					NA	NA					"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493"	"unprognostic (4.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.43e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.47e-2)"	0.0	0.2	3.1	0.0	1.2	0.0	0.2	1.7	0.7	0.5	5.9	0.0	0.0	0.3	0.1	0.0	10.4	0.2	0.0	1.2	2.1	0.1	0.1	3.5	0.0	3.9	3.5	0.4	0.1	0.7	0.0	0.9	0.0	2.8	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.1	8.9	1.5	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	1.2	1.7	0.7	1.2	2.1	3.9	3.5	0.4	2.8	3.7	1.5	1.6	0.2	3.2	1.1	13.7	0.2	0.0	0.2	5.4	0.0	0.3	0.8	0.6	1.1	0.0	42.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	49.8	230.5	1.3	0.1	1.8	0.0	3.9	0.0	0.0	1.2	0.0	4.6	1.3	0.3	0.0	0.0	0.1	0.0	3.8	0.0	6.1	0.0	0.0	9.8	0.9	0.7	0.0	2.8	0.1	1.7	0.0	5.0	15.8	0.1	0.0	0.4	0.0	0.1	0.0	0.5	318.9	0.2	0.0	0.7	1.6	28.4	2.7	0.0	0.0	0.0	0.5	5.4	0.1	0.1
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520988	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 23.7;fallopian tube: 34.2;testis: 33.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 29.6;Endometrial ciliated cells: 48.8;Late spermatids: 35.0;Respiratory ciliated cells: 132.2;Spermatocytes: 56.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;HDLM-2: 1.4;SK-BR-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021649, HPA021843"	Enhanced					NA	NA					"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	0.0	0.0	5.8	0.0	2.8	0.0	0.5	3.6	2.6	1.3	23.7	0.0	0.0	0.9	0.2	0.0	34.2	0.1	0.0	2.8	5.7	1.1	0.1	4.6	0.0	6.2	7.4	1.4	0.1	0.9	1.2	9.6	0.0	4.6	0.2	0.0	2.7	0.0	0.1	0.1	0.0	0.0	0.0	6.3	0.0	0.2	33.8	3.3	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.6	0.2	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	1.0	0.2	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	2.8	3.6	2.6	2.8	5.7	6.2	7.4	1.4	4.6	6.3	3.3	2.4	0.0	0.0	0.5	3.9	0.1	0.0	0.0	5.0	0.0	0.0	0.5	0.3	0.4	0.0	11.0	0.0	4.2	0.2	0.0	0.0	1.9	0.0	29.6	48.8	0.5	0.2	0.0	0.0	9.4	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	16.2	0.0	2.0	0.0	0.0	35.0	0.3	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.4	132.2	1.3	0.0	0.0	1.4	56.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DRC1	"C2orf39, CCDC164, CILD21, FLJ32660, MGC16372"	ENSG00000157856	"Dynein regulatory complex subunit 1"	Q96MC2	2	26401920-26456711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 39.6;testis: 21.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 142.0;Endometrial ciliated cells: 112.8;Late spermatids: 321.2;Respiratory ciliated cells: 260.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	89	"neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	89	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 6.9"							NA	NA						"unprognostic (2.28e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.56e-3)"	"unprognostic (7.02e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.06e-3)"	"unprognostic (8.19e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-2)"	0.0	0.0	6.3	0.0	2.4	0.7	0.0	2.6	1.4	0.8	8.5	0.1	0.0	0.9	0.1	0.0	39.6	0.0	0.0	1.7	5.8	0.1	0.0	3.1	0.0	4.9	4.7	1.0	0.0	0.0	0.0	3.2	0.0	4.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	21.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	6.3	2.4	2.6	1.4	1.7	5.8	4.9	4.7	1.0	4.3	5.6	2.9	5.0	0.2	0.0	1.1	1.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.3	0.5	0.0	17.9	1.8	0.0	0.0	0.0	0.1	0.0	0.0	142.0	112.8	1.2	0.3	0.0	0.0	4.3	0.7	0.0	0.5	0.0	1.5	1.3	0.0	0.0	0.0	0.1	0.0	4.8	0.1	10.2	0.0	0.0	321.2	2.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	1.2	0.4	0.0	0.2	1.3	0.1	260.8	0.0	0.0	0.0	2.4	39.5	1.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0
DRC7	"C16orf50, CCDC135, CFAP50, DKFZp434I099, FAP50"	ENSG00000159625	"Dynein regulatory complex subunit 7"	Q8IY82	16	57694793-57731805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 21.3;testis: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 119.1;Late spermatids: 134.4;Spermatocytes: 48.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	8	"basophil: 10.9"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 10.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.0;HMC-1: 1.6;JURKAT: 1.8;NB-4: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.04e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (9.96e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.34e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.53e-2)"	0.0	0.0	4.8	0.3	1.9	1.0	0.0	2.9	1.8	0.5	9.5	0.0	0.0	0.6	0.8	0.0	21.3	0.7	0.0	1.6	6.8	0.8	0.3	1.9	0.1	4.8	6.6	0.6	0.2	1.2	0.7	1.0	0.1	4.2	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.1	5.0	0.2	0.2	46.5	2.9	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.7	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.3	0.3	1.6	0.6	0.0	0.2	0.0	0.6	0.2	1.8	0.7	0.0	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	10.9	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	4.8	1.9	2.9	1.8	1.6	6.8	4.8	6.6	0.6	4.2	5.0	2.9	3.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.4	119.1	25.1	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	134.4	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.8	21.9	0.0	0.0	0.1	0.1	48.2	4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1
DYDC1	"bA36D19.5, DPY30D1"	ENSG00000170788	"DPY30 domain containing 1"	Q8WWB3	10	80336105-80356755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 127.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 222.4;Late spermatids: 83.5;Spermatocytes: 349.2"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA037790, HPA037791"	Uncertain					NA	NA					"HPA037790: AB_10805351, HPA037791: AB_10796215"	"unprognostic (8.95e-2)"	"unprognostic (8.28e-3)"		"unprognostic (7.11e-2)"			"unprognostic (3.12e-1)"	"unprognostic (1.87e-1)"		"unprognostic (1.90e-1)"				"unprognostic (9.96e-2)"	"unprognostic (7.95e-2)"			0.0	0.0	0.6	0.0	0.5	0.2	0.0	0.1	0.3	0.3	1.9	0.0	0.0	0.2	1.5	0.0	5.7	0.0	0.0	0.2	0.6	0.0	0.0	1.0	0.0	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	127.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.6	0.5	0.1	0.3	0.2	0.6	0.4	0.8	0.2	0.2	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.4	15.1	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	83.5	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.1	0.0	0.0	36.3	0.0	6.6	0.0	0.3	349.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYDC2	"bA36D19.6, MGC16186"	ENSG00000133665	"DPY30 domain containing 2"	Q96IM9	10	80344745-80368073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"fallopian tube: 98.3"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 182.5;Respiratory ciliated cells: 324.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;NTERA-2: 3.2;SCLC-21H: 2.9;SH-SY5Y: 1.9;U-2197: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038006, HPA038007"	Enhanced					NA	NA					"HPA038006: AB_10672734, HPA038007: AB_2675783"	"unprognostic (1.60e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.40e-2)"	0.1	0.1	5.8	0.1	2.8	0.8	0.3	1.9	2.1	1.2	4.7	0.3	0.1	1.9	4.5	0.5	98.3	0.3	0.0	2.1	4.2	0.3	0.6	4.6	0.0	5.1	4.4	1.2	0.1	0.8	0.3	0.8	0.3	3.6	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	7.2	0.0	0.3	10.9	3.2	0.2	0.2	0.0	0.1	0.0	0.1	3.9	0.1	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.4	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.8	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.4	0.0	3.2	0.0	0.0	0.9	0.2	0.8	0.0	0.0	2.9	1.9	0.0	0.0	0.3	0.8	0.0	1.4	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.8	2.8	1.9	2.1	2.1	4.2	5.1	4.4	1.2	3.6	7.2	3.2	3.9	0.0	0.0	3.1	0.3	0.0	0.0	0.1	20.6	0.0	0.0	0.3	0.1	0.2	0.0	29.6	0.0	0.0	0.0	0.1	0.1	1.9	0.5	61.4	182.5	1.6	0.1	0.0	0.0	0.8	0.5	0.0	0.9	0.0	2.4	0.0	1.3	0.0	0.6	0.1	0.0	0.3	0.0	14.2	0.0	0.3	30.4	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.3	0.0	0.1	324.1	0.0	0.0	0.2	4.3	8.5	3.1	0.1	0.0	0.0	0.4	0.2	0.0	0.1
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487834	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 75.6;ovary: 100.5;pituitary gland: 27.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 33.5;Muller glia cells: 100.3;Peritubular cells: 21.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 23.8;hypothalamus: 75.6;medulla oblongata: 19.5;pons: 22.9;thalamus: 28.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 44.1;HeLa: 21.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 70.7"	"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	1.8	10.1	7.7	1.0	4.6	0.0	1.7	3.2	23.8	0.7	2.8	0.6	0.1	2.2	0.0	0.4	3.6	0.5	0.2	0.4	75.6	4.0	2.6	0.4	0.3	19.5	7.6	2.1	100.5	0.7	1.2	27.8	0.3	22.9	0.4	0.0	13.5	0.6	1.5	3.0	0.6	0.4	1.5	3.1	4.5	0.9	1.9	28.7	0.2	1.5	0.0	0.4	0.4	1.1	4.7	0.0	0.1	0.1	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	4.6	3.2	23.8	0.4	75.6	19.5	7.6	2.1	22.9	3.1	28.7	4.7	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	33.5	0.5	0.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	1.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.0	0.0	100.3	0.0	0.0	0.0	0.1	0.0	21.1	0.0	0.0	0.0	0.1	0.0	3.7	0.0	1.0	2.3	0.5	1.6	0.0	0.0	0.0	0.1	0.6	0.0	0.1
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 92.4;testis: 37.8"	"Group enriched"	"Detected in many"	19	"Early spermatids: 538.8;Endometrial ciliated cells: 159.1;Late spermatids: 552.0;Respiratory ciliated cells: 310.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 6.5;ASC diff: 2.6;ASC TERT1: 6.2;CAPAN-2: 3.1;hTEC/SVTERT24-B: 2.6;SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: AB_2686220"	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.3	1.5	9.8	0.1	5.0	0.7	3.0	4.2	2.9	9.3	19.0	0.5	0.6	12.5	2.6	0.7	92.4	0.7	0.2	3.3	12.6	0.4	0.7	10.7	0.1	12.3	10.9	2.4	19.5	3.3	0.0	3.2	0.5	7.3	5.4	0.4	0.0	2.1	5.9	0.0	4.7	1.0	2.9	11.5	0.3	0.6	37.8	6.0	0.4	0.1	0.2	0.2	2.4	3.5	9.1	6.5	0.0	0.8	0.0	2.6	6.2	0.0	0.1	0.6	0.0	0.2	0.0	3.1	0.0	0.0	0.1	0.0	1.7	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.2	2.6	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.5	4.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.0	1.2	0.3	0.0	0.0	0.1	0.0	9.8	5.0	4.2	2.9	3.3	12.6	12.3	10.9	2.4	7.3	11.5	6.0	9.1	0.4	0.0	5.9	0.0	0.0	6.8	9.7	14.7	4.0	0.0	0.4	9.1	0.4	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	538.8	159.1	4.7	1.2	0.0	0.0	0.7	1.5	0.1	2.2	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.2	0.0	0.3	552.0	4.7	0.8	1.8	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	5.7	0.0	3.4	0.0	0.3	310.7	0.0	0.0	0.7	6.2	16.9	4.5	0.1	1.8	0.3	0.4	3.9	0.0	2.5
ENKUR	"C10orf63, CFAP106, enkurin, MGC26778"	ENSG00000151023	"Enkurin, TRPC channel interacting protein"	Q8TC29	10	24981979-25062279	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.8;choroid plexus: 12.8;fallopian tube: 44.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 73.9;Endometrial ciliated cells: 143.5;Respiratory ciliated cells: 288.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.1;glioma: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.5;CAPAN-2: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037593, HPA037594, HPA061503"	Enhanced					NA	NA					"HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543"	"unprognostic (2.33e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.69e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.20e-6)"	"unprognostic (3.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.43e-3)"	0.1	0.4	11.9	0.5	8.8	0.4	0.1	11.7	9.1	1.4	12.8	0.3	1.3	1.6	0.2	0.0	44.0	0.3	0.1	8.8	19.8	0.4	0.7	4.4	0.0	13.6	13.6	6.2	0.2	0.0	0.0	5.6	0.7	13.7	0.1	0.1	1.9	0.1	0.0	0.2	0.1	1.6	0.2	14.4	0.3	0.3	6.9	11.0	0.1	0.5	0.1	0.1	0.0	0.0	13.2	0.1	0.4	0.4	1.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	2.7	0.2	0.3	0.0	0.4	0.2	0.0	0.3	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.8	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.3	0.0	6.2	11.9	8.8	11.7	9.1	8.8	19.8	13.6	13.6	6.2	13.7	14.4	11.0	13.2	0.2	0.0	1.1	19.2	0.6	0.0	0.7	10.7	0.0	0.3	0.1	0.4	0.3	0.0	27.3	1.8	0.0	0.4	0.2	4.0	0.0	2.5	73.9	143.5	2.3	1.0	2.4	0.0	8.1	5.1	1.8	1.4	3.6	1.8	1.3	0.3	0.0	0.2	0.0	0.0	3.3	0.6	8.2	0.0	0.0	12.6	1.2	25.0	0.0	2.8	2.0	18.7	4.1	2.0	3.1	11.2	0.1	0.7	0.0	0.7	2.0	0.9	288.8	1.6	0.0	0.7	2.9	35.8	4.9	0.0	0.1	0.3	0.3	0.7	0.5	0.2
ERAS	"HRAS2, HRASP"	ENSG00000187682	"ES cell expressed Ras"	Q7Z444	X	48826513-48830138	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 1.7;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.1;ovarian cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (2.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.72e-4)"	"unprognostic (9.40e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-2)"	0.1	0.0	1.2	0.0	0.9	0.1	0.1	1.1	1.5	0.4	0.7	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.8	1.9	0.5	0.6	0.1	0.0	1.0	1.1	0.9	0.4	0.0	0.0	1.0	0.0	1.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	1.0	1.9	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	1.1	1.5	0.8	1.9	1.0	1.1	0.9	1.0	0.8	1.9	1.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.1	1.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ERICH3	"C1orf173, DKFZp547I048, RP11-653A5.1"	ENSG00000178965	"Glutamate rich 3"	Q5RHP9	1	74568117-74673792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.5;testis: 24.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 326.4;Endometrial ciliated cells: 139.8;Late spermatids: 326.9;Respiratory ciliated cells: 234.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028655, HPA072916"	Approved					NA	NA					"HPA028655: AB_10961002, HPA072916: "	"unprognostic (4.49e-4)"	"unprognostic (1.02e-2)"		"prognostic favorable (1.56e-5)"	"unprognostic (1.71e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-4)"	"unprognostic (9.21e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	0.0	2.5	2.3	0.0	4.3	0.0	0.8	0.3	5.8	5.5	0.0	0.0	0.0	1.0	0.0	0.0	17.5	0.0	0.0	3.8	3.4	0.0	0.0	2.7	0.2	0.2	0.9	3.5	0.1	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	24.2	2.5	0.6	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	4.3	0.3	5.8	3.8	3.4	0.2	0.9	3.5	0.2	0.0	2.5	0.5	0.0	3.2	3.1	3.6	0.3	0.0	0.0	0.0	0.0	3.5	2.8	0.3	0.6	0.0	28.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	326.4	139.8	1.0	0.4	3.5	0.0	56.8	0.0	0.0	0.5	0.0	3.2	1.3	0.0	0.0	0.1	0.0	0.0	51.8	0.0	0.0	0.0	0.0	326.9	3.1	0.7	0.0	1.0	0.0	0.1	1.0	24.6	3.2	0.0	0.0	3.8	0.0	0.6	0.0	0.0	234.6	0.5	6.6	0.0	0.1	32.9	1.5	0.0	0.0	0.1	0.3	0.1	0.0	0.3
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 84.5;endometrium 1: 111.9;fallopian tube: 65.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 40.2;endometrial cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"MCF7: 46.0;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	4.3	1.9	3.3	1.5	0.9	0.8	29.4	3.1	1.3	84.5	3.3	0.9	0.4	111.9	1.2	0.5	65.5	1.2	1.6	0.7	5.4	2.8	17.0	2.0	1.6	0.5	0.5	0.6	9.1	1.0	0.2	6.7	0.4	0.9	6.2	0.5	3.5	0.9	9.9	5.9	1.0	0.8	50.8	0.4	1.7	0.6	2.3	3.9	1.1	3.4	2.6	2.3	2.2	47.3	0.6	0.6	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.6	0.0	0.0	0.0	1.2	0.1	46.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.2	57.4	0.0	0.1	0.2	0.2	0.5	0.0	5.2	1.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.9	3.1	1.3	0.7	5.4	0.5	0.5	0.6	0.9	0.4	3.9	0.6	0.6	0.0	1.1	1.3	2.3	1.0	1.7	0.0	0.0	3.9	86.6	16.4	4.4	0.0	1.0	0.0	8.4	0.1	0.4	0.1	1.9	0.0	40.1	77.9	79.9	2.7	1.8	0.0	4.5	0.2	0.1	11.3	0.0	98.9	2.5	36.9	5.0	52.1	0.9	62.2	5.4	0.0	0.0	4.0	3.1	10.3	4.1	2.5	1.8	1.0	0.2	2.4	0.0	25.1	0.6	0.1	0.0	2.2	8.5	0.6	0.0	3.7	1.3	4.6	0.0	56.7	11.7	1.8	1.3	0.4	1.7	0.1	2.2	4.8	0.1	6.8
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 56.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	12.1	1.5	11.0	2.4	11.3	0.1	11.1	14.9	12.4	56.1	9.4	7.1	0.3	17.4	3.7	34.5	34.3	1.8	3.2	9.8	9.8	4.7	2.1	2.2	0.8	15.6	11.3	9.0	0.7	1.9	9.4	5.3	6.4	12.0	23.8	3.1	1.2	31.5	9.4	2.5	5.0	1.1	1.8	9.7	0.6	8.9	5.7	12.0	19.0	14.7	3.4	6.7	4.9	16.6	15.3	0.2	4.4	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	2.5	1.9	0.3	40.1	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.1	0.3	2.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	7.7	0.1	0.0	0.6	0.1	0.0	0.1	0.8	0.5	0.0	0.0	58.3	0.0	0.0	24.8	0.0	3.0	5.3	0.2	0.0	0.0	4.5	0.3	8.8	110.9	139.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	11.3	14.9	12.4	9.8	9.8	15.6	11.3	9.0	12.0	9.7	12.0	15.3	0.4	0.0	0.0	153.8	0.9	0.6	47.5	50.4	14.8	0.4	7.8	7.6	0.5	2.8	33.0	0.0	6.2	27.7	0.0	2.5	0.0	0.9	0.2	43.7	3.9	0.6	1.2	0.0	1.5	0.0	3.0	4.8	9.2	53.8	1.3	9.8	0.4	3.3	7.4	0.0	5.1	0.6	34.6	0.0	0.4	0.3	0.0	1.1	3.6	13.1	2.6	0.0	0.0	48.7	1.0	1.1	1.7	0.7	3.4	10.9	0.0	6.3	22.2	0.4	0.0	0.3	2.8	0.2	7.4	16.0	0.3	10.8	0.6	4.2	3.6	34.6
FAM183A	"hCG23177, LOC440585"	ENSG00000186973	"Family with sequence similarity 183 member A"	A6NL82	1	43145153-43156396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"fallopian tube: 117.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 516.6;Late spermatids: 244.5;Respiratory ciliated cells: 1012.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 19.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;hTCEpi: 2.4;NTERA-2: 3.1;SCLC-21H: 2.7;SuSa: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043382, HPA049120"	Approved					NA	NA					"HPA043382: AB_2678456, HPA049120: AB_2680640"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.42e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.73e-2)"	0.0	0.0	3.6	0.0	1.3	0.0	1.0	2.0	0.7	2.4	7.7	0.2	0.1	2.1	0.5	1.0	117.9	0.0	0.0	0.8	6.1	0.9	0.1	7.0	0.0	7.5	3.8	0.0	0.2	0.2	0.9	5.6	0.6	3.8	2.0	0.3	0.2	1.4	0.2	0.0	9.8	0.0	0.2	5.3	0.0	0.1	6.9	1.9	0.3	0.0	0.0	0.3	0.5	1.1	2.4	0.3	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.6	3.5	0.0	0.4	0.2	0.3	0.4	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	1.4	0.6	2.7	0.0	0.0	0.1	0.0	5.2	0.7	0.0	0.5	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.3	2.0	0.7	0.8	6.1	7.5	3.8	0.0	3.8	5.3	1.9	2.4	0.0	0.0	7.4	0.0	0.0	1.9	14.0	66.1	3.4	0.0	1.4	2.3	0.2	0.0	109.2	3.7	0.0	2.1	0.1	0.4	3.9	0.0	107.7	516.6	3.5	1.3	4.2	0.0	0.0	0.0	0.2	1.2	0.0	5.7	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.4	54.9	0.0	0.0	244.5	1.8	0.7	3.6	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.7	0.0	3.9	0.0	2.0	1012.8	0.1	0.0	0.0	13.3	7.6	3.5	2.3	2.6	2.1	0.6	0.2	0.5	9.7
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"fallopian tube: 78.3"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 162.2;Respiratory ciliated cells: 294.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"U-87 MG: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain					NA	NA					"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.1	0.0	6.6	0.9	1.6	0.0	0.0	2.3	0.9	1.4	4.7	0.1	0.1	1.5	0.0	0.0	78.3	0.2	10.1	1.1	4.5	0.0	0.0	9.9	1.8	8.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	9.2	0.1	0.2	0.0	2.6	0.0	0.0	0.0	3.6	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.6	2.3	0.9	1.1	4.5	8.6	6.4	0.0	5.9	9.2	2.6	3.9	0.0	0.0	3.9	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	19.8	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	162.2	1.0	0.7	0.0	0.0	0.2	0.0	0.0	2.2	0.0	2.3	1.3	0.0	0.0	0.0	0.3	0.0	0.9	0.0	12.2	0.0	0.0	9.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	294.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1
FAM81B	FLJ25333	ENSG00000153347	"Family with sequence similarity 81 member B"	Q96LP2	5	95391366-95450454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 48.7;testis: 84.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 854.5;Late spermatids: 1757.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	61	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	61	"granulocytes: 6.7"	"Cell line enriched"	"Detected in single"	5	"CAPAN-2: 1.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA072554	Approved					NA	NA					"HPA072554: AB_2686533"	"unprognostic (2.22e-3)"	"unprognostic (8.86e-3)"		"unprognostic (2.61e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-1)"		"unprognostic (2.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.28e-2)"	0.0	0.1	2.6	0.0	1.1	0.6	0.3	2.0	1.2	1.1	13.5	0.0	0.0	0.9	3.8	0.0	48.7	0.2	5.4	0.7	5.2	0.9	0.0	4.4	0.0	3.9	3.3	0.2	0.1	0.4	2.5	3.8	0.0	3.2	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	4.3	0.0	0.2	84.1	1.7	0.1	1.6	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	1.1	2.0	1.2	0.7	5.2	3.9	3.3	0.2	3.2	4.3	1.7	4.8	0.0	9.6	1.8	0.0	0.0	0.4	0.0	9.5	0.0	0.0	1.0	0.6	6.1	0.0	23.9	5.5	0.0	0.1	0.1	0.0	0.0	0.5	854.5	158.5	0.8	0.5	1.8	0.0	0.9	0.7	0.1	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	12.2	0.0	0.0	1757.9	8.4	3.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.7	0.0	3.0	0.0	0.6	0.0	0.3	227.1	0.0	6.6	0.5	2.4	18.0	6.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	290.4	124.1	19.2	73.0	23.5	1.7	320.9	26.9	31.4	1103.1	680.7	193.6	76.2	414.1	127.1	308.6	502.0	682.1	458.5	47.1	21.9	61.7	15.8	418.5	16.3	20.8	25.4	14.2	215.9	107.3	218.6	91.0	510.0	30.9	470.8	84.4	3.2	122.2	160.0	36.3	286.3	176.0	181.9	14.9	25.1	271.4	22.1	23.8	20.7	197.0	47.9	13.1	710.5	948.5	13.9	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	19.2	23.5	26.9	31.4	47.1	21.9	20.8	25.4	14.2	30.9	14.9	23.8	13.9	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FGF20		ENSG00000078579	"Fibroblast growth factor 20"	Q9NP95	8	16992181-17002345	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5"	"Cell type enriched"	"Detected in some"	7	"Microglial cells: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;CAPAN-2: 5.3;OE19: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"						"Secreted in other tissues"	NA	NA						"unprognostic (1.93e-2)"		"unprognostic (2.19e-1)"	"unprognostic (5.57e-3)"	"unprognostic (3.95e-2)"			"unprognostic (1.59e-3)"		"unprognostic (1.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.08e-2)"		0.1	0.6	0.8	0.0	0.9	0.0	0.2	2.5	1.3	1.0	0.5	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.1	0.8	1.1	0.0	0.0	0.1	0.1	1.0	1.2	0.6	0.6	0.1	0.0	0.4	0.1	1.2	0.2	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	1.2	1.0	0.6	0.2	1.1	0.2	0.2	0.0	0.4	0.1	0.1	1.6	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.6	1.6	0.2	0.8	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	2.5	1.3	0.8	1.1	1.0	1.2	0.6	1.2	1.2	1.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
FGF3	"HBGF-3, INT2"	ENSG00000186895	"Fibroblast growth factor 3"	P11487	11	69809968-69819416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"brain: 3.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.4"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.1"	"Not detected"	"Not detected"			HPA012692	Enhanced				"Secreted in brain"	NA	NA					"HPA012692: AB_1848526"				"unprognostic (6.42e-3)"						"unprognostic (7.82e-2)"	"unprognostic (1.89e-1)"			"unprognostic (3.61e-1)"	"unprognostic (7.75e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.1	0.7	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF8	AIGF	ENSG00000107831	"Fibroblast growth factor 8"	P55075	10	101770130-101780369	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"skeletal muscle: 49.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.1;testis cancer: 3.3"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	17	"RH-30: 37.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (1.56e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.09e-2)"		"unprognostic (8.75e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.35e-9)"	"unprognostic (6.17e-3)"	"unprognostic (9.01e-2)"		"unprognostic (1.97e-1)"	0.5	0.0	0.7	0.0	0.6	0.2	0.2	0.5	1.2	0.1	0.8	0.2	0.3	0.2	0.2	0.9	0.1	0.3	0.3	0.9	0.8	0.1	0.1	0.3	0.3	0.6	0.7	0.7	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.1	0.5	0.0	0.1	49.2	0.2	0.0	0.0	0.4	0.6	0.1	1.1	0.6	0.0	0.2	0.0	0.0	0.2	0.0	1.0	0.6	0.1	0.3	1.4	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.6	0.7	0.4	0.6	0.0	0.0	0.5	0.3	0.0	0.0	1.1	1.0	0.4	0.3	0.5	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.0	1.0	0.3	0.9	0.0	0.4	0.6	2.2	0.2	0.0	0.1	0.6	37.8	0.8	0.0	0.2	0.9	0.9	0.0	0.6	0.5	0.0	0.6	0.1	0.6	0.6	1.1	0.8	0.2	0.2	0.8	1.3	0.8	0.7	0.8	1.9	0.4	0.5	0.3	0.5	0.6	0.4	0.4	0.4	0.4	0.5	0.6	0.5	1.1	0.7	0.9	0.4	0.5	0.3	0.7	0.6	0.5	1.2	0.9	0.8	0.6	0.7	0.7	0.6	0.4	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004234-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"brain: 18.9"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 32.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.6;HDLM-2: 14.7;HEK 293: 10.7;JURKAT: 5.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.6"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073369: AB_2686597"	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	4.2	0.0	2.6	0.0	0.0	6.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	18.9	0.0	0.0	0.0	0.2	10.1	6.6	0.1	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.0	0.2	0.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	2.5	0.0	6.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.7	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.2	2.6	6.1	0.7	0.1	18.9	10.1	6.6	0.1	5.5	7.9	11.9	4.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	32.5	7.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.8	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.8	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0
FOXJ1	"FKHL13, HFH-4, HFH4"	ENSG00000129654	"Forkhead box J1"	Q92949	17	76136333-76141245	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.2;choroid plexus: 64.0;fallopian tube: 53.6"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 234.7;Respiratory ciliated cells: 124.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 29.9;CAPAN-2: 25.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 43.1"	HPA005714	Enhanced					NA	NA					"HPA005714: AB_1078902"	"prognostic favorable (9.39e-4)"	"unprognostic (4.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.71e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-1)"	0.0	0.0	14.9	0.1	12.3	0.3	0.0	18.0	10.9	3.6	64.0	0.6	0.3	2.2	0.5	0.3	53.6	0.0	0.0	14.1	24.6	2.3	0.0	10.5	0.0	27.9	24.6	5.5	0.2	0.9	0.0	2.2	0.0	23.0	0.5	0.2	0.4	0.1	2.6	0.4	0.8	0.2	0.0	23.9	0.0	0.6	16.8	27.8	0.2	3.0	0.0	0.0	0.9	0.1	28.2	0.0	0.5	1.7	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	3.1	25.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.9	12.3	18.0	10.9	14.1	24.6	27.9	24.6	5.5	23.0	23.9	27.8	28.2	2.2	9.6	3.1	1.0	2.3	0.8	1.0	4.4	0.0	0.4	5.6	4.2	0.9	1.5	12.0	9.2	4.2	0.2	4.8	1.0	0.0	0.6	21.4	234.7	4.5	0.7	1.8	3.0	0.0	0.0	0.6	1.6	4.1	10.7	1.3	0.1	0.4	0.0	0.1	0.0	0.1	3.2	4.1	0.6	0.0	19.1	0.3	1.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.8	0.4	1.3	0.5	0.2	3.5	124.0	8.7	0.0	1.8	3.5	20.7	2.0	0.8	0.9	0.3	3.5	1.1	2.3	0.7
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277978-109309284	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 11.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Endometrial ciliated cells: 2.6;Ionocytes: 2.0;Respiratory ciliated cells: 1.2;Spermatocytes: 2.8;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;SCLC-21H: 3.5;SH-SY5Y: 3.6;U-266/70: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: AB_2680992"	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.2	1.4	0.4	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.8	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	11.5	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	2.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.9;skin 1: 8.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	0.7	0.1	0.9	0.1	0.6	0.0	0.8	1.3	0.6	6.5	0.3	0.3	0.1	2.8	0.9	16.9	1.4	1.6	0.2	0.7	0.7	0.1	0.0	0.8	0.4	1.3	1.0	0.3	2.9	0.1	0.0	0.9	2.4	1.0	2.9	0.2	0.4	4.2	1.5	1.0	8.7	0.4	0.4	0.8	0.0	0.4	0.1	2.7	0.3	1.0	0.8	0.7	2.6	6.9	1.1	0.0	0.0	5.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	1.3	0.6	0.7	0.7	1.3	1.0	0.3	1.0	0.8	2.7	1.1	0.4	0.0	0.5	0.0	0.0	8.4	4.7	0.1	12.5	0.1	0.6	0.8	0.6	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	2.1	2.1	0.0	0.0	0.0	0.2	0.6	8.4	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	13.1	9.3	0.0	0.4	25.5	8.5	0.8	0.1	0.0	0.0	1.8
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 66.9;parathyroid gland: 46.7;retina: 29.9"	"Group enriched"	"Detected in many"	8	"Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.1;HEL: 64.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 547.6"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	0.2	3.0	22.7	0.0	29.7	3.3	0.1	16.4	32.6	0.8	0.0	0.0	0.0	1.6	4.3	0.4	0.2	0.1	0.0	15.4	66.9	4.9	0.1	0.2	0.1	13.7	40.0	24.3	0.2	0.2	46.7	5.0	0.4	13.5	0.8	0.1	29.9	0.1	0.3	0.0	0.1	0.1	0.0	6.3	0.1	0.0	3.2	24.4	0.8	0.1	0.0	0.2	0.6	0.4	14.0	18.2	0.7	0.0	7.3	0.0	0.0	0.1	0.4	0.0	2.6	1.7	4.6	6.7	0.0	0.9	0.5	2.9	20.1	2.3	0.6	1.6	2.8	13.4	64.5	6.0	0.2	0.0	0.3	1.1	0.0	5.5	0.0	2.3	0.6	0.1	0.5	17.0	0.3	0.8	1.5	0.0	0.0	8.1	9.7	6.7	1.0	4.6	0.4	8.5	9.4	6.7	2.1	12.6	0.0	3.5	0.6	0.2	0.0	0.0	12.0	1.7	2.4	7.0	0.0	0.0	0.1	11.5	3.2	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	29.7	16.4	32.6	15.4	66.9	13.7	40.0	24.3	13.5	6.3	24.4	14.0	0.0	0.0	0.0	14.7	0.0	0.3	2.1	7.7	2.2	32.5	0.1	0.1	1.3	0.0	3.6	0.0	10.4	0.0	0.0	0.2	7.9	4.5	5.6	4.4	0.4	0.4	3.0	5.5	2.6	5.6	0.1	0.2	0.0	2.9	0.0	5.5	0.0	0.0	4.0	5.0	392.8	0.3	2.0	0.8	0.4	6.2	0.6	0.5	0.0	7.5	0.0	4.9	0.0	146.8	7.6	2.9	0.0	0.0	0.1	0.9	0.0	0.0	4.7	6.0	0.0	0.0	1.2	4.4	7.7	0.6	0.1	0.5	0.0	0.1	0.1	0.4
GALP		ENSG00000197487	"Galanin like peptide"	Q9UBC7	19	56176008-56185775	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Hormone, Neuropeptide"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 1.8;Glandular and luminal cells: 1.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053938	Uncertain				"Secreted in brain"	NA	NA					"HPA053938: AB_2682315"				"unprognostic (8.51e-3)"			"unprognostic (1.22e-2)"			"unprognostic (2.65e-1)"					"unprognostic (7.02e-2)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GFRA3	GFRa-3	ENSG00000146013	"GDNF family receptor alpha 3"	O60609	5	138252380-138274621	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.7;Enteroendocrine cells: 53.1;granulocytes: 26.7;Late spermatids: 20.9;Spermatogonia: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.9"	"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 32.0"	"Not detected"	"Not detected"							HPA020731	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		150000	"Plasma membrane"	Cytosol	"HPA020731: AB_1849635"	"unprognostic (1.22e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	1.8	1.7	0.0	2.1	0.1	0.0	1.6	2.5	0.3	6.6	0.0	9.6	2.7	0.5	2.6	2.3	1.3	1.9	3.8	0.1	0.2	0.5	0.5	2.1	0.1	0.1	0.2	0.1	1.3	3.7	0.0	2.1	0.0	0.9	4.2	3.8	0.0	3.3	5.9	0.2	2.7	3.3	2.0	0.1	0.0	6.3	4.2	0.1	0.5	0.8	0.4	0.1	5.1	7.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.1	0.0	0.0	2.0	1.2	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	32.0	0.5	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.3	0.1	0.2	0.1	0.2	0.1	0.9	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	8.7	0.0	0.0	0.0	53.1	0.0	0.2	0.2	0.2	0.5	0.0	0.0	26.7	0.3	0.0	0.0	0.1	0.0	0.1	0.2	6.1	0.0	0.2	20.9	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.8	8.4	0.1	0.0	0.3	0.0	0.1	0.0	0.1
GFRA4		ENSG00000125861	"GDNF family receptor alpha 4"	Q9GZZ7	20	3659248-3663399	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.6;Late spermatids: 3.2;Proximal tubular cells: 1.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA															"unprognostic (3.50e-2)"						"unprognostic (2.36e-1)"		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499923-49528078	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"T-47d: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain					NA	NA					"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909698	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 67.8;fallopian tube: 65.9;placenta: 22.9;skin 1: 26.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.0	67.8	0.2	0.1	0.1	0.0	1.8	0.1	0.0	0.7	0.4	0.0	0.3	0.8	0.9	0.0	65.9	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.9	0.1	3.0	0.0	22.9	0.1	0.1	0.0	0.0	0.3	0.2	0.0	26.2	0.4	0.1	0.0	0.0	2.4	11.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.0	0.0	194.9	0.0	0.0	0.0	0.0	1.3	47.0	0.5	0.5	0.0	0.0	0.0	0.0	7.5	1.1	0.0	0.7	1.3	7.4	0.0	0.4	15.7	0.0	0.0	0.0	2.0	0.0	0.4	2.1	1.5	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	24.8	0.0	0.0	0.0	0.8	0.5	0.5	0.0	9.8	515.3	0.1	91.3	0.0	0.0
HOATZ	"C11orf88, FLJ46266"	ENSG00000183644	"HOATZ cilia and flagella associated protein"	Q6PI97	11	111514785-111537031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 27.2;fallopian tube: 89.7;testis: 29.4"	"Cell type enriched"	"Detected in single"	28	"Cardiomyocytes: 5.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;Karpas-707: 1.7;SuSa: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"							NA	NA						"unprognostic (2.25e-1)"	"unprognostic (3.07e-5)"	"unprognostic (3.85e-4)"	"unprognostic (4.16e-2)"	"unprognostic (4.44e-5)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.86e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.80e-3)"	"unprognostic (7.57e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	0.0	0.0	8.1	0.1	2.3	0.1	0.0	3.2	2.1	4.2	27.2	0.0	0.2	3.1	0.4	0.0	89.7	0.2	0.0	1.2	5.5	0.0	0.0	11.8	0.1	8.8	7.1	0.1	0.1	0.0	0.0	0.4	0.3	7.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	8.4	0.2	0.1	29.4	3.5	0.1	0.8	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.2	0.2	0.1	0.3	0.9	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	8.1	2.3	3.2	2.1	1.2	5.5	8.8	7.1	0.1	7.0	8.4	3.5	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593779	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.1;epididymis: 18.6;kidney: 17.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 25.4;Endometrial ciliated cells: 48.8;Glandular and luminal cells: 46.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enhanced"	"Detected in many"		"medulla oblongata: 38.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8;HeLa: 8.7;RPTEC TERT1: 21.7"	"Region enriched"	"Detected in single"	230	"pons and medulla: 22.9"	"Group enriched"	"Detected in some"	9	"medulla oblongata: 19.3;spinal cord: 14.3"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (8.59e-5)"	2.7	3.9	0.3	2.5	6.8	0.1	1.8	0.0	0.8	5.7	0.0	12.8	1.7	2.3	18.6	0.2	7.5	0.2	0.1	0.0	0.1	17.6	0.6	5.9	0.1	38.1	0.5	0.0	0.2	0.7	1.0	0.0	1.2	10.4	1.1	4.9	0.0	0.0	6.9	0.4	0.7	12.3	2.0	21.6	2.6	4.9	0.8	4.1	0.0	0.5	0.2	0.0	2.8	1.6	13.4	2.6	6.5	0.0	3.2	3.2	3.5	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.0	6.5	3.7	0.7	0.0	0.3	0.0	0.0	0.0	28.8	1.3	8.7	0.0	5.5	0.0	1.4	1.8	0.0	3.9	0.0	1.1	2.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	0.0	3.6	2.3	0.0	1.2	0.0	21.7	2.2	0.0	0.0	0.2	0.0	3.3	0.1	0.6	0.0	6.5	0.9	2.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.8	0.0	0.8	0.0	0.1	38.1	0.5	0.0	10.4	21.6	4.1	13.4	4.9	0.0	1.1	0.0	0.0	0.9	0.2	0.0	1.2	0.0	0.3	0.3	0.4	0.0	0.0	53.3	0.0	0.0	0.1	13.5	25.4	0.0	0.9	48.8	4.1	6.6	4.2	2.7	0.0	0.0	0.0	3.8	1.1	46.0	0.0	0.0	8.2	0.0	0.7	0.0	0.0	11.4	0.0	4.2	0.8	0.5	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.4	0.0	0.1	7.0	0.5	0.0	0.0	0.0	0.2	4.9	8.6	11.0	0.3	0.3	0.0	0.6	0.0	11.3	0.1
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 40.7;kidney: 41.5"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Group enriched"	"Detected in many"	6	"medulla oblongata: 12.6;spinal cord: 16.8;white matter: 10.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1"	"Region enriched"	"Detected in single"	102	"pons and medulla: 10.1"	"Group enriched"	"Detected in some"	168	"medulla oblongata: 8.1;spinal cord: 25.4"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	6.2	7.5	0.1	4.4	2.0	0.2	4.6	0.3	0.2	18.4	0.0	13.2	1.1	4.4	40.7	0.3	13.5	0.3	0.7	0.1	0.4	41.5	0.8	6.3	0.4	12.6	0.1	0.0	0.3	1.2	1.3	0.1	2.7	1.1	2.0	6.1	0.0	0.2	21.3	1.7	1.1	14.1	2.3	16.8	3.0	9.3	1.1	2.0	0.0	0.7	0.5	0.0	3.8	2.2	10.7	5.2	11.9	0.0	6.2	5.3	5.5	0.1	0.0	0.0	0.0	0.0	6.5	7.7	0.0	28.2	14.2	2.0	0.1	1.4	0.4	0.0	0.2	80.3	7.1	23.8	0.0	7.9	0.6	18.0	6.9	0.2	11.4	0.2	4.3	5.4	0.5	4.7	0.1	15.7	0.3	0.0	0.3	0.0	20.0	4.7	0.0	13.1	0.7	53.2	2.6	0.0	0.0	4.4	0.0	8.2	0.1	2.1	2.5	30.1	1.0	6.0	5.0	22.2	0.0	0.0	0.1	0.9	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.3	0.2	0.1	0.4	12.6	0.1	0.0	1.1	16.8	2.0	10.7	10.6	0.0	0.0	0.0	0.4	0.8	0.5	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	136.1	0.0	0.2	0.0	18.1	113.5	0.1	1.0	80.7	5.5	10.6	7.7	0.4	0.0	2.0	2.9	3.0	0.0	56.4	0.0	0.0	4.2	0.0	1.7	0.0	0.0	9.0	0.0	18.6	3.1	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.8	0.0	0.0	0.6	9.5	2.8	0.0	0.0	0.0	0.9	6.4	4.8	6.2	0.0	1.1	0.3	1.2	0.0	11.0	1.2
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48615292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 80.5;epididymis: 48.5;kidney: 26.5;seminal vesicle: 21.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Group enriched"	"Detected in many"	8	"medulla oblongata: 34.4;spinal cord: 80.5;white matter: 41.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3"	"Region enriched"	"Detected in single"	65	"pons and medulla: 6.5"	"Region enriched"	"Detected in all"	5	"spinal cord: 51.2"	HPA075905			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.6	7.3	0.0	1.5	3.8	0.0	2.7	0.0	0.0	10.8	0.0	3.1	0.0	2.8	48.5	0.0	1.4	0.0	0.0	0.0	0.1	26.5	0.0	0.4	0.0	34.4	0.0	0.0	0.1	0.1	0.8	0.1	0.3	3.5	1.0	1.2	0.0	0.0	21.0	0.4	0.5	7.1	1.5	80.5	0.1	6.7	1.0	6.2	0.0	0.1	0.0	0.0	3.7	0.7	41.6	2.1	5.3	0.0	0.8	0.7	1.0	0.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	34.0	5.3	0.6	0.0	0.1	0.0	0.0	17.2	36.9	1.0	0.1	0.0	0.3	0.0	5.5	1.1	0.0	0.1	0.0	0.7	2.1	0.2	11.6	0.0	17.3	0.0	0.0	0.4	0.0	11.3	0.0	0.0	3.6	0.1	35.3	1.0	0.0	0.1	0.6	0.0	5.4	0.1	0.4	0.0	8.8	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	34.4	0.0	0.0	3.5	80.5	6.2	41.6	4.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	88.3	0.0	0.0	0.1	1.8	72.4	0.0	0.3	21.3	2.1	2.6	44.1	0.0	0.0	0.0	0.8	0.3	0.0	26.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.2	2.7	8.9	0.0	0.0	0.0	0.1	0.8	2.3	9.2	0.0	0.0	0.0	0.3	0.0	5.0	0.0
IGHD2-15	"D2, IGHD215"	ENSG00000211918	"Immunoglobulin heavy diversity 2-15"		14	105897957-105897987	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"bone marrow: 2.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"naive B-cell: 39.9"	"Lineage enriched"	"Detected in single"	400	"B-cells: 39.9"	"Cell line enriched"	"Detected in single"	28	"HEL: 2.7"															NA	NA																							0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD3-22	IGHD322	ENSG00000211911	"Immunoglobulin heavy diversity 3-22"		14	105886031-105886061	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.6;lymphoid tissue: 2.7;stomach 1: 3.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 48.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 48.9"	"Cell line enriched"	"Detected in single"	13	"SH-SY5Y: 1.3"															NA	NA													"unprognostic (4.12e-1)"						"unprognostic (1.53e-1)"				0.0	0.0	0.1	0.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.2	3.1	0.0	0.0	0.7	0.0	0.0	2.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	48.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog signaling molecule"	Q14623	2	219054424-219060921	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 14.1;intestine: 17.9;stomach 1: 15.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 31.5;Enteroendocrine cells: 49.2;Granulosa cells: 122.4;Intestinal goblet cells: 34.7;Proximal enterocytes: 18.8;Undifferentiated cells: 23.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8;endometrial cancer: 30.9"	"Region enriched"	"Detected in single"	6	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 16.4;OE19: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		23000000				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	1.7	4.9	0.0	17.9	12.3	14.1	0.0	0.3	0.9	0.7	0.0	0.0	0.0	2.4	3.5	1.3	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.5	0.1	0.2	2.4	12.5	0.0	0.0	0.7	0.0	0.0	13.0	0.7	0.2	0.0	15.1	0.1	0.1	0.0	1.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.8	0.0	1.8	0.0	0.0	0.4	31.5	0.0	0.1	0.0	6.0	0.5	0.1	49.2	0.0	0.0	3.3	0.0	0.1	12.2	8.9	0.0	122.4	0.0	0.6	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	14.0	0.0	0.0	1.8	18.8	3.2	0.9	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	23.6	0.3
IL19	"IL-10C, IL-19, MDA1, NG.1, ZMDA1"	ENSG00000142224	"Interleukin 19"	Q9UHD0	1	206770764-206842979	"Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 20.1;salivary gland: 7.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 11.3;Breast glandular cells: 3.2;Club cells: 9.6;Endometrial ciliated cells: 2.9;Glandular and luminal cells: 5.2;Ionocytes: 4.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BJ hTERT+: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	172000					"unprognostic (6.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.17e-2)"		"unprognostic (2.48e-5)"		"unprognostic (1.07e-1)"	"unprognostic (8.72e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.04e-3)"			"unprognostic (9.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-1)"	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	20.1	0.0	0.1	0.0	0.3	0.0	1.8	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.1	7.0	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.2	0.2	0.2	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	11.3	0.0	0.0	3.2	0.0	0.1	0.0	9.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.9	0.7	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	4.1	0.0	1.2	0.2	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358285	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.6;pancreas: 1.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.7;Glandular and luminal cells: 2.7;Proximal tubular cells: 1.1;Spermatocytes: 2.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.2;EFO-21: 4.1;Hep G2: 5.3"									HPA036021	Approved					NA	NA					"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	4.6	0.9	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	3.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539030-49558337	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 39.7;pituitary gland: 25.9"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 11.4;Excitatory neurons: 58.2;Inhibitory neurons: 19.2;Late spermatids: 10.6;Respiratory ciliated cells: 10.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.8;AN3-CA: 3.5;HMC-1: 3.4;RPTEC TERT1: 9.1;U-2 OS: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.2	2.9	27.1	0.0	22.0	0.2	0.6	0.0	39.7	0.6	0.0	0.2	0.1	0.6	0.1	0.1	5.9	0.3	0.6	27.3	5.2	3.4	0.3	1.0	0.5	4.8	2.4	29.5	0.3	1.3	2.6	25.9	0.0	13.6	0.7	0.0	0.0	0.3	0.4	0.1	0.2	0.3	0.0	0.0	1.4	0.3	2.8	2.9	0.2	1.3	0.0	0.2	0.1	0.3	22.5	0.4	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.2	1.7	0.6	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	9.1	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	27.1	22.0	0.0	39.7	27.3	5.2	4.8	2.4	29.5	13.6	0.0	2.9	22.5	0.1	0.0	0.5	4.9	0.0	0.1	0.2	0.5	0.0	0.1	0.1	2.0	1.0	5.7	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.2	6.0	11.4	0.4	0.1	2.4	0.0	58.2	0.0	0.1	0.6	0.0	0.5	0.0	2.4	0.7	0.0	0.0	1.7	19.2	0.0	0.0	0.6	0.5	10.6	0.3	0.6	0.0	1.0	0.7	0.4	2.1	6.0	2.6	0.1	0.1	1.2	0.1	0.0	0.0	0.2	10.9	0.3	0.0	0.4	0.3	1.1	3.4	0.0	0.3	0.0	0.7	0.0	0.2	0.0
KCNRG		ENSG00000198553	"Potassium channel regulator"	Q8N5I3	13	50015254-50020922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"fallopian tube: 36.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.4;Endometrial ciliated cells: 46.0;Late spermatids: 12.6;Respiratory ciliated cells: 88.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001027			Uncertain	Vesicles		NA	NA			Vesicles		"HPA001027: "	"unprognostic (1.85e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.16e-2)"	0.5	0.4	0.4	0.6	1.9	1.9	0.8	3.1	1.1	1.0	0.2	0.5	0.5	1.3	0.5	0.8	36.0	0.4	0.6	0.3	1.1	0.8	0.4	3.2	0.6	1.4	0.8	0.1	0.5	0.4	1.1	0.5	0.2	1.3	0.6	0.8	0.8	0.5	0.4	0.7	0.9	0.6	0.5	0.7	0.6	0.5	2.0	1.1	0.6	0.5	0.5	0.6	0.7	0.5	3.4	0.4	0.3	1.1	0.4	0.4	0.5	0.2	0.0	0.9	0.8	0.0	1.3	0.4	0.8	0.2	1.1	0.5	0.5	0.8	0.3	0.6	0.6	0.5	1.7	0.5	0.7	1.0	1.5	0.4	0.6	0.8	0.5	1.4	0.7	1.6	3.1	0.7	0.1	1.0	0.5	1.6	1.5	0.9	1.0	0.6	1.0	0.0	0.0	0.7	1.0	1.0	2.2	0.3	0.7	0.8	0.6	0.6	0.4	0.5	0.7	0.3	0.4	0.3	0.1	0.2	0.9	0.2	0.5	0.2	1.0	0.3	0.2	0.1	0.3	0.2	0.4	0.1	0.3	0.3	0.6	0.2	0.2	1.2	0.4	0.2	0.3	0.4	0.1	0.4	1.9	3.1	1.1	0.3	1.1	1.4	0.8	0.1	1.3	0.7	1.1	3.4	1.1	0.0	2.7	0.7	0.9	0.1	0.9	3.8	0.0	1.0	0.6	0.9	0.5	0.0	6.2	0.0	2.1	0.8	0.5	0.8	0.0	0.5	19.4	46.0	1.0	0.8	4.2	0.0	0.7	1.4	0.5	0.8	0.0	1.0	0.0	0.5	0.0	0.3	0.5	3.3	0.7	0.9	0.0	0.0	0.3	12.6	0.6	1.3	0.0	0.0	1.3	0.7	0.0	1.0	0.5	0.6	0.3	0.7	0.0	0.9	0.8	2.1	88.6	1.2	0.0	1.4	1.5	11.4	1.5	0.0	0.1	0.7	0.5	0.5	0.7	1.3
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782550	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"skin 1: 44.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Endothelial cells: 1.5;Hepatic stellate cells: 2.2;Melanocytes: 8.8;Muller glia cells: 3.0;Spermatogonia: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9;thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"EFO-21: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"hippocampal formation: 80.6"	HPA055114	Enhanced					NA	NA					"HPA055114: AB_2682700"		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	8.8	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0
KRT28	KRT25D	ENSG00000173908	"Keratin 28"	Q7Z3Y7	17	40792196-40799959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"skin 1: 7.6"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.3"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.6;endometrial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			HPA066890	Enhanced					NA	NA					"HPA066890: AB_2685742"																		0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT71	"K6IRS1, KRT6IRS, KRT6IRS1"	ENSG00000139648	"Keratin 71"	Q3SY84	12	52543909-52553145	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 62.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"CACO-2: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049404	Enhanced					NA	NA		110000000			"HPA049404: AB_2680748"	"unprognostic (9.12e-2)"	"unprognostic (2.38e-1)"				"unprognostic (1.21e-1)"		"unprognostic (1.04e-1)"		"unprognostic (1.51e-1)"	"unprognostic (2.18e-1)"			"unprognostic (1.47e-1)"		"unprognostic (3.14e-1)"	"unprognostic (1.69e-2)"	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007298-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"fallopian tube: 117.3"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.2;Hep G2: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.6	0.2	0.1	0.1	0.1	0.6	0.5	0.2	4.5	0.2	0.1	0.0	0.7	0.1	0.6	117.3	0.8	0.0	0.1	0.1	0.0	0.1	7.0	0.1	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.2	0.1	3.4	0.1	0.2	0.3	0.1	0.0	0.0	0.2	1.4	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.2	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.5	0.0	6.4	7.2	0.0	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.1	0.1	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	98.1	0.8	0.7	20.9	0.0	0.1	0.2	0.0	1.1	0.0	2.1	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	329.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439798-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;fallopian tube: 17.0;placenta: 19.2;skeletal muscle: 22.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 37.1;SH-SY5Y: 104.5"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 34.1"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	0.9	1.6	2.8	0.4	6.8	0.0	1.5	4.1	6.2	1.5	0.2	3.4	5.1	4.0	1.2	0.1	17.0	0.4	0.1	2.7	7.1	0.3	0.9	0.9	0.1	8.1	5.5	1.6	0.7	0.0	0.2	1.0	19.2	8.4	1.2	3.6	0.2	2.0	7.4	22.5	2.7	5.5	0.2	6.3	0.0	2.3	0.1	5.4	0.1	0.3	0.9	1.7	0.1	0.4	19.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.5	0.0	11.9	0.0	1.0	37.1	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	12.2	1.6	2.4	0.0	0.0	0.0	14.6	0.2	104.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	4.1	6.2	2.7	7.1	8.1	5.5	1.6	8.4	6.3	5.4	19.4	0.0	0.0	0.0	1.3	0.2	0.9	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	55.2	0.0	1.2	0.0	0.0	0.6	35.7	5.3	0.5	4.9	0.0	6.8	0.0	2.3	1.4	0.0	84.4	0.0	0.0	0.0	1.0	6.4	0.0	12.3	3.0	0.0	0.0	1.6	0.2	0.0	0.4	1.8	0.0	0.0	0.0	0.0	45.2	105.0	0.1	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	3.4	0.0	0.0	0.0	1.3	26.4	0.5	0.0	20.3	0.0
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508749-61511018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.7;fallopian tube: 29.0;pituitary gland: 34.0"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4"	"Region enriched"	"Detected in many"	7	"basal ganglia: 222.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 30.9;hippocampal formation: 24.2"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	3.2	0.9	11.3	0.4	34.7	0.0	3.0	1.0	11.1	5.0	3.3	2.1	0.3	4.9	1.9	0.5	29.0	0.3	1.4	14.1	3.9	0.9	0.1	4.9	0.0	5.4	3.5	8.8	2.3	1.3	2.2	34.0	0.5	11.0	1.6	0.3	0.1	1.3	0.5	0.7	0.9	1.4	1.6	2.7	0.4	2.9	5.9	5.4	2.7	1.6	0.9	0.0	1.1	2.6	3.5	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	5.4	0.5	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	34.7	1.0	11.1	14.1	3.9	5.4	3.5	8.8	11.0	2.7	5.4	3.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.6	0.4	1.1	0.0	3.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	3.2	49.3	0.5	0.4	4.2	0.0	1.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	37.2	0.2	19.7	0.7	20.6	0.8	1.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1
LRRC18	"MGC34773, UNQ933, UNQ9338, VKGE9338"	ENSG00000165383	"Leucine rich repeat containing 18"	Q8N456	10	48909483-48914232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 9.8;fallopian tube: 7.6;testis: 14.1"	"Group enriched"	"Detected in some"	8	"Early spermatids: 222.0;Late spermatids: 64.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039256, HPA076699"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA039256: AB_10671873, HPA076699: "	"unprognostic (1.31e-2)"		"unprognostic (3.66e-2)"	"unprognostic (9.83e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.98e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.16e-2)"		"unprognostic (8.57e-3)"	"unprognostic (4.08e-1)"		"unprognostic (1.13e-1)"	0.0	0.0	0.4	0.4	0.4	0.4	0.3	0.6	0.3	0.6	9.8	0.4	0.2	0.2	0.0	0.1	7.6	0.3	0.3	0.8	0.8	0.0	0.0	1.5	0.2	0.7	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.7	0.0	0.1	0.0	0.0	0.8	0.4	0.2	0.8	0.1	0.2	14.1	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.6	0.3	0.8	0.8	0.7	0.8	0.1	0.7	0.8	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.0	6.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	64.1	1.8	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.2	2.8	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414697-69553865	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3"	"Group enriched"	"Detected in all"	9	"dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	5.3	1.3	5.0	8.4	4.2	16.0	20.6	12.1	4.2	27.2	6.8	31.0	10.4	6.1	3.2	3.2	4.5	7.3	1.4	2.9	3.9	5.6	12.3	1.8	8.0	4.4	3.9	2.4	3.2	8.4	0.3	1.6	1.7	5.1	3.4	32.0	5.9	2.5	3.1	40.9	2.1	10.9	3.3	4.6	4.1	7.5	1.3	5.0	11.6	3.3	21.3	5.9	3.3	1.2	8.2	0.1	40.0	17.6	21.4	7.4	4.0	2.5	0.3	5.8	1.6	2.4	1.2	1.7	1.1	14.2	0.8	1.3	1.9	6.1	0.8	0.5	1.3	3.2	0.1	10.3	11.4	7.4	1.7	1.3	19.0	0.5	0.3	0.0	1.4	28.4	5.3	0.1	2.5	0.0	0.3	21.6	0.7	12.5	0.9	7.3	7.7	1.8	0.5	7.8	5.4	7.8	11.8	1.7	1.3	3.9	9.3	5.4	2.3	5.1	1.9	2.3	1.6	0.5	1.7	2.2	0.5	1.6	2.5	1.5	2.5	22.0	4.0	2.8	2.6	5.0	4.1	3.1	3.5	7.1	5.2	3.6	3.4	45.9	4.7	1.1	78.3	5.0	6.2	5.0	4.2	12.1	4.2	2.9	3.9	4.4	3.9	2.4	5.1	4.6	5.0	8.2	11.2	3.2	6.7	27.7	7.7	2.7	4.1	0.8	8.6	5.2	14.3	29.1	1.3	5.7	3.6	0.0	2.1	9.7	29.2	42.3	23.5	1.9	10.2	53.9	11.5	7.9	45.6	5.0	26.0	4.1	6.6	5.0	9.2	82.7	1.3	13.4	4.2	2.5	6.2	3.3	22.4	22.9	0.0	6.8	7.4	2.9	4.4	6.9	3.6	24.4	9.6	31.8	10.3	32.6	52.5	1.1	16.7	3.8	10.7	1.3	14.5	1.5	4.2	4.2	0.0	3.9	5.7	0.1	1.8	4.8	4.3	0.8	13.3	1.4	30.6	2.8
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	"Mitogen-activated protein kinase kinase kinase 19"	Q56UN5	2	134964485-135047468	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.2;choroid plexus: 7.8;fallopian tube: 18.4;testis: 5.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 59.7;Endometrial ciliated cells: 73.7;Late spermatids: 148.4;Respiratory ciliated cells: 121.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011388			Uncertain	Cytosol		NA	NA			Cytosol		"HPA011388: AB_1848822"	"unprognostic (7.12e-3)"	"unprognostic (6.55e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.83e-4)"	0.0	0.1	3.3	0.0	1.3	0.0	0.0	1.4	0.8	0.4	7.8	0.0	0.0	0.6	0.0	0.0	18.4	0.0	0.1	0.8	3.2	0.0	0.0	1.5	0.1	4.5	3.5	0.2	0.0	0.0	0.0	0.3	0.0	2.9	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	5.2	0.0	0.0	5.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.3	1.4	0.8	0.8	3.2	4.5	3.5	0.2	2.9	5.2	1.9	3.2	0.1	0.0	1.1	2.3	0.1	0.0	0.1	2.6	0.0	0.3	0.0	0.0	0.4	0.0	11.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	59.7	73.7	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	2.0	0.0	0.0	148.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	121.0	0.2	0.0	0.0	0.8	7.5	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1
MS4A8	"CD20L5, MS4A4, MS4A8B"	ENSG00000166959	"Membrane spanning 4-domains A8"	Q9BY19	11	60699585-60715807	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 130.9;intestine: 199.3"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 376.4;Enteroendocrine cells: 473.4;Ionocytes: 140.4;Proximal enterocytes: 694.6;Respiratory ciliated cells: 502.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.9;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007319	Enhanced					NA	NA					"HPA007319: AB_1854138"	"unprognostic (7.28e-3)"	"unprognostic (2.11e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.52e-2)"			"unprognostic (9.41e-2)"	"unprognostic (4.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-2)"		"unprognostic (1.59e-3)"	0.0	0.8	1.7	3.6	1.4	0.0	0.0	0.2	1.0	25.8	4.4	18.4	191.5	8.3	0.0	0.3	130.9	10.9	0.0	0.6	0.7	0.1	0.0	16.7	0.2	0.1	0.2	1.0	0.3	2.2	0.7	7.6	0.1	0.1	1.7	17.1	0.0	0.6	7.2	4.7	0.0	199.3	1.0	0.0	0.0	46.0	0.5	0.5	0.1	0.0	0.0	1.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.2	1.0	0.6	0.7	0.1	0.2	1.0	0.1	0.0	0.5	0.3	0.0	6.4	6.4	0.0	0.2	0.0	0.2	11.9	0.0	0.0	0.0	0.0	0.3	18.6	58.8	1.8	0.0	0.0	0.0	15.0	0.0	0.3	1.3	376.4	3.2	0.3	473.4	0.0	0.4	2.5	0.0	2.0	14.3	11.6	1.3	0.0	0.0	0.0	0.0	0.0	0.1	42.5	140.4	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	46.1	0.0	0.0	1.7	694.6	0.2	502.8	0.0	0.0	0.0	3.5	0.3	0.7	0.0	0.0	0.0	0.5	0.2	24.7	0.4
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724582-174730896	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.0;placenta: 33.8;urinary bladder: 17.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 18.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 322.0"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.2"	"Low region specificity"	"Detected in many"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.1	0.3	0.8	0.5	1.4	0.0	8.2	4.2	1.1	2.7	1.0	0.6	0.3	6.9	0.0	0.6	0.9	0.9	1.7	1.1	4.3	0.2	0.0	0.8	0.1	7.7	1.5	0.5	0.2	0.4	26.0	0.3	33.8	4.1	2.5	0.1	0.0	0.8	0.8	1.9	5.9	0.8	1.4	4.8	0.8	2.8	5.6	1.4	0.1	0.7	1.8	0.1	17.7	1.8	5.3	0.4	4.0	1.1	3.2	0.0	0.0	322.0	2.2	3.6	0.7	0.1	56.6	23.0	0.0	8.6	0.2	19.6	6.2	17.6	6.4	0.2	0.0	10.7	0.0	1.4	0.0	2.4	0.0	3.0	3.7	4.5	3.1	3.5	0.0	0.0	0.0	0.0	0.0	5.0	27.7	0.0	0.4	2.5	38.3	8.5	0.0	8.8	0.1	4.0	35.3	0.0	2.5	0.0	43.0	2.9	69.6	25.7	0.2	0.0	1.1	5.5	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	4.2	1.1	1.1	4.3	7.7	1.5	0.5	4.1	4.8	1.4	5.3	1.5	0.0	0.0	2.3	0.0	9.6	2.4	0.1	3.4	0.2	15.8	18.9	1.7	0.0	0.1	0.0	0.0	162.6	0.2	0.3	0.0	0.6	0.2	65.7	4.9	0.7	0.0	0.0	0.0	0.0	13.9	5.3	5.1	62.2	4.5	0.1	0.4	0.0	11.3	0.0	0.0	1.9	0.0	0.6	2.9	0.6	0.0	1.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.3	1.9	0.1	0.1	0.0	0.0	8.9	4.8	1.4	4.5	2.0	11.4	233.8	1.0	0.6	1.2	9.8
MYH7B	"dJ756N5.1, KIAA1512, MHC14, MYH14"	ENSG00000078814	"Myosin heavy chain 7B"	A7E2Y1	20	34955810-35002437	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 251.4;skeletal muscle: 158.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 86.6;Early spermatids: 34.0;Late spermatids: 67.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;U-138 MG: 1.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.05e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.02e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.44e-5)"	1.3	1.0	14.1	0.3	16.3	0.5	1.4	10.6	15.5	3.4	6.1	1.7	1.2	1.9	1.3	1.7	2.5	0.6	251.4	10.0	11.3	2.4	2.3	1.4	0.5	14.9	14.5	8.8	4.5	1.1	0.0	3.6	0.2	21.3	4.9	0.1	2.2	2.8	0.4	158.6	1.2	1.4	0.2	10.8	1.4	0.9	29.3	19.5	0.2	3.4	26.9	0.1	1.2	1.7	23.8	0.9	0.3	0.2	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.6	0.5	0.2	0.6	0.0	0.2	0.5	0.0	0.0	0.1	0.1	0.2	0.5	0.6	0.7	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.6	0.0	0.7	0.2	0.5	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.4	0.1	0.2	0.2	0.2	1.3	0.3	0.4	1.5	0.7	0.2	0.2	0.9	0.1	0.3	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	14.1	16.3	10.6	15.5	10.0	11.3	14.9	14.5	8.8	21.3	10.8	19.5	23.8	0.6	0.0	5.6	7.5	1.1	3.6	1.6	0.1	1.2	16.5	1.2	1.0	86.6	1.5	0.7	5.5	8.4	1.3	0.3	0.5	0.0	0.5	34.0	0.7	1.0	2.1	0.0	0.0	3.4	0.6	0.6	2.2	0.0	1.0	1.3	2.0	1.8	0.2	0.4	10.1	3.8	0.5	0.0	1.6	2.1	67.9	2.1	1.2	0.0	2.8	0.5	4.3	0.0	1.5	17.3	0.6	0.1	3.4	0.6	1.1	0.6	0.6	0.3	14.1	6.6	9.4	2.5	11.0	6.3	0.3	5.4	0.8	0.9	1.5	1.0	0.9
NEUROG2	"Atoh4, bHLHa8, Math4A, ngn-2, NGN2"	ENSG00000178403	"Neurogenin 2"	Q9H2A3	4	112513516-112516180	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.4;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast myoepithelial cells: 3.4;Early spermatids: 1.9;Late spermatids: 1.1;Muller glia cells: 8.1;Spermatocytes: 1.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 203.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	10	"hippocampal formation: 12.3"	CAB012342	Uncertain					NA	NA					"CAB012342: "	"unprognostic (1.09e-1)"	"unprognostic (2.52e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.75e-2)"		"unprognostic (1.04e-1)"	"unprognostic (1.13e-3)"						"unprognostic (1.02e-1)"	"unprognostic (3.30e-1)"		0.0	0.0	0.7	0.0	0.9	0.0	0.2	1.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	2.0	203.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.3	2.2	3.4	0.3	0.5	0.2	0.3	0.3	0.1	0.2	0.8	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535229	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 148.4;retina: 64.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	0.2	0.7	42.0	1.2	71.8	0.8	0.2	0.0	148.4	0.3	0.0	0.8	0.5	0.5	0.1	0.1	0.6	0.3	4.9	55.3	27.0	1.4	0.2	0.2	3.6	57.3	14.8	77.1	0.6	5.1	1.8	6.4	0.0	62.9	0.7	0.2	64.8	1.0	0.4	0.2	0.2	1.5	0.1	0.0	1.3	1.3	0.9	19.8	1.4	0.2	0.1	2.2	0.4	0.3	94.9	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.1	0.0	12.1	0.7	0.0	2.8	0.1	0.1	0.1	0.0	14.0	0.0	0.4	4.2	0.3	0.0	2.2	0.0	0.4	21.5	2.4	0.0	0.0	0.3	0.0	0.0	3.5	16.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	15.8	0.0	0.1	42.0	71.8	0.0	148.4	55.3	27.0	57.3	14.8	77.1	62.9	0.0	19.8	94.9	0.2	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	76.1	0.2	0.1	4.5	0.0	0.0	0.0	81.3	0.1	24.9	0.1	0.0	0.3	0.2	1.3	0.2	0.6	0.0	0.0	49.9	0.7	0.0	0.1	0.5	2.0	0.0	0.2	0.0	0.0	0.0	69.0	47.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	6.5	0.0	12.7	1.0	1.0	2.0	0.1	0.0	0.0	0.2	0.1	0.0	2.3	0.0	89.4	0.0	0.2	0.2	0.4	1.7	0.0	0.0	0.0	0.6	0.1	0.1	0.1
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 14.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Excitatory neurons: 24.5;Inhibitory neurons: 51.8;Oligodendrocyte precursor cells: 40.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6;ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol		NA	NA		83000	Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	1.7	0.1	7.1	0.2	8.5	0.0	1.7	0.0	11.1	1.6	0.0	1.3	0.2	1.1	0.2	0.8	0.6	0.4	0.3	11.0	11.7	0.2	0.0	0.1	0.2	1.1	3.1	6.9	1.0	0.1	0.1	0.7	0.1	2.6	0.2	1.7	1.8	0.6	0.3	0.4	1.0	0.4	0.9	0.0	0.0	0.5	0.6	14.5	0.8	0.2	0.9	0.0	0.8	0.6	2.3	0.0	0.0	18.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	3.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	8.5	0.0	11.1	11.0	11.7	1.1	3.1	6.9	2.6	0.0	14.5	2.3	29.9	0.0	0.5	13.4	0.0	3.1	0.1	0.9	4.6	12.9	0.5	0.8	1.8	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.4	6.2	11.3	1.8	0.0	24.5	0.0	0.1	2.9	0.0	1.4	0.0	2.5	1.1	0.0	0.1	0.0	51.8	0.1	0.0	0.3	3.4	2.2	3.4	0.1	0.0	7.5	0.0	1.9	0.0	40.7	2.2	0.1	0.1	0.4	0.0	0.4	0.0	0.2	1.3	1.9	0.0	5.9	7.8	0.1	1.5	1.0	1.6	0.0	0.2	0.7	0.0	0.1
PMCH	MCH	ENSG00000183395	"Pro-melanin concentrating hormone"	P20382	12	102196459-102197833	"Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Hormone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	91	"brain: 97.3"	"Group enriched"	"Detected in some"	4	"B-cells: 2.7;Exocrine glandular cells: 2.0;monocytes: 1.0;T-cells: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"thalamus: 97.3"	"Immune cell enriched"	"Detected in some"	10	"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	85	"T-cells: 9.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 44.9"	"Group enriched"	"Detected in many"	129	"hypothalamus: 624.3;thalamus: 339.8"	"Region enriched"	"Detected in some"	34	"hypothalamus: 83.0"	"HPA046055, HPA061884"	Enhanced	Supported			"Secreted to blood"	NA	NA	274000				"HPA046055: AB_2679517, HPA061884: AB_2684632"	"unprognostic (3.23e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.73e-2)"		"unprognostic (4.31e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.16e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.53e-2)"	0.0	0.0	36.1	0.5	1.8	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	64.7	0.0	0.0	0.1	1.0	0.3	22.5	0.1	0.0	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.4	0.5	0.0	97.3	1.0	0.0	0.1	0.4	0.1	0.0	0.2	0.4	0.2	0.5	0.4	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	44.9	0.0	0.7	0.8	0.4	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.2	5.3	0.5	0.9	0.0	0.0	0.0	0.8	1.5	0.6	0.7	1.3	0.4	0.6	1.8	0.0	0.3	0.5	0.5	0.6	0.8	0.1	0.3	0.3	0.1	0.6	0.6	0.5	0.2	0.7	0.1	0.8	0.6	0.5	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	36.1	1.8	0.1	0.3	0.0	64.7	0.3	22.5	0.1	6.4	0.0	97.3	0.2	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 22.2"	"Cell type enhanced"	"Detected in single"		"Endometrial ciliated cells: 1.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in some"		"medulla oblongata: 22.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.3;MCF7: 1.8;RPMI-8226: 1.4"	"Group enriched"	"Detected in some"	58	"hypothalamus: 11.3;pons and medulla: 21.5"	"Region enriched"	"Detected in single"	14	"medulla oblongata: 5.5"	HPA014976	Uncertain				"Secreted in brain"	NA	NA					"HPA014976: AB_2732413"	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.8	0.0	0.0	0.1	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.8	22.2	0.0	0.0	0.4	4.5	0.6	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PZP	CPAMD6	ENSG00000126838	"PZP alpha-2-macroglobulin like"	P20742	12	9148840-9208395	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 82.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.2;Hepatocytes: 26.4;Late spermatids: 11.0;Oligodendrocyte precursor cells: 8.5;Respiratory ciliated cells: 24.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0;liver cancer: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Group enriched"	"Detected in some"	9	"HeLa: 5.7;SiHa: 2.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"	NA	NA		15000000000			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.2	0.0	5.7	0.0	0.9	0.1	0.2	1.6	0.9	0.1	0.4	0.0	0.0	1.3	0.1	0.0	1.2	0.0	0.4	0.7	1.9	0.1	82.2	0.8	0.0	2.2	3.9	0.2	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.6	0.0	2.3	3.9	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.9	1.6	0.9	0.7	1.9	2.2	3.9	0.2	4.1	1.4	3.9	1.3	1.9	3.2	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.8	0.0	0.0	1.6	0.0	2.7	0.0	2.1	0.0	1.4	0.0	0.0	0.0	26.2	4.7	0.2	2.1	0.0	0.0	3.7	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.8	26.4	0.0	0.0	2.9	0.0	0.0	0.3	0.0	11.0	0.0	0.2	0.0	2.8	0.0	0.0	2.1	8.5	4.6	0.0	0.0	0.4	0.7	0.0	0.0	0.0	24.7	0.6	0.0	0.3	0.4	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 25.1;pituitary gland: 35.0;testis: 17.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"							HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.0	1.6	2.1	0.0	2.2	0.0	0.0	3.0	2.1	0.8	0.3	0.8	0.0	0.8	0.1	0.1	25.1	0.0	0.4	2.2	2.2	0.7	0.0	2.4	0.0	1.2	1.1	2.5	0.1	0.8	0.1	35.0	0.0	1.2	0.4	0.3	4.9	0.0	0.5	0.1	0.0	0.3	0.3	0.1	0.0	0.9	17.1	1.4	0.0	0.0	0.0	0.0	0.3	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.7	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.2	3.0	2.1	2.2	2.2	1.2	1.1	2.5	1.2	0.1	1.4	1.1	0.0	19.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	8.5	1.1	0.4	15.7	0.0	9.3	5.5	16.7	0.0	0.0	0.1	3.9	3.8	88.9	133.2	0.8	0.4	46.2	0.0	1.8	0.9	0.0	1.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	3.2	0.0	0.0	0.0	57.1	0.6	0.2	3.6	0.0	0.0	0.8	0.0	1.0	0.2	0.4	0.1	1.5	0.0	0.1	0.1	3.0	73.9	3.0	0.0	0.5	1.8	30.1	8.9	0.0	0.0	0.0	0.2	0.1	0.8	0.0
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.6;kidney: 11.2"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 15.9;Club cells: 9.8;Endometrial ciliated cells: 13.4;Glandular and luminal cells: 20.5;Ionocytes: 22.4;Proximal tubular cells: 26.4;Respiratory ciliated cells: 13.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057675	Uncertain					NA	NA					"HPA057675: AB_2683499"	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.1	0.1	0.3	0.4	0.2	0.0	1.0	0.2	0.4	1.5	0.2	0.4	0.4	1.2	16.6	4.9	1.3	5.8	0.1	0.2	0.1	11.2	0.2	0.3	0.0	0.2	0.2	0.1	0.3	0.3	0.1	2.0	0.0	0.2	1.0	0.4	1.2	6.9	0.3	0.0	0.4	0.3	0.0	0.3	0.1	3.4	5.1	0.3	0.0	0.4	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.5	0.0	0.4	15.9	0.0	0.6	3.8	2.9	0.4	5.7	9.8	5.5	0.0	0.0	0.2	0.9	1.9	0.2	0.2	13.4	1.1	0.5	8.4	0.0	0.0	0.9	0.1	0.2	4.6	20.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	22.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.2	0.7	0.4	0.0	0.5	0.2	26.4	13.0	3.3	0.0	0.4	0.6	3.3	0.7	1.4	0.0	0.0	0.3	0.1	1.5	1.0
RSPH1	"CILD24, FLJ32753, RSP44, RSPH10A, TSGA2"	ENSG00000160188	"Radial spoke head component 1"	Q8WYR4	21	42472486-42496246	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"fallopian tube: 162.9"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 857.0;Respiratory ciliated cells: 1058.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 3.0"	"Group enriched"	"Detected in some"	4	"MCF7: 11.0;OE19: 39.0;RPTEC TERT1: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016816, HPA017382"	Enhanced		Supported	Centrosome		NA	NA			Centrosome		"HPA016816: AB_1858393, HPA017382: AB_1858392"	"unprognostic (1.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.99e-1)"	0.2	3.5	18.8	0.8	12.7	0.3	2.1	13.4	11.9	6.7	25.9	4.0	7.6	5.4	17.2	0.9	162.9	3.0	0.1	10.8	18.1	5.3	0.6	14.3	0.3	17.6	20.1	9.1	1.3	3.2	5.1	26.1	0.1	19.6	3.2	3.7	12.5	1.4	3.3	0.7	3.6	5.7	1.0	18.4	0.2	5.3	31.1	13.2	1.5	8.0	0.1	0.3	1.5	0.8	15.1	1.6	1.2	0.1	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.4	0.1	0.5	0.0	0.4	1.9	0.0	0.5	0.0	0.2	0.1	5.4	0.5	0.0	0.0	0.1	0.2	0.3	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	11.0	0.1	0.2	0.3	39.0	0.5	0.0	0.4	0.0	15.4	1.3	2.5	0.9	2.4	3.7	0.3	0.0	4.2	0.4	0.2	0.0	0.1	0.1	0.0	0.4	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.1	0.1	18.8	12.7	13.4	11.9	10.8	18.1	17.6	20.1	9.1	19.6	18.4	13.2	15.1	0.4	0.0	6.2	6.5	0.9	5.1	4.5	64.6	2.8	13.3	7.2	5.8	0.6	24.3	107.1	18.4	37.5	0.1	2.9	10.5	39.2	12.6	73.9	857.0	6.2	1.3	9.0	0.0	11.5	3.8	0.0	2.7	4.6	13.9	0.0	0.4	0.0	0.2	0.1	3.3	5.9	13.5	61.1	0.0	0.0	113.4	1.8	0.9	0.0	0.0	1.0	19.9	0.0	0.5	0.3	1.9	11.2	2.6	0.8	9.5	21.4	15.7	1058.1	28.1	0.0	0.9	23.9	79.3	16.8	0.7	4.5	0.8	1.3	2.1	10.6	6.4
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head component 4A"	Q5TD94	6	116616479-116632985	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 17.6;fallopian tube: 37.5"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 92.4;Respiratory ciliated cells: 260.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 3.3;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.5"	"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.5	0.5	6.3	0.3	1.6	0.9	0.6	2.0	1.3	1.2	17.6	0.3	0.3	1.6	0.5	0.2	37.5	0.5	0.4	1.3	4.4	0.5	0.5	4.6	0.3	5.2	4.9	0.4	0.8	0.8	2.0	4.3	0.1	3.8	0.5	0.2	6.1	0.4	0.2	0.9	0.5	0.5	0.4	6.1	0.9	0.5	2.8	2.1	0.5	0.9	0.2	0.3	0.3	0.3	2.9	0.0	0.1	0.6	1.4	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.3	0.5	0.4	0.1	0.0	0.5	0.1	0.1	0.2	0.2	0.3	0.5	0.2	0.2	0.5	0.0	0.3	0.4	0.1	0.1	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.7	3.3	1.3	0.2	1.2	0.5	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	2.4	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.6	2.0	1.3	1.3	4.4	5.2	4.9	0.4	3.8	6.1	2.1	2.9	0.8	3.2	3.4	7.2	0.3	0.0	0.1	4.9	0.0	3.3	0.4	0.8	0.6	0.0	22.9	0.0	2.1	0.0	0.1	0.1	1.9	0.4	33.1	92.4	1.6	2.2	0.0	0.0	10.6	0.4	0.1	1.1	0.5	1.4	2.5	0.7	1.8	0.0	0.1	1.7	12.9	0.0	10.2	0.0	0.0	9.3	0.3	0.4	1.8	0.0	0.0	2.0	0.0	3.5	5.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	260.6	3.7	0.0	2.0	2.4	9.3	1.6	0.0	0.1	0.3	0.5	5.7	0.0	0.1
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777242-45851753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;fallopian tube: 3.1"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.5;ovarian cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.0	0.2	0.5	0.1	1.0	0.1	0.0	2.5	0.9	0.9	0.0	0.0	0.0	0.3	0.3	0.0	3.1	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.8	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.3	0.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	2.5	0.9	0.5	0.7	0.8	2.8	0.8	0.9	0.3	0.3	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	1.8	2.1	0.0	0.0	0.0	1.9	0.0	0.0	28.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295400	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.9;Syncytiotrophoblasts: 17.4"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	5.7	8.4	3.1	5.0	3.9	6.1	8.6	3.9	4.4	8.7	4.3	7.4	6.1	13.5	7.7	5.5	7.2	5.2	4.6	3.0	3.9	14.3	4.7	6.9	5.1	4.5	3.9	2.2	2.9	12.3	6.1	12.9	4.2	5.3	8.7	5.4	4.6	6.5	5.3	2.2	4.0	7.8	4.1	3.7	9.0	12.7	24.7	4.0	5.3	9.2	1.5	3.5	6.1	5.0	4.2	5.0	13.5	2.4	10.0	7.5	2.9	5.5	3.2	2.8	3.4	3.7	1.6	12.4	5.8	3.3	3.7	7.1	11.0	2.8	3.8	1.9	3.2	3.6	4.8	11.1	1.9	2.7	0.7	12.8	5.9	2.1	6.5	1.2	2.5	5.4	6.8	1.4	2.0	2.9	2.7	5.3	2.7	0.8	3.4	4.4	5.8	1.6	2.6	2.6	12.6	1.2	3.0	9.2	5.4	4.1	2.4	12.2	3.6	7.6	2.3	1.7	5.6	2.7	4.3	2.9	2.1	5.9	8.6	6.1	4.1	5.6	7.6	4.0	8.8	3.3	1.9	3.7	4.3	5.7	3.6	1.3	2.5	1.1	2.8	6.5	3.0	4.1	2.5	3.1	3.9	3.9	4.4	3.0	3.9	4.5	3.9	2.2	5.3	3.7	4.0	4.2	3.1	0.0	5.4	5.2	3.6	0.8	1.5	1.4	2.8	4.3	6.3	4.1	1.0	5.7	1.8	11.0	8.4	9.2	2.1	3.8	11.7	2.8	3.8	10.2	1.9	2.8	9.0	4.6	0.5	7.1	2.3	3.0	5.1	10.6	5.1	1.3	1.8	2.8	6.7	1.7	0.7	3.0	2.0	6.4	1.5	5.5	1.5	4.2	0.0	4.7	5.8	7.9	3.1	1.0	2.5	3.2	6.0	1.2	3.7	1.9	2.4	7.3	2.0	9.0	0.0	1.1	1.2	20.9	0.8	1.9	0.3	17.4	3.2	9.1	3.1	1.9
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.3;kidney: 21.7;stomach 1: 33.4;testis: 26.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.1	0.1	4.1	0.8	6.0	1.1	0.1	5.3	5.0	2.4	2.9	6.5	9.6	1.1	2.8	0.1	24.3	9.7	0.0	4.0	4.6	21.7	6.6	2.5	0.4	5.5	6.0	3.3	0.1	5.7	2.1	0.0	0.3	6.2	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.8	0.2	33.4	26.3	5.0	0.1	0.1	0.0	0.3	1.8	0.1	8.7	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	4.1	6.0	5.3	5.0	4.0	4.6	5.5	6.0	3.3	6.2	4.8	5.0	8.7	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SP9	ZNF990	ENSG00000217236	"Sp9 transcription factor"	P0CG40	2	174334954-174338500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.0"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 11.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.2;fHDF/TERT166: 5.5;HEK 293: 2.2;THP-1: 11.6"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.8;olfactory bulb: 11.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.6;olfactory bulb: 21.6"	HPA062616	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062616: AB_2684808"	"unprognostic (2.04e-2)"	"unprognostic (6.94e-3)"		"unprognostic (1.44e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.55e-3)"		"unprognostic (8.54e-2)"	"unprognostic (3.12e-1)"						"unprognostic (1.01e-1)"			0.0	0.0	2.5	0.0	3.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	7.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.5	0.0	0.1	0.2	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	0.0	2.8	0.6	0.9	1.3	0.3	1.2	0.7	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0
SPEF1	"C20orf28, CLAMP, DKFZP434I114, SPEF1A"	ENSG00000101222	"Sperm flagellar 1"	Q9Y4P9	20	3777504-3781448	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;choroid plexus: 12.8;fallopian tube: 11.6;testis: 12.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 104.7;Respiratory ciliated cells: 66.5;Rod photoreceptor cells: 22.4;Spermatocytes: 24.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.2;hTEC/SVTERT24-B: 1.1;MCF7: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050786	Enhanced					NA	NA					"HPA050786: AB_2681238"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.08e-3)"	"unprognostic (8.12e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.41e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.60e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (7.49e-2)"	0.0	0.3	5.4	0.0	7.6	0.0	0.1	3.3	4.5	1.0	12.8	0.1	0.0	0.4	0.5	0.0	11.6	0.0	0.2	4.8	6.5	2.1	0.1	2.8	0.0	6.3	6.0	3.0	0.4	0.6	0.3	2.9	0.0	4.9	0.2	0.0	2.1	0.1	0.1	0.0	0.1	0.0	0.0	7.1	0.0	0.1	12.5	4.1	0.0	1.7	0.0	0.0	0.1	0.0	3.2	0.9	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.4	0.3	0.0	0.4	0.6	0.0	0.5	0.0	0.0	0.3	0.1	0.4	0.1	0.1	0.0	0.1	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	7.6	3.3	4.5	4.8	6.5	6.3	6.0	3.0	4.9	7.1	4.1	3.2	0.3	0.0	0.0	2.3	0.1	0.4	0.1	3.5	0.0	1.5	1.5	1.1	0.4	0.0	9.9	3.7	16.7	0.1	0.1	0.1	5.9	1.2	5.5	104.7	1.0	0.4	0.0	0.0	16.7	0.2	0.2	0.3	0.0	1.7	0.0	0.2	0.7	0.2	0.2	0.0	6.6	0.0	4.1	0.0	0.0	4.1	0.3	0.3	0.0	1.9	0.0	2.6	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	7.3	66.5	22.4	0.0	0.3	1.5	24.9	2.8	0.0	0.1	0.1	0.3	0.2	0.3	0.1
SPINK9		ENSG00000204909	"Serine peptidase inhibitor Kazal type 9"	Q5DT21	5	148321203-148339852	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.6"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 16.0;Alveolar cells type 2: 27.9;Club cells: 14.9;granulocytes: 10.1;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.4;U-266/84: 26.9"					"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		24000	"Nucleoplasm, Vesicles"		"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.5	3.2	19.5	3.0	16.1	6.6	0.5	20.1	24.1	0.6	5.4	2.0	2.2	2.6	1.9	2.2	1.0	1.4	2.0	15.6	14.8	1.8	1.6	1.2	2.6	12.8	13.4	13.5	1.8	1.1	0.5	0.1	3.2	20.5	2.5	1.7	10.4	1.5	0.5	3.8	3.4	2.4	0.5	3.1	2.0	2.5	4.3	8.8	3.2	1.5	0.1	1.7	0.9	0.0	30.6	15.4	2.6	2.9	3.4	0.7	1.2	2.8	3.5	0.2	0.3	0.5	5.3	10.8	3.4	24.4	0.1	2.0	3.5	0.9	0.7	1.0	6.1	1.4	7.7	8.3	2.7	0.3	2.9	2.6	0.2	0.7	0.5	0.1	2.0	0.0	2.5	4.9	18.3	0.4	9.6	2.5	4.7	13.7	5.5	5.0	3.9	3.4	4.0	1.0	10.0	6.3	7.9	3.0	8.6	2.8	8.6	14.0	3.0	5.9	4.4	14.1	3.9	4.5	11.1	26.9	4.0	2.6	2.1	6.2	12.4	1.8	1.0	1.1	1.0	1.4	0.8	1.3	1.4	0.4	1.9	1.8	1.8	6.6	3.9	2.2	1.9	0.9	0.1	19.5	16.1	20.1	24.1	15.6	14.8	12.8	13.4	13.5	20.5	3.1	8.8	30.6	0.1	16.0	27.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.0	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.9	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.1	10.1	0.1	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	2.2	0.4	0.0	0.1	0.0	0.3	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.7	0.0	0.0	0.2
TCTE1	"D6S46, DRC5, FAP155, MGC33600"	ENSG00000146221	"T-complex-associated-testis-expressed 1"	Q5JU00	6	44278734-44297698	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 14.6;testis: 30.2"	"Group enriched"	"Detected in some"	10	"Early spermatids: 161.8;Late spermatids: 359.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;U-266/84: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031739			Uncertain	Vesicles		NA	NA			Vesicles		"HPA031739: AB_10601269"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.23e-5)"	"unprognostic (7.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.68e-1)"	0.2	0.2	3.1	0.0	1.4	0.9	0.2	6.4	1.5	0.6	1.0	0.2	0.0	0.4	0.2	0.1	14.6	0.1	0.0	1.4	1.0	0.1	0.1	1.4	0.0	2.6	2.4	0.9	0.5	0.1	0.0	0.5	1.9	2.8	0.2	0.1	1.0	0.2	0.1	0.1	0.5	0.2	0.1	3.3	0.2	0.1	30.2	1.4	0.1	0.1	0.2	0.0	0.1	0.2	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.4	6.4	1.5	1.4	1.0	2.6	2.4	0.9	2.8	3.3	1.4	1.2	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.7	0.0	1.1	0.1	0.1	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	161.8	7.3	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	359.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	16.0	0.2	0.0	0.4	0.3	23.9	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TCTEX1D4		ENSG00000188396	"Tctex1 domain containing 4"	Q5JR98	1	44805893-44807351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 17.8;fallopian tube: 10.3"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 94.5;Respiratory ciliated cells: 129.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 7.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.7;TIME: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062652	Enhanced					NA	NA					"HPA062652: AB_2684818"	"unprognostic (3.12e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.58e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.83e-3)"	0.7	2.0	2.1	1.2	1.5	2.5	0.4	1.7	2.2	0.8	17.8	0.3	0.4	1.4	2.2	0.7	10.3	1.8	0.6	0.9	4.8	0.6	0.6	2.8	0.3	4.9	3.2	0.3	0.4	0.9	0.4	0.9	0.1	2.5	0.3	0.2	0.0	1.1	0.3	0.4	0.5	0.5	0.1	3.3	0.4	1.0	0.4	3.3	0.0	0.9	0.2	0.0	0.4	0.3	4.0	0.5	0.9	0.3	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.4	0.7	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	1.1	0.0	0.1	0.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.2	0.5	0.9	0.0	0.0	1.8	0.1	0.7	0.2	0.3	0.7	0.4	0.0	0.2	0.2	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.2	2.1	1.5	1.7	2.2	0.9	4.8	4.9	3.2	0.3	2.5	3.3	3.3	4.0	0.2	0.0	0.5	0.0	0.3	0.3	0.4	11.4	0.0	0.0	0.6	0.8	0.2	1.5	10.6	1.8	0.0	0.2	0.1	0.9	0.0	1.2	0.0	94.5	0.9	0.4	0.0	0.0	0.0	4.0	0.2	0.4	0.0	1.5	0.0	0.2	0.0	1.2	0.8	0.0	0.0	1.7	10.2	1.2	0.9	0.1	0.3	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	2.4	0.0	0.0	0.4	2.3	1.3	129.4	0.0	0.0	0.8	3.8	0.1	0.6	0.0	0.0	0.3	0.3	0.5	0.6	0.5
TEKT1		ENSG00000167858	"Tektin 1"	Q969V4	17	6789133-6831761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 50.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 412.2;Endometrial ciliated cells: 173.1;Late spermatids: 146.2;Respiratory ciliated cells: 288.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 7.8"	"HPA044444, HPA062285"	Approved					NA	NA					"HPA044444: AB_10961038, HPA062285: AB_2684737"	"unprognostic (7.28e-3)"	"unprognostic (7.24e-3)"		"prognostic favorable (6.08e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.91e-1)"		"unprognostic (4.22e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.63e-6)"	"unprognostic (6.28e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.13e-1)"	0.0	0.0	4.6	0.0	1.8	0.6	0.0	2.4	1.2	0.9	8.1	0.0	0.0	1.2	0.3	0.9	50.9	1.0	0.5	1.5	5.0	0.0	0.2	4.6	0.3	5.2	4.2	0.5	0.3	0.0	0.0	0.8	0.0	4.0	0.0	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.1	5.8	0.1	0.1	10.0	2.2	0.1	0.3	0.0	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.8	2.4	1.2	1.5	5.0	5.2	4.2	0.5	4.0	5.8	2.2	4.3	0.1	0.0	1.5	2.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.5	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	412.2	173.1	1.5	0.2	0.0	0.0	1.9	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	18.3	0.0	0.0	146.2	2.8	0.3	0.0	0.0	0.0	1.0	0.0	1.5	1.1	0.0	0.0	0.7	0.0	0.2	0.0	0.1	288.1	0.0	0.0	0.0	5.3	38.2	3.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1
TEKT2	TEKTB1	ENSG00000092850	"Tektin 2"	Q9UIF3	1	36084094-36088275	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 63.3;testis: 71.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 523.7;Late spermatids: 306.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	8	"NB-4: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA027248, HPA027461"	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA027248: AB_1857884, HPA027461: AB_10600912"	"unprognostic (1.02e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-3)"	"unprognostic (5.28e-4)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (9.78e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.68e-2)"	0.1	0.5	5.1	0.1	2.4	1.5	1.0	2.8	2.6	2.2	10.3	0.5	0.1	1.5	0.1	0.2	63.3	0.1	0.1	2.2	3.5	2.3	0.1	6.3	0.1	3.9	4.6	1.7	0.5	2.4	0.7	4.3	0.0	3.5	0.7	0.0	0.2	0.4	0.6	0.0	0.2	0.2	0.4	4.7	0.0	0.4	71.7	2.6	1.1	2.7	0.0	0.0	0.1	0.3	3.3	0.0	0.0	4.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	37.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.1	2.4	2.8	2.6	2.2	3.5	3.9	4.6	1.7	3.5	4.7	2.6	3.3	0.2	0.0	0.0	0.0	0.2	0.1	0.6	9.4	0.0	0.0	0.8	0.6	0.6	0.0	8.0	1.8	0.0	0.2	0.0	0.0	0.0	0.9	523.7	81.2	0.8	0.4	1.8	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.1	12.2	0.0	0.0	306.1	5.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.1	0.0	3.8	0.0	0.4	0.0	2.5	84.7	0.1	0.0	0.0	2.6	27.6	4.0	0.0	0.0	0.0	0.2	0.4	0.1	0.5
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.5;intestine: 19.5;stomach 1: 15.1"	"Cell type enriched"	"Detected in many"	30	"Enteroendocrine cells: 1466.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Region enriched"	"Detected in some"	10	"midbrain: 21.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.5	0.1	0.3	1.2	0.4	1.1	1.3	0.3	0.4	0.5	4.2	9.1	10.2	0.9	0.9	0.2	0.9	0.1	0.3	0.4	2.1	0.3	0.2	0.8	0.5	0.3	21.5	0.3	0.7	0.5	0.1	3.1	0.2	0.5	1.5	19.5	1.8	0.5	0.1	0.4	1.5	11.3	0.2	0.2	0.7	15.1	0.9	0.6	0.4	0.5	0.1	0.7	0.4	0.4	0.4	0.1	0.0	0.5	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.0	0.7	0.3	1.1	0.0	1.5	0.3	0.0	0.6	0.0	0.2	0.1	0.2	0.8	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.1	0.4	0.1	0.5	0.0	0.1	0.3	0.0	0.3	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.3	0.4	0.4	2.1	0.3	21.5	0.3	0.5	0.2	0.6	0.4	1.4	0.0	0.0	1.0	1.1	0.4	0.4	0.5	0.0	14.9	1.9	1.0	0.8	0.0	0.1	5.5	2.1	0.2	0.6	1.7	0.0	0.2	0.8	0.1	0.6	0.7	1466.7	0.4	0.5	0.6	0.0	1.2	2.0	0.2	0.0	5.6	0.4	0.2	0.2	1.7	0.4	48.2	0.0	0.3	1.4	0.8	0.9	0.5	0.0	0.0	0.1	1.4	1.0	0.0	0.6	0.4	13.4	1.2	0.3	2.3	1.5	0.3	0.9	5.6	6.6	1.3	1.3	2.8	3.7	0.0	1.4	0.0	1.2	0.0	2.7	0.4
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 866.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 61.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 65.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		43000	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	42.3	27.4	246.3	8.1	187.4	1.0	81.9	195.1	227.4	46.5	150.6	77.5	23.9	29.6	9.7	100.2	866.0	22.1	58.2	177.3	237.5	59.6	4.5	149.3	4.5	227.5	212.4	149.8	8.7	24.1	13.7	41.0	79.1	216.2	19.1	14.2	9.7	39.8	13.4	72.8	169.2	38.3	21.6	223.5	17.8	44.0	15.5	199.5	4.7	18.6	56.2	9.2	33.1	36.8	289.0	0.4	59.9	0.6	0.4	0.4	9.4	0.2	1.7	0.4	0.4	0.9	3.9	12.0	0.0	0.9	0.8	0.2	11.3	9.2	0.0	0.1	0.0	3.5	0.0	1.5	1.7	0.1	0.0	0.0	2.4	0.3	3.6	0.0	1.8	0.6	0.0	0.1	0.0	5.4	0.3	0.0	0.2	1.9	40.8	0.0	0.0	31.1	0.2	0.0	0.0	47.8	20.7	0.0	0.1	2.4	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.9	0.0	25.4	12.4	0.0	37.6	0.2	0.0	0.0	0.0	33.1	0.1	0.0	0.0	5.8	0.0	65.8	0.3	0.0	9.4	246.3	187.4	195.1	227.4	177.3	237.5	227.5	212.4	149.8	216.2	223.5	199.5	289.0	14.7	16.0	129.8	17.0	0.2	303.9	8.8	92.5	5.7	3.8	5.9	5.0	4.1	30.0	160.4	18.4	4.2	8.3	0.2	28.4	5.9	166.8	60.1	962.0	30.9	31.6	177.9	0.0	0.5	1.8	4.3	141.9	7.1	14.7	25.4	1.0	5.0	0.1	2.9	0.0	0.7	65.1	132.2	3.8	82.5	23.7	29.2	13.7	501.6	1.0	10.7	68.7	1.0	1.0	30.0	8.4	39.7	3.4	0.0	5.6	29.8	0.9	1825.2	8.9	236.7	259.3	163.7	8.1	5.8	1.6	495.3	80.0	5.5	0.8	27.3	10.1
TSNAXIP1	TXI1	ENSG00000102904	"Translin associated factor X interacting protein 1"	Q2TAA8	16	67806765-67832148	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.7;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 99.9;Endometrial ciliated cells: 41.1;Late spermatids: 178.6;Respiratory ciliated cells: 51.9;Spermatocytes: 53.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.0;SiHa: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA053516			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053516: AB_2682175"	"unprognostic (9.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.59e-3)"	0.4	1.0	2.0	0.4	1.4	0.1	0.6	1.1	1.8	1.1	2.6	0.7	0.0	0.9	0.9	0.3	8.7	0.4	0.3	1.6	1.5	1.2	0.8	1.3	0.1	1.9	2.3	1.0	1.5	1.2	1.3	6.5	0.1	1.7	0.9	0.1	3.5	0.3	0.4	0.2	0.2	0.3	0.4	1.7	0.3	0.5	21.7	1.3	0.2	0.7	0.0	0.1	0.6	0.5	1.3	0.5	0.1	1.1	3.0	1.4	0.4	0.4	0.1	0.7	0.2	1.0	0.3	0.3	0.4	0.4	0.1	0.3	0.6	0.3	0.4	0.6	0.1	0.4	0.0	0.4	0.0	0.4	0.7	0.0	0.3	0.4	1.4	0.2	0.2	0.0	0.6	0.2	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.8	0.3	0.0	1.3	0.3	0.8	1.0	2.0	0.0	0.2	0.3	0.8	0.0	0.3	0.1	0.0	0.3	0.1	0.5	1.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	1.1	1.8	1.6	1.5	1.9	2.3	1.0	1.7	1.7	1.3	1.3	0.6	0.0	2.7	9.1	0.2	0.1	0.4	2.5	0.6	2.9	1.0	1.1	12.0	0.0	4.8	5.5	4.2	0.4	0.2	0.2	0.0	0.7	99.9	41.1	2.0	1.1	0.0	0.4	7.9	0.0	0.2	1.6	0.0	1.3	0.0	1.3	0.7	0.7	0.3	3.3	4.9	0.0	10.2	0.0	0.2	178.6	2.8	0.3	0.0	3.7	0.0	3.7	0.0	3.0	1.3	0.1	0.0	1.9	0.0	0.3	0.0	2.5	51.9	10.2	6.6	0.6	1.7	53.3	8.9	0.1	0.3	0.5	0.2	1.4	0.0	0.2
TTC29	NYD-SP14	ENSG00000137473	"Tetratricopeptide repeat domain 29"	Q8NA56	4	146706617-146945882	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"fallopian tube: 20.2;testis: 72.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 697.9;Late spermatids: 445.9;Respiratory ciliated cells: 97.7;Spermatocytes: 157.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;hTERT-HME1: 1.4;U-266/70: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037006, HPA061473"	Uncertain					NA	NA					"HPA037006: AB_10670379, HPA061473: AB_2684534"	"unprognostic (1.28e-3)"			"unprognostic (1.52e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.70e-1)"		"unprognostic (6.70e-2)"		"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.67e-4)"	"unprognostic (9.81e-4)"	"unprognostic (7.30e-2)"	"unprognostic (6.88e-4)"		0.1	0.0	3.4	0.0	0.9	0.0	0.1	1.4	0.5	0.4	3.8	0.0	0.0	0.3	2.2	0.0	20.2	0.0	0.0	1.0	3.0	0.2	0.0	2.0	0.0	3.3	3.3	0.1	0.0	0.0	0.7	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	72.5	1.3	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	1.4	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	1.4	0.5	1.0	3.0	3.3	3.3	0.1	2.8	4.6	1.3	2.2	0.2	0.0	1.8	7.8	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	697.9	48.9	0.3	0.7	0.0	0.0	5.3	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	2.0	0.0	0.0	445.9	7.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	4.9	0.0	0.1	0.0	0.1	97.7	0.0	0.0	0.0	1.4	157.6	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TTLL10	"FLJ36119, TTLL5"	ENSG00000162571	"Tubulin tyrosine ligase like 10"	Q6ZVT0	1	1173880-1197936	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 10.7;fallopian tube: 10.8;testis: 42.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 244.1;Late spermatids: 768.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.5;endometrial cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"SCLC-21H: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042712	Uncertain					NA	NA					"HPA042712: AB_10797019"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.66e-3)"	"prognostic favorable (1.61e-5)"	"unprognostic (5.33e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.14e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.00e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.39e-2)"	1.3	0.0	2.5	0.1	0.7	0.0	1.1	0.7	0.5	0.9	10.7	0.1	0.1	0.2	0.4	0.3	10.8	0.3	0.1	0.9	1.4	0.3	0.0	2.9	0.1	1.9	2.1	0.0	0.0	0.3	0.0	2.1	1.5	1.7	0.3	0.1	0.0	0.3	0.1	0.4	0.2	0.2	0.0	2.5	0.1	0.5	42.2	0.9	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.5	0.7	0.7	0.5	0.9	1.4	1.9	2.1	0.0	1.7	2.5	0.9	0.6	14.4	0.0	0.5	0.0	0.3	1.8	0.7	3.0	0.0	0.1	1.4	1.0	0.8	1.5	3.4	0.0	2.1	0.0	0.9	0.9	0.0	0.5	244.1	52.2	0.6	2.1	0.0	0.0	0.2	1.3	1.0	0.3	3.6	6.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	3.1	0.0	0.0	1.1	768.4	5.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.5	1.0	4.5	0.0	1.5	0.4	0.1	72.5	0.1	6.6	0.9	1.0	9.3	2.1	1.0	2.0	0.1	0.9	0.0	3.6	1.3
UCMA	"C10orf49, GRP"	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221766-13234374	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;ovary: 1.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"	NA	NA		20000			"HPA046718: AB_2679771"															"unprognostic (4.25e-1)"			0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.0	2.7	0.2	1.1	1.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.2	0.7	0.2	0.2	2.7	0.2	1.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0
VAX2	DRES93	ENSG00000116035	"Ventral anterior homeobox 2"	Q9UIW0	2	70900576-70965373	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.2;retina: 11.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.5;Cone photoreceptor cells: 16.7;Horizontal cells: 11.8;Muller glia cells: 7.6;Rod photoreceptor cells: 19.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 4.7;MCF7: 5.6;RH-30: 4.6;SCLC-21H: 4.6;SH-SY5Y: 5.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.2"	HPA009708			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA009708: AB_2668261"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.74e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.65e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.18e-2)"	1.0	0.4	1.7	0.1	0.9	0.0	1.2	5.2	1.7	0.8	0.4	0.5	0.0	1.1	0.0	0.4	0.7	0.0	0.6	1.8	1.7	0.4	0.0	0.5	0.0	0.8	1.0	0.6	0.7	1.2	0.2	0.9	0.2	2.7	0.7	0.0	11.2	0.8	0.0	0.5	1.1	0.3	0.3	0.6	0.0	0.2	0.2	1.6	0.0	0.2	0.1	0.0	0.5	0.4	0.8	1.5	3.6	0.8	4.7	1.2	0.7	2.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	1.8	0.0	0.1	0.0	3.0	0.0	0.0	2.1	0.6	0.0	0.0	1.2	0.0	0.2	0.0	1.3	0.4	0.2	0.0	0.0	1.8	5.6	0.0	0.0	2.0	0.0	0.0	0.0	4.6	0.0	1.5	1.2	4.6	5.6	3.7	0.0	2.1	0.1	2.1	0.2	0.9	2.2	0.5	1.1	0.9	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.9	5.2	1.7	1.8	1.7	0.8	1.0	0.6	2.7	0.6	1.6	0.8	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	9.5	1.4	1.4	0.1	0.0	0.1	0.0	16.7	0.1	0.1	0.2	1.9	1.2	0.1	0.0	0.1	1.5	0.0	0.0	0.6	0.6	0.4	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	11.8	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.0	4.2	7.6	0.0	2.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.5	0.0	0.8	0.8	0.0	0.2	0.0	0.0	0.1	0.1	0.8	0.1	0.0
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 22.5;testis: 30.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 467.1;Late spermatids: 995.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 7.1"	"Low region specificity"	"Detected in all"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	3.7	0.0	1.9	0.0	0.0	1.9	0.8	0.5	4.0	0.1	0.0	0.2	0.0	0.0	22.5	0.0	0.0	1.1	3.4	0.0	0.0	2.5	0.0	5.6	4.5	0.2	0.2	0.0	0.0	0.2	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1	30.2	2.5	0.7	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.9	1.9	0.8	1.1	3.4	5.6	4.5	0.2	3.6	6.5	2.5	2.9	0.3	0.0	1.1	11.8	0.1	0.3	1.7	2.2	0.0	1.0	0.1	0.3	0.9	0.0	12.1	1.8	31.3	0.0	0.0	0.8	0.0	0.0	467.1	53.8	0.6	0.6	1.8	0.0	1.9	0.4	0.2	0.8	4.6	1.6	0.0	0.1	1.1	0.0	0.2	0.0	1.0	2.8	6.1	0.0	0.8	995.9	4.7	0.7	0.0	3.7	0.6	0.7	0.0	1.5	0.7	0.2	2.7	5.7	0.2	0.4	0.2	0.0	124.5	0.5	0.0	0.5	1.0	17.6	6.0	0.0	0.4	0.0	0.1	0.2	1.0	0.8
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.1;brain: 17.0"	"Group enriched"	"Detected in some"	7	"Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9;pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 31.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.9"	"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507"	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.0	41.1	8.7	0.0	2.2	0.1	0.0	0.8	17.0	0.4	0.0	0.3	1.9	0.2	0.1	0.0	1.3	0.0	0.0	7.4	1.8	0.1	0.0	0.1	0.0	8.0	0.9	2.9	0.4	5.7	1.4	8.4	0.0	5.9	0.5	0.3	0.2	0.6	2.5	0.0	0.0	1.2	0.0	0.1	0.0	2.9	1.0	3.6	0.0	0.3	0.0	0.0	0.1	0.1	7.2	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.9	0.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.3	0.0	0.0	31.7	2.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	2.2	0.8	17.0	7.4	1.8	8.0	0.9	2.9	5.9	0.1	3.6	7.2	0.4	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	7.6	0.1	0.1	112.4	0.0	39.2	0.2	0.0	0.0	6.1	0.8	0.0	0.2	1.1	0.0	0.2	3.3	29.2	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	1.7	0.2	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1
WDR38		ENSG00000136918	"WD repeat domain 38"	Q5JTN6	9	124853417-124857890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"fallopian tube: 78.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 26.9;Endometrial ciliated cells: 93.3;Late spermatids: 92.6;Respiratory ciliated cells: 127.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 12.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056607			Approved	Vesicles		NA	NA			Vesicles		"HPA056607: AB_2683188"	"unprognostic (5.66e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.01e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.42e-2)"	0.0	0.0	5.3	0.0	2.5	0.0	0.0	3.9	1.3	1.3	13.6	0.0	0.0	0.7	0.0	0.0	78.4	0.0	0.1	1.9	6.5	0.1	0.0	5.2	0.0	6.9	7.6	0.8	0.0	0.0	0.0	0.3	0.0	6.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	7.9	0.0	0.0	7.6	3.6	0.1	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	2.5	3.9	1.3	1.9	6.5	6.9	7.6	0.8	6.1	7.9	3.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.9	93.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	0.0	0.0	92.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	127.9	0.0	0.0	0.0	2.8	1.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2
WFDC6	"C20orf171, dJ461P17.11, WAP6"	ENSG00000243543	"WAP four-disulfide core domain 6"	Q9BQY6	20	45534196-45539482	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 253.1"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 34.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.9;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-87 MG: 2.6"														"Secreted in male reproductive system"	NA	NA						"unprognostic (3.68e-3)"			"unprognostic (2.21e-3)"				"unprognostic (1.26e-2)"		"unprognostic (8.74e-2)"					"unprognostic (2.91e-2)"			0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.2	253.1	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
WNT7A	Wnt-7a	ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880071	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;gallbladder: 2.3;placenta: 2.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2;ovarian cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.0	0.0	3.5	0.1	3.1	0.1	0.0	1.0	3.7	0.2	0.4	0.0	0.0	1.1	0.2	0.4	0.1	2.3	0.0	2.3	2.3	0.2	0.0	2.0	0.2	5.0	1.8	3.3	0.0	0.1	0.0	0.0	2.7	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	3.2	1.3	0.0	1.3	2.0	0.0	0.0	0.0	0.1	0.3	0.1	2.7	8.6	0.0	0.8	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	7.6	0.0	56.0	0.0	0.1	11.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	1.7	100.3	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.5	3.1	1.0	3.7	2.3	2.3	5.0	1.8	3.3	2.5	3.2	2.0	2.7	0.0	12.8	0.0	8.5	0.0	5.9	2.8	2.6	0.0	0.0	0.0	0.0	0.7	8.6	1.4	0.0	0.0	68.7	0.0	0.0	0.0	13.8	17.3	14.5	0.4	0.6	0.0	0.0	4.0	9.1	147.5	0.4	0.0	17.9	0.0	0.0	0.0	0.0	7.4	0.0	2.4	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	1.0	0.0	0.0	0.0	4.5	0.3	98.8	0.0	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	6.0	2.3	0.0	1.3	185.7	1.5	0.0	0.0	6.0
ZBBX	FLJ23049	ENSG00000169064	"Zinc finger B-box domain containing"	A8MT70	3	167239843-167407874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 13.7;choroid plexus: 24.1;fallopian tube: 23.4;testis: 36.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 423.4;Endometrial ciliated cells: 107.4;Excitatory neurons: 80.1;Late spermatids: 232.4;Respiratory ciliated cells: 226.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036327, HPA036328"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036327: AB_10672240, HPA036328: AB_2675063"	"unprognostic (2.68e-3)"	"unprognostic (4.49e-2)"		"unprognostic (6.94e-2)"	"unprognostic (3.99e-1)"			"unprognostic (4.08e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"		0.0	0.2	11.7	0.0	2.7	0.0	0.0	2.9	2.9	0.4	24.1	0.0	0.0	0.8	0.1	0.0	23.4	0.0	0.0	2.0	7.8	0.2	0.0	3.5	0.0	12.6	9.5	0.7	0.0	0.0	0.3	2.0	0.0	6.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	36.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	2.7	2.9	2.9	2.0	7.8	12.6	9.5	0.7	6.4	13.7	2.7	6.5	0.0	0.0	1.1	7.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	25.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	423.4	107.4	0.6	0.6	0.0	0.0	80.1	0.0	0.0	0.5	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	23.8	0.0	6.1	0.0	0.0	232.4	1.5	0.4	0.0	1.9	0.0	0.0	0.0	4.5	1.1	0.1	0.0	1.5	0.0	0.1	0.0	0.2	226.2	0.0	0.0	0.0	1.2	37.4	11.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1
ZMYND10	"BLU, CILD22, DNAAF7"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50345732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"fallopian tube: 121.2;testis: 260.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 309.4;Endometrial ciliated cells: 221.8;Late spermatids: 415.3;Respiratory ciliated cells: 390.8;Spermatocytes: 529.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 5.6;U-87 MG: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035255			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.3	0.1	9.6	0.2	4.9	0.7	1.1	6.5	3.2	2.9	24.4	0.2	0.2	1.7	1.7	0.2	121.2	0.5	0.2	3.5	15.0	2.0	1.0	11.2	0.2	10.9	11.0	1.9	0.6	1.1	3.8	6.0	0.1	9.1	0.7	0.1	3.3	0.3	0.4	0.4	0.5	0.4	0.5	11.8	0.7	0.3	260.5	5.8	0.5	1.9	0.2	0.1	0.2	0.3	9.6	1.6	0.6	0.2	0.5	0.6	0.9	0.3	0.2	0.9	1.6	0.5	0.0	1.0	0.7	0.6	1.0	0.2	0.2	1.5	0.0	0.1	0.4	0.6	1.5	1.2	0.0	0.0	0.5	0.8	0.0	0.1	2.0	0.1	1.5	0.1	1.3	0.5	0.1	0.2	1.0	0.3	2.7	0.0	0.2	0.7	0.7	0.0	0.5	2.0	0.0	1.8	0.5	0.1	0.5	0.0	0.0	5.6	0.6	0.0	0.3	0.4	0.9	0.1	1.0	0.4	0.1	3.9	2.2	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	9.6	4.9	6.5	3.2	3.5	15.0	10.9	11.0	1.9	9.1	11.8	5.8	9.6	0.5	3.2	5.1	1.3	0.7	0.5	0.4	24.2	1.2	1.2	2.3	1.7	0.8	0.0	33.1	1.8	4.2	0.1	1.7	0.2	0.0	1.1	309.4	221.8	2.4	1.2	0.0	3.2	0.5	0.0	0.2	1.1	0.0	3.6	0.0	0.3	0.7	0.4	0.6	0.0	0.3	0.7	22.4	0.0	0.4	415.3	9.0	1.3	1.8	1.0	0.9	1.2	2.1	0.5	1.3	0.1	0.0	5.7	0.9	0.6	0.0	1.0	390.8	7.6	0.0	0.9	9.8	529.7	9.1	1.1	0.4	0.1	1.7	0.2	0.3	0.1
